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1.1 Introduction 
Circa 80% of the world’s energy supply is currently provided by fossil feedstocks.1 
Additionally, the total energy demand is expected to have increased by approximately one-
third in 2035 compared to 2011.2 If we continue spending our fossil feedstocks at the current 
pace, it is close to certain that they will become fully depleted within one century. It is 
therefore of utmost importance to explore alternative resources for the fossil feedstocks. 
Besides the fact that the majority (ca. 90%) of the fossil feedstocks are currently used for 
energy purposes, approximately 10% is used by the chemical industry as its main resource for 
producing chemicals. Thus, also from a chemical point of view, it is of crucial importance to 
start investigating alternative feedstocks. 
Sunshine most likely is the best alternative for fossil feedstocks to fulfill our energy demands, 
because this resource is widely abundant and can provide sufficient energy to supply our 
demands in the long run. The most obvious way in which this can be achieved is by direct 
conversion of solar energy into electricity using photovoltaic devices. However, other 
alternative resources that are considered potential substitutes for fossil feedstocks (i.e. wind 
energy, hydropower, direct water splitting and biofuels) are actually also powered by the sun, 
albeit indirectly via processes such as surface heating, evaporation of water or photosynthesis. 
These natural resources are converted into electricity relatively easy and are therefore directly 
applicable in our existing energy supply chain.  
Substituting fossil feedstocks with solar resources for the production of chemicals is 
somewhat more complicated. The energy that is radiated by the sun should then be used to 
drive the transformation of low-energy molecules into compounds that can be used as starting 
materials for the (petro)chemical industry. To achieve this, we may learn from Nature since 
plants convert CO2 into glucose via photosynthesis to fulfill their energy demand. Similar to 
photosynthesis, artificial conversion of CO2 can give access to compounds that are highly 
useful for the chemical industry. For example, hydrogenation of CO2 can lead to methane, 
methanol or CO, of which the latter forms syngas with H2 and can as such be employed in the 
Fischer–Tropsch synthesis or in hydroformylation to obtain hydrocarbons. Albeit that these 
processes are conceivable, it remains difficult to compete with the widely abundant plant-
based resources that rely on photosynthesis. Renewables from biomass are therefore 
considered of high potential and of great importance as future substitutes for fossil feedstocks. 
On the other hand, producing renewables from biomass has significant disadvantages. The 
raw material for example is rather bulky and hence transportation is expensive. This brings 
extra costs in decentralizing and increasing the number of processing sites.  
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Figure 1.1 Different pathways for the conversion of non-food biomass. 
Biomass, in particular the lignocellulosic feedstocks, can be processed following different 
pathways as is delineated in Figure 1.1. The raw material can be either converted into syngas 
or into small molecules via pyrolysis or gasification. Although these small molecules can be 
directly fed into the current chemical production lines, it is obviously not efficient to break 
down medium-sized molecules that are subsequently used as starting material for the 
production of other medium-sized compounds. The more complex structural features found in 
Nature could be more beneficially used when the raw biomass material would be converted 
into lignin, hemicellulose and cellulose by means of biochemical conversion. Subsequent 
transformation of these three main ingredients into medium-sized chemical intermediates 
would then give rise to new feedstocks for the chemical industry. However, these feedstocks 
are significantly different from the fossil feedstocks and new chemical and catalytic 
methodologies are therefore required in order to efficiently convert them into the desired 
products. 
In order to satisfy these demands, several Dutch universities jointly with the chemical 
industry and the government initiated the CatchBio program, which aims at the catalytic 
conversion of components that are present in biomass into useful fuels, chemicals and 
pharmaceuticals.3 The research described in this thesis was performed within the CatchBio 
framework aiming at the development of methodology for the synthesis of pharmaceutically 
relevant building blocks from biomass, in particular focusing on strategies that would involve 
new catalytic reactions or turning stoichiometric processes into catalytic ones. Additionally, 
introduction of nitrogen atoms, again preferentially in a catalytic manner, was a focus 
considering the importance of nitrogen atoms in drugs. 
non-food biomass
(second generation, lignocellulose)
biochemical conversion
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thermochemical
conversion
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With these prerequisites in mind, we initially focused on iron-based catalysis to prepare 
enantiomerically pure amines from biomass-derived starting compounds. Iron is 
environmentally benign, non-toxic and the most abundant metal on our planet and therefore 
cheap. Because of these properties, iron offers obvious advantages over other transition 
metals and it is therefore not surprising that iron catalysis has gained popularity during the 
past decade. Although a variety of different reactions have been successfully catalyzed by 
iron, the majority of these reactions concern iron-catalyzed oxidation or cross-coupling.4 
Interestingly, iron is less often employed as a Lewis acid and even to a lesser extent as an 
enantiodirective Lewis acid by combining with optically active ligands. It has nevertheless 
been shown that iron-based optically active complexes can direct the addition of nucleophiles 
to carbonyl groups and enones.5 However, there is only limited precedent on the asymmetric 
activation of the corresponding nitrogen analogues, i.e. imines, by chiral iron-based Lewis 
acids.6,7  
 
Scheme 1.1 Aza-Diels–Alder reaction by Whiting et al. and ligands L1–6. 
As an example, Whiting and co-workers showed that the aza-Diels–Alder reaction of 
Danishefsky’s diene (1) and imine 2 was successfully catalyzed by FeCl3 in combination with 
BOX-ligand L1 (Scheme 1.1).6 Since the authors performed a combinatorial screen on the 
reaction between these specific substrates by varying the metal salt, ligands and additives, we 
were interested in reacting a wider range of substrates under similar conditions using FeCl3. 
In this fashion, the scope may be extended and might ultimately lead to the reaction of imines 
that are derived from biomass e.g. upon condensation with lignocellulosic aldehydes. In our 
attempts to reproduce the results of Whiting, we were indeed able to obtain the desired 
products, however, in lower yields and importantly without any ee. Our findings were 
supported by a corrigendum on the initial paper by Whiting stating that they unable to 
reproduce their initial results and that the FeCl3-catalyzed experiments in fact did not even 
give any ee at all.8 
Me3SiO
OMe
N PMP
MeO2C H
+
NN
O O
MeMe
R R
L1, R = t-Bu
N
NN
O O
R R
PPh2N
O
t-Bu
N
O
CO2Me
PMP
FeCl3 (10 mol %)
L1 (10 mol %)
4 Å MS
67%
1 2 3
92% ee
R
R
L2, R = Ph
L3, R = i-Pr
L6L4, R = OH
L5, R = PPh2
Introduction 
 
13 
 
Scheme 1.2 Iron-catalyzed aza-Diels–Alder reactions of diene 1 and imines 4a–e. 
Nevertheless, we pursued investigations to identify a suitable iron-based catalyst for the 
enantioselective reaction of Danishefsky’s diene (1) with different imines. Initially, different 
combinations of iron(II) and iron(III) salts with ligands L1–6 (Scheme 1.1) were screened in 
the reaction of diene 1 with imines 4a and b and although the targeted piperidinones 5a and b 
were formed, the ee of the products did not exceed 0% (Scheme 1.2). Kobayashi and co-
workers showed that imine 4c could be activated using a chiral iron-based Lewis acid for the 
addition of a silyl ketene acetal.7 Most likely, the o-hydroxyl group participates in forming a 
bidentate complex with the metal center and thereby creates the desired asymmetric 
environment around the electrophilic reaction site. However, when 4c was reacted by us with 
Danishefsky’s diene (1) in the presence of FeCl3 and t-Bu-BOX ligand L1, the reaction 
proceeded in moderate yield, but the enantioselectivity remained absent. Reacting related 
imines 4d and 4e, which could also coordinate to the iron ion in a bidentate fashion, gave the 
same unsatisfactory results. 
 
Scheme 1.3 Iron-catalyzed asymmetric conjugate addition of thiophenol to enone 6. 
Discouraged by our results on the activation of imines using chiral iron complexes, we 
continued by investigating iron-catalyzed asymmetric conjugate additions. It is known from 
previous reports that enone 6 (Scheme 1.3) can form active bidentate complexes with iron in 
situ, which can enantioselectively undergo Diels–Alder reactions9 and conjugate additions.10 
Kawatsura and co-workers showed that the enantioselective conjugate addition of thiophenol 
to enone 6 is catalyzed by the Fe(BF4)2 complex with i-Pr-PyBOX ligand L3. Inspired by this 
work, we envisioned exploring iron-catalyzed asymmetric conjugate additions of allylsilanes 
to enone 6. However, despite the fact that multiple combinations of iron sources and ligands 
were examined, we failed in finding a combination of reactants that would give the desired 
enantioselectivity. Due to the lack of ee and therefore a starting point for further optimization 
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studies, it was decided to abandon iron catalysis at this stage as was also agreed by the 
industrial partners that were involved in this project. 
In order to continue to pursue the synthesis of enantiopure amine-containing building blocks, 
we set out to investigate the proline-catalyzed asymmetric Mannich, a reaction that was 
previously studied in our group. The aim was to concentrate our efforts on expanding the 
scope of this reaction, ideally by employing renewables from biomass. For the selection of 
biomass-derived substrates, the NREL (National Renewable Energy Laboratory) report, 
presenting a top 30 list of potential platform chemicals for a biobased economy, was used as a 
starting point.11 From this list, furfural particularly attracted our attention because of its 
compelling combination of a furan ring and an aldehyde in a single molecule. Furfural is 
produced via acidic hydrolysis of hemicellulose and besides the fact that approximately 65% 
of total production capacity is converted into furfuryl alcohol, furfural itself is commonly 
used as extractant in the production of lubricating oils. From a synthetic point of view, the 
furan ring can be easily oxidized giving access to carboxylic acids upon the action of ozone or 
to six-membered heterocycles via an (aza-)Achmatowicz reaction. The latter reaction would 
be ideal for the preparation of the targeted heterocyclic building blocks and therefore we 
started investigating the synthesis of the required enantiomerically pure furanyl amines and 
their aza-Achmatowicz products. 
1.2 Outline 
Chapter 2 contains a comprehensive literature overview of the aza-Achmatowicz reaction and 
its applications. The aforementioned plan to use the organo-catalyzed Mannich reaction for 
the preparation of enantiomerically pure aza-Achmatowicz substrates was brought to practice 
in Chapter 3. Additionally, this chapter contains the results of the subsequent aza-
Achmatowicz reactions and the functionalization of the resulting piperidinones via N-
acyliminium ion chemistry. Our findings on the syntheses of pharmaceutically relevant 
bicyclic scaffolds are described in Chapters 4 and 5. More specifically, the synthesis of 
bicyclic N,O-acetals is delineated in Chapter 4, while Chapter 5 shows the synthesis of an 
aza-tropane analogue via a similar procedure. Finally, Chapter 6 highlights the application of 
the methodology described in Chapter 3 in a total synthesis of the naturally occurring alkaloid 
(−)-sedacryptine and two of its epimers. 
1.3 References 
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2.1 Introduction 
The furan moiety can be considered as a masked carboxylic acid, which is accessible through 
ozonolysis1 or oxidation with RuCl3/NaIO42. This methodology has especially proven its 
value in the synthesis of non-natural amino acids starting from α-furanyl amines. 
Additionally, Achmatowicz Jr. showed in 1971 that furanyl alcohols are excellent precursors 
for pyranones by means of reaction with bromine in MeOH.3 Shortly after, Lefebvre et al. 
reported the use of m-CPBA as an oxidant to accomplish the same transformation.4 When 
furfuryl alcohol is reacted with methanolic bromine or NBS, bromonium ion 2 is formed, 
which is subsequently opened by methanol to form a cis/trans-mixture of the relatively stable 
and hence isolable acetal 6 (Scheme 2.1). Subsequent acidic hydrolysis initiates the formation 
of cis-dicarbonyl alcohol 7, which immediately forms hydroxy pyranone 8 upon ring-closure. 
 
Scheme 2.1 Achmatowicz reaction mechanism with Br2/MeOH. 
The reaction following the Lefebvre protocol commences with epoxidation rather than 
bromination of the furanoid resulting in intermediate 9, which instantaneously opens to form 
the identical keto-aldehyde intermediate 7 as in the reaction with bromine. Again, subsequent 
hemiacetal formation results in the pyranone 8. 
 
Scheme 2.2 Achmatowicz reaction with m-CPBA following the Lefebvre procedure. 
It was anticipated that the Achmatowicz reaction could also be an effective method for the 
preparation of piperidines from α-furanyl amines. In 1955, Clauson-Kaas had already 
described that the anionic oxidation of furfuryl amine 10 results in the formation of 3-
hydroxypyridine 14 (Scheme 2.3).5 He postulated that this reaction proceeded via cis-
dicarbonyl amine intermediate (13), which is the aza-analogue of intermediate 7 that was 
described by Achmatowicz Jr. However, the putative aza-Achmatowicz product appeared to 
be unstable and immediately aromatized to form the pyridine product. Nevertheless, this 
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reaction has shown its value in the synthesis of substituted pyridines6 such as pyridoxine (15, 
vitamin B6).6a 
 
Scheme 2.3 Synthesis of pyridine 14 and the structure of pyridoxine (15) by Clauson-Kaas et al. 
In 1986, Ciufolini and Wood disclosed an elegant solution to circumvent aromatization of the 
aza-Achmatowicz product by hydrogenation of the relatively stable bismethyl ether 
intermediates 17a–c (Scheme 2.4).7 Hydrolysis of the resulting tetrahydrofurans 18a–c with 
triflic acid afforded the targeted bicyclic piperidinones 19a–c as stable products after 
purification by column chromatography. By having established a methodology for the 
synthesis of piperidinones 19a–c starting from α-furanyl amines 16a–c, the paper by 
Ciufolini and Wood is nowadays considered the first example of an aza-Achmatowicz 
reaction, albeit that a three-step procedure is required to obtain the desired piperidinones. 
 
Scheme 2.4 Three-step aza-Achmatowicz procedure by Ciufolini and Wood.8 
During their work on the kinetic resolution of racemic N-tosylated α-furanyl amines using the 
Sharpless asymmetric epoxidation reaction, Zhou and co-workers showed that when 20 was 
reacted under the Lefebvre conditions (i.e. m-CPBA in CH2Cl2), the corresponding 
piperidinone 21 was directly obtained as a stable product that could be purified by 
chromatography over silica gel (Scheme 2.5).9 Furthermore, compound 21 was obtained as a 
single diastereoisomer and was initially assigned being the 2,6-trans isomer. However, 
Speckamp and co-workers showed that the stereochemistry could not be unequivocally 
assigned using NMR analysis by measuring the J-couplings of the relevant protons.10 
Extensive analysis of the stereochemistry by Zhou11 and Padwa12 later revealed that the 2,6-
cis-isomer was the actual diastereoisomer that was obtained from the reaction; a result that 
can be explained by the A1,3-strain of the tosyl protecting group that forces the C-2 and C-6 
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substituents to adopt a pseudo axial orientation. Since it would not be trustworthy to rectify 
the potentially incorrect 2,6-trans stereochemistry of the N-tosylated aza-Achmatowicz 
products, the compounds delineated herein are depicted with the stereochemistry as published 
in the original publications. 
 
Scheme 2.5 Aza-Achmatowicz reaction of N-tosyl α-furanyl amines with m-CPBA. 
 
2.2 Functionalization and applications of aza-Achmatowicz products 
The aforementioned three-step approach by Ciufolini et al. to obtain aza-Achmatowicz 
products 19a–c (Scheme 2.4) was further applied to the synthesis of piperazic acid derivative 
22 and β-hydroxy-α-aminoacids 23a and b (Scheme 2.6).13  
  
Scheme 2.6 Applications of the aza-Achmatowicz reaction products by Ciufolini et al. 
Furthermore, Ciufolini used the same methodology for the synthesis of 28 (Scheme 2.7), an 
illustrative example of the antibiotic class of carbacephems.14 By reacting β-lactam 24 
following the described three-step procedure with bromine, dimethyl acetal 25 was isolated in 
95% yield. Subsequent olefin hydrogenation over Raney nickel resulted in simultaneous 
reduction of the azide moiety. The corresponding amine was protected as an iso-butyl 
carbamate (Ibc), after which hydrolysis of the acetals led to aza-Achmatowicz product 27 in 
99% yield. Cyanocarbacephem 28 was synthesized by five additional synthetic 
transformations. In addition to these examples, Ciufolini and co-workers published an 
excellent review of their efforts on the aza-Achmatowicz reaction.15 
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Scheme 2.7 Synthesis of cyanocarbacephem 28 by Ciufolini and co-workers. 
The hemiaminal moiety is a common distinctive feature of the products obtained via the aza-
Achmatowicz reaction. Albeit that the hemiaminal sometimes renders the aza-Achmatowicz 
products labile under acidic conditions, Speckamp and co-workers recognized these products 
as useful precursors for N-sulfonyliminium or N-acyliminium ions.10 Therefore, piperidinone 
30, which is readily available via the aza-Achmatowicz reaction, was treated with BF3·Et2O. 
The resulting N-sulfonyliminium ion intermediate then reacts instantaneously with the 
nucleophile leading to the corresponding 6-substituted piperidinones (Scheme 2.8). In this 
fashion, allylsilanes and enol acetates were successfully applied as nucleophiles affording 
piperidinones 31a–b and 32a–b, respectively. 
 
Scheme 2.8 N-Sulfonyliminium ion chemistry on aza-Achmatowicz product 30. 
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Scheme 2.9 Reductive addition of hydrazoic acid to δ-lactams 34a–c by Haroutounian et al. and the application to 
the synthesis of Ala-Ser peptidomimetic 38. 
Haroutounian and co-workers were interested in functionalizing δ-lactams 34a–c via 
conjugate addition of hydrazoic acid. The required unsaturated ketones were readily prepared 
by aza-Achmatowicz rearrangement of α-furanyl amines 33a–c, which directly afforded the 
desired spirocyclic lactam 34a (Scheme 2.9). However, for the preparation of 34b and c, 
subsequent oxidation using the Jones reagent was necessary to obtain the required lactams. 
Suprisingly, instead of the anticipated azide products, reacting 34a–c with hydrazoic acid 
exclusively led to amines 35a–c via a 1,4-oxidative addition reaction.16 Similar oxidative 
additions had hitherto only been reported for reactions where the azide anion adds to a 
naphthoquinone species. The reaction was later found useful in the synthesis of 38 as a 
conformationally constrained peptidomimetic of the corresponding Ala-Ser dipeptide, which 
can potentially probe recognition events in protein chemistry and biology.17 For the synthesis 
of peptidomimetic 38, Haroutounian et al. reduced enamine 35c using Zn powder in acetic 
acid, since standard hydrogenation did not give the expected results (Scheme 2.9). The 
resulting amine seemed to be rather labile and was henceforth immediately reacted with 
CbzCl to give 36. Stereoselective reduction with NaBH4 afforded 37, which was transformed 
into the targeted peptidomimetic 38 in five subsequent steps. 
 
Scheme 2.10 Synthesis of the pinnaic acid core structure 43 by Marquez and co-workers. 
Interestingly, while Haroutounian and co-workers observed that N-tosylamine 33a solely 
afforded spiro[5.5]lactam 34a upon treatment with m-CPBA, Marquez et al. obtained 
spiro[4.5]hemiaminal 40 under the same conditions (Scheme 2.10).18 Formation of the N-
sulfonyliminium ion upon treatment of the crude hemiaminal with BF3·Et2O and subsequent 
addition of allyltrimethylsilane (41) afforded 42. With 42 in hand, further synthetic 
elaboration led to compound 43, which resembles the core structure of pinnaic acid. 
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Although Haroutounian showed that hydrazoic acid was smoothly introduced in δ-lactams 
34a–c via oxidative conjugate addition, there was also interest in Michael addition to the 
enone moiety that is present in aza-Achmatowicz products, with alternative nucleophiles than 
azide. Therefore, Haroutounian and co-workers investigated the 1,4-addition of different 
nucleophiles to unsaturated ketone 44 (Scheme 2.11).19 Thus, treatment of 44 with a 
nucleophile, followed by immediate stereoselective reduction with NaBH4 afforded 
piperidines 47a–e. It is noteworthy that reduction of intermediates 46d and 46e also yielded 
small amounts of the C-3 hydroxy epimer, while 46a–c were obtained in diastereomerically 
pure form. Furthermore, it is proposed that the selectivity concerning the introduction of the 
functional group finds its origin in the bulky character of the tosyl group shielding one side of 
the molecule. As a consequence, a 2,6-pseudo-diaxial conformation is adapted by 44, which 
enables attack by the nucleophile from the least hindered equatorial side. 
 
Scheme 2.11 Conjugate addition reactions to 44 and 45. 
Harris and Padwa were also attracted by the versatility of these products and investigated 
similar conjugate additions on aza-Achmatowicz product 45. However, instead of focusing on 
heteroatom nucleophiles, they investigated carbon-carbon bond formation using various 
cuprate reagents. The authors found that 1,4-addition products 48a–d were formed as single 
diastereoisomers that could be isolated in high yields (Scheme 2.11).12,20 Conjugate addition 
of thiophenol and glycine methyl ester also furnished the corresponding adducts 48e and f in 
comparable yields and selectivities. In continuation of this work, the addition of nucleophiles 
to the N-sulfonyliminium ion derived from 48a and d would show the broader applicability of 
this methodology to synthesize 3,5-substituted indolizidines. Thus, the addition of 
allyltrimethylsilane to the N-sulfonyliminium ion that was generated by reacting 48a or d 
with BF3·Et2O afforded 49 and 50 in diastereomerically pure form both in 85% yield. When 
the N-sulfonyliminium ion derived from 48a was treated with propenyl acetate, 51 was also 
isolated as a single diastereoisomer in 70% yield. This methodology was subsequently 
applied to the synthesis of 6-epi-indolizidine 223A (see Section 2.4).12 
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Scheme 2.12 N-Sulfonyliminium ion functionalization by Harris and Padwa. 
Previous examples have clearly demonstrated that aza-Achmatowicz products can be 
successfully functionalized via conjugate addition of either heteroatom or carbon 
nucleophiles. Moreover, Furkert and Husbands showed that the C-4 position of the aza-
Achmatowicz products, i.e. the olefinic α-carbon, can also be functionalized. The authors 
anticipated that the functionalization of the C-4 position of aza-Achmatowicz product 54 
allow the synthesis of a promising opioid receptor antagonist (56, Scheme 2.13).21 Their 
synthesis commenced with sulfinimine 52, which was reacted with m-CPBA to 
simultaneously oxidize the sulfinyl functionality and rearrange the furan ring in an aza-
Achmatowicz reaction. Immediate reduction of the N-sulfonyliminium ion derived from 
hemiaminal 53 furnished piperidinone 54 in 78% yield starting from 52. C-4 bromination was 
accomplished by reacting 54 with bromine to form the intermediate dibromide, which via an 
E1cB-type reaction afforded 4-bromopiperidinone 55. Further synthetic elaboration led to 
trans-3,4-dimethyl piperidine 56 with the bromide playing a key-role as one of the reaction 
partners in the Suzuki coupling for the introduction of the requisite 3-hydroxyphenyl moiety. 
 
Scheme 2.13 An aza-Achmatowicz approach to opioid antagonist 56 by Furkert and Husbands. 
Altenbach and co-workers applied the aza-Achmatowicz reaction to the synthesis of building 
block 58 resembling iso-levoglucosenone (59), a key compound in the total synthesis of 
various natural products (Scheme 2.14). The conspicuous bicyclic framework brings 
structural rigidity and the two-atom bridge effectively shields one side of the molecule, 
allowing for facile diastereoselective functionalization. Furthermore, the augmented stability 
of the bridged hemiaminal ether renders protection of the hydroxyl of the hemiaminal in 57 
redundant. The bridged bicyclic framework was established via cyclization on the N-
sulfonyliminium ion derived from 57, which was formed under reflux conditions in benzene 
in the presence of a catalytic amount of p-toluenesulfonic acid. Building block 58, prepared in 
racemic and enantiopure form, was successfully used in the synthesis of 
deoxygalactonojirimycin (±)-60, (±)-deoxygulonojirimycin (61) and (+)-1,3-
dideoxygulonojirimycin (62).22 
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Scheme 2.14 Preparation of iso-levoglucosenone analogue 58. 
The products from classical Achmatowicz reactions are particularly known for their 
versatility in carbohydrate synthesis. As with the previous example, the aza-variant of this 
reaction has shown its usefulness in the synthesis of iminosugars. Nelson and co-workers 
cleverly combined the regular and the aza-Achmatowicz reaction in a two-directional 
approach to prepare disaccharide mimetics. They prepared difuranyl amino alcohol derivative 
63 (Scheme 2.15), which contains both the α-furanyl amine and alcohol moieties that can 
simultaneously undergo an aza and ‘regular’ Achmatowicz reaction.23 Thus, by treatment of 
63 with NBS and NaOAc, both furanyls were oxidatively rearranged and the resulting 
hemiacetals were subsequently acetalized with trimethyl orthoformate to furnish compound 
64. Further elaboration led to aza-C-(1→1)-linked disaccharide mimetics 65, 66 and 67, 
which are precursors to potential glycosidase inhibitors. 
 
Scheme 2.15 A two-directional approach to aza-C-(1→1)-linked disaccharide mimetics by Nelson et al. 
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As part of their research on β- and γ-secretases, which are considered potential targets for the 
prevention and treatment of Alzheimer’s disease, Fukuyama and co-workers extensively 
screened their in-house compound library for secretase inhibitory activity. Interestingly, aza-
Achmatowicz product 70 appeared to be a potent γ-secretase inhibitor (Scheme 2.16).24 For 
the synthesis of 70, a three-step procedure was utilized to prepare α-furanyl carbinol 68 from 
furfural. Compound 68 was then reacted in a Mitsunobu reaction with NsNHCbz, which upon 
desulfonylation afforded aza-Achmatowicz substrate 69. Treatment of 69 with m-CPBA 
smoothly afforded the targeted γ-secretase inhibitor 70 as a 10:1 mixture of diastereoisomers. 
 
Scheme 2.16 Synthesis of potent γ-secretase inhibitor 70 by Fukuyama et al. 
The aforementioned examples focused on the functionalization of aza-Achmatowicz products 
or their application in the synthesis of biologically active products. Apart from this, the aza-
Achmatowicz reaction has also been used to validate the applicability of other methodologies. 
For instance, Tomioka and co-workers delineated their results on the radical addition of ethers 
to imines in the presence of dimethylzinc and air.25 To demonstrate the relevance of their 
methodology, product 73 was subjected to the typical aza-Achmatowicz conditions (i.e. m-
CPBA in CH2Cl2) affording the corresponding piperidinone 74 (Scheme 2.17). 
 
Scheme 2.17 Application of α-furanyl amine 73 in the aza-Achmatowicz reaction. 
 
2.3 Enantiopure α-furanyl derivatives in aza-Achmatowicz reactions 
In the previous section, no attention was drawn to the enantiopurity of the aza-Achmatowicz 
substrates and the corresponding products. This section therefore focuses at the preparation of 
optically active α-furanyl amines and the aza-Achmatowicz reactions that follow. Despite the 
fact that a comprehensive overview on this topic was already published by the group of Zhou 
in 1999,26 an update is desirable since several new methods have been published thereafter. 
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Cong and co-workers used a strategy that relied on the chiral pool to synthesize enantiopure 
aza-Achmatowicz substrates.27 The authors prepared α-allenylketone 75 in seven steps from 
commercially available L-serine, which upon Ag(I)-catalyzed cycloisomerization afforded α-
furanyl amine 76 in 74% yield (Scheme 2.18). Subsequent treatment of 76 with m-CPBA 
afforded N-Boc-protected piperidinone 77 in 80% yield, which was converted in five 
additional synthetic transformations into polyhydroxylated piperidine 78. The latter product 
shows structural resemblance to 1-deoxygalactonojirimycin and 1-deoxygulonojirimycin, 
which both exhibit potential medicinal activity. 
 
Scheme 2.18 Preparation of aza-Achmatowicz substrate 76 via Ag(I)-catalyzed cycloisomerization of enantiopure 
allene 75. 
Alternatively, Haroutounian and co-workers disclosed another approach relying on the chiral 
pool to obtain optically active aza-Achmatowicz substrates. By starting from D-glucal, the 
required enantiomerically pure α-furanyl amines were obtained in a four-step procedure as 
depicted in Scheme 2.19.28a,28b First, the reaction of D-glucal (79) with HgSO4 under acidic 
conditions29 resulted in a vicinal diol, which was subsequently silylated with TBDPSCl to 
afford mono-protected diol 80. Mitsunobu reaction with diphenylphosphoryl azide (DPPA), 
followed by hydrogenation of the resulting azide and subsequent tosylation led to (S)-α-
furanyl amine 81 with high enantiomeric excess (>98%) in 67% yield over five steps starting 
from D-glucal. 
 
Scheme 2.19 Synthesis of enantiopure piperidine building block 82 from D-glucal by Haroutounian et al. 
Aza-Achmatowicz reaction of 81 by treatment with m-CPBA furnished piperidinone 82, 
which is a versatile building block en route to piperidine alkaloids as emphasized by its 
application in the synthesis of pipecolic acid derivatives,28e a constrained peptidomimetic17 
and several (formal) total syntheses.28a-d 
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Scheme 2.20 Preparation and subsequent aza-Achmatowicz reaction of α-furanyl amine 87 by Bi and Aggarwal. 
Bi and Aggarwal used glyceraldehyde dimethyl acetonide 84 as their stoichiometric source of 
enantiopurity for the synthesis of optically active α-furanyl amine 87 and its corresponding 
aza-Achmatowicz product 88.30 By deprotonation of sulfur ylide 83 and subsequent reaction 
with aldehyde 84, an isomeric mixture of cis/trans epoxides was formed of which 85 was the 
major component. The cis/trans mixture of 85 was then treated with aqueous ammonia to 
open the epoxide with inversion of stereochemistry, after which subsequent desulfonylation 
of the resulting amine with sodium amalgam provided 86. Protection of amine 86 with CbzCl, 
followed by aza-Achmatowicz reaction with m-CPBA smoothly furnished piperidinone 88 in 
72% yield. 
 
Scheme 2.21 Diastereoselective addition of a Grignard reagent on sulfinimine 89 by Shimizu and co-workers. 
Shimizu and co-workers reported the preparation of chiral aza-Achmatowicz substrates via 
addition of a nucleophile to optically active sulfinimine 89 (Scheme 2.21).31 By reacting 89 
with allylmagnesium bromide, either 90a or b could be isolated in excellent yield and in a 
highly diastereoselective fashion depending on an additive that was added to the reaction 
mixture. Additionally, 91 was oxidatively rearranged by treatment with m-CPBA to afford 
piperidinone 92, which served as a precursor for the synthesis of indrizidine 223AB (see 
Section 2.4). 
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Scheme 2.22 Diastereoselective reduction of N-sulfinyl ketimine 93 by Padwa et al. 
Padwa et al. used a similar strategy, but instead of reacting chiral furfural-derived 
sulfinimines with carbon nucleophiles, they used a sterically demanding reducing agent to 
stereoselectively reduce acetylfuran-derived N-sulfinyl ketimine 93 (Scheme 2.22).32 Hence, 
93 was reacted with LiAlH(t-BuO)3 and the resulting sulfinyl amine was immediately 
oxidized to afford optically active α-furanyl amine 94 in >75% ee. Aza-Achmatowicz 
reaction with m-CPBA and subsequent protection of the hemiaminal by treatment with 
(EtO)3CH furnished piperidinone 95 in excellent yield (95%). 
 
Scheme 2.23 Diastereoselective additions using boronates as chiral auxiliaries by Yim and Wong. 
Yim and Wong applied another approach using chiral auxiliaries to enantiopure aza-
Achmatowicz substrates. 2,3-Disubstituted furyl sulfonylimine 96 was prepared bearing a 
chiral boronate ester that serves as a directing group for the addition of various nucleophiles 
to the imine (Scheme 2.23).33 Furthermore, boronate esters are good reaction partners in 
Suzuki reactions and therefore allow modification of the furanyl ring when the auxiliary turns 
dispensable after the addition reaction. To illustrate this, the authors reacted imine 96 with 
either Grignard reagent 97 or metal enolate 98 followed by reduction to obtain α-furanyl 
amines 99 and 100, respectively. By reacting 99 and 100 in a Suzuki reaction, the boronate 
ester was advantageously used to undergo transistion-metal catalyzed arylation leading to 2,3-
disubstituted furanyl amines 101 and 103. Interestingly, subjecting these substrates to the aza-
Achmatowicz reaction smoothly afforded 4-substituted piperidinones in good yields and in 
enantiomerically pure form (104 and 105). 
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Scheme 2.24 Organometallic enantiomeric scaffolds via the aza-Achmatowicz reaction. 
A somewhat different methodology that also makes use of chiral auxiliaries was reported by 
Liebeskind and co-workers. Instead of using the auxiliary for the synthesis of 
enantiomerically pure aza-Achmatowicz substrates or the corresponding products, the authors 
synthesized a diastereomeric mixture of aza-Achmatowicz products starting from enantiopure 
α-furanyl amine 106 (Scheme 2.24).34 The resulting piperidinones were then oxidatively 
added to Mo(DMF)3(CO)3 and the ligand was subsequently exchanged with potassium 
tris(pyrazolyl)borohydride (KTp). This afforded a mixture of pyridinyl complexes which 
could be separated by column chromatography to provide enantiopure 107a and b with 
>99.9% de. These compounds, which are considered organometallic enantiomeric scaffolds, 
have proven their usefulness for further synthetic elaboration using organometallic reagents35 
or as reaction partner in [5+2] cycloadditions.36 
  
Scheme 2.25 Enzymatic resolution of 108 using papain and synthesis of alkaloids building block 113. 
The previously described examples showed that the desired optically active α-furanyl amines 
are indeed accessible from cheap and readily available starting materials (i.e. from the chiral 
pool); however, stoichiometric amounts of optically active starting materials are still required. 
Therefore, Ciufolini and co-workers employed an enzymatic kinetic resolution step for the 
preparation of enantiomerically pure α-furanyl amines.37 Selective hydrolysis of racemic 
furylglycine (108) using papain afforded a readily separable mixture of (S)-carboxylic acid 
109 and (R)-ester 110 (Scheme 2.25). Subsequent methylation of (S)-109 with diazomethane 
furnished (S)-110 in 31% yield so that both enantiomers of 110 were obtained in 97% ee. (R)-
110 was then used to prepare enantiomerically pure alkaloid building block 113 via the three-
step procedure for aza-Achmatowicz reactions that was earlier described by Ciufolini.7 
N
O
O O Ph
n-Pr
TpMo(CO)2
N
O
O O Ph
n-Pr
TpMo(CO)2
H
B NN
N
N
N
N
1)
2)
m-CPBA
Mo(DMF)3(CO)3
then KTpHN
O
O
O Ph
n-Pr
+
Tp106 107a 107b
33%
NHCO2Et
CO2MeO
NHCO2Et
CO2RO
NHCO2Et
CO2MeO+
papain
NHCO2Et
CO2MeO
LiAlH4, –78 °C HN
O
O
O
H
N
O
O
MeO
HN
O
O
O
H
MeO
MeO
Br2 H
O
HH2, Rh(Al2O3)
TfOH (10 mol %)
H2O (2 equiv)
1)
2)
1)
2)NaH
108 (S)-109, R = H
(S)-110, R = Me (31%)
(R)-110 45%
111 112 113(R)-110
77% 96% 71%
CH2N2
The aza-Achmatowicz reaction in the synthesis of nitrogen heterocycles 
 
31 
In lieu of an enzyme, Zhou et al. utilized the Sharpless asymmetric epoxidation protocol for 
the kinetic resolution of racemic α-furanyl amines (114a–f) generating optically active aza-
Achmatowicz products (115a–f, Scheme 2.26),9a which were obtained in good yields (45–
50%) and ee’s varying between 90 and >99%. 
 
Scheme 2.26 Kinetic resolution of 114a–f using the Sharpless asymmetric epoxidation. 
Although kinetic resolution of racemic substrates offers a valuable solution for obtaining 
enantiomerically pure aza-Achmatowicz products, the intrinsic maximum yield of 50% limits 
the feasibility of this reaction for large-scale processes or expensive substrates. To overcome 
this limitation, Nelson and co-workers reasoned that enantiotopic difuryl sulfonamide 116 
could be completely converted upon exposure to Sharpless asymmetric epoxidation 
conditions affording a single enantiomer of 117 (Scheme 2.27).38 Thus, 116 was prepared by 
addition of 2-lithiofuran to the N-tosylimine of furfural and further oxidized under regular 
Achmatowicz conditions (i.e. m-CPBA or NBS/NaOAc). The reaction of difuryl sulfonamide 
116 with m-CPBA afforded racemic piperidinone 117 in a mediocre 29% yield along with an 
equimolar amount of pyridine side product 118. Following the initial plans, 116 was also 
reacted with the Sharpless asymmetric epoxidation reagent (Ti(i-PrO)4, (+)-DET, TBHP); 
however, this only resulted in quantitative recovery of the starting material. 
 
Scheme 2.27 Oxidation of difuryl sulfonamide 116 by Nelson and co-workers. 
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Albeit that the catalytic desymmetrization approach by Nelson can be considered elegant, a 
more universal alternative for the preparation of enantiomerically pure aza-Achmatowicz 
products would be to catalytically generate the desired optically active substrates. As an 
example, O’Doherty et al. investigated the Sharpless asymmetric aminohydroxylation for the 
enantioselective synthesis of the requisite α-furanyl amines.39a Thus, vinylfuran 119, which 
was prepared by a Peterson olefination reaction on furfural, was treated with CbzNClNa and 
the OsO4/(DHQ)2PHAL mixture for the Sharpless asymmetric aminohydroxylation (Scheme 
2.28).39b An inseparable 1:2 mixture of regioisomers 122a and b was obtained of which the 
primary alcohol (122a) could be selectively silylated with TBDMSCl to effect a change of 
polarity that rendered it separable by chromatography. α-Furanyl amine 123 and its 
enantiomer ent-123 were accordingly obtained in yields of 21–24% but with good 
enantioselectivities (>86% ee). 
 
Scheme 2.28 Sharpless asymmetric aminohydroxylation of olefinic furans 119–121 and subsequent aza-
Achmatowicz reactions. 
In addition, Zhou and co-workers reported a similar reaction on vinyl acrylate 120 leading to 
amino alcohol 124a in comparable yield and ee (37% and 87%, respectively), but the 
regioselectivity of this reaction appeared significantly higher (ratio 124a/b 7:1) indicating a 
directing effect by the electron-withdrawing ester moiety in 120 (Scheme 2.28).40 When 5-
Me-furanoid 121 was reacted under the same conditions, the regioselectivity of the reaction 
was further increased to >20:1 in favor of the desired isomer 125a, which was isolated in 
excellent ee (99%). Protection of 124a with MOMCl and subsequent aza-Achmatowicz 
reaction with m-CPBA gave piperidine 127 in 78% yield. 
O’Doherty initially reacted N-Cbz α-furanyl amine 123 with NBS in H2O to afford 
piperidinone 128 in a moderate 55% yield along with several side products that were 
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identified by the authors as lactam 129, pyridine 130, trans-enal 131 and its corresponding 
acid 132.39b Fortunately, the formation of these side products could to a large extent be 
suppressed by using anhydrous m-CPBA as the oxidant yielding 128 in 81% along with 7% 
of the recovered starting material. It was also shown that the addition of water to the reaction 
mixture led to increased amounts of acid 132 and hence lowered the yield. Furthermore, 
adding an excess of m-CPBA (2.2 equiv) resulted in decreased yields of 128 while lactam 129 
could be isolated as the major product. 
 
Scheme 2.29 Asymmetric dihydroxylation approach by Zhou et al. 
The Sharpless asymmetric aminohydroxylation approach offers a highly enantioselective and 
versatile route to optically active aza-Achmatowicz substrates, although due to the low 
conversions and hence yields of these reactions, there is still considerable room for 
improvement. In another report by Zhou and co-workers, the authors investigated an 
alternative strategy by switching to the Sharpless asymmetric dihydroxylation of vinylfuran 
(119).11 Thus, the reaction of vinylfuran (119) with K2OsO2(OH4), (DHQD)2PHAL and 
K3Fe(CN)6 afforded diol 133 in 92% yield and 92% ee (Scheme 2.29). Selective substitution 
of the benzylic oxygen with NaN3 occurred with inversion of stereochemistry and afforded 
azido alcohol 135 in 91% ee. Subsequent benzyl protection, azide reduction and tosylation of 
the primary amine afforded aza-Achmatowicz substrate 136, which was treated with m-CPBA 
to afford piperidinone 137 in 82% yield as the 2,6-cis-diastereoisomer (confirmed by X-ray 
analysis). Compound 137 was then converted into two 1-deoxyazasugar isomers using 
standard functional group interconversions. 
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Scheme 2.30 Copper-catalyzed Mannich-type reaction of glycine Schiff base with imine 71. 
More recently, Feng and co-workers disclosed the copper-catalyzed Mannich-type reaction of 
glycine Schiff bases with different N-tosyl aldimines.41 Optimization studies showed that 
N,N’-dioxide ligand 139 gave the best results in combination with Cu(OAc)2·H2O so that this 
catalyst was consequently applied on a wide variety of aldimines affording the corresponding 
products in yields ranging from 71 to 99%. In this fashion, the reaction of Schiff base 138 
with imine 71 furnished α-furanyl amine 140 with a syn/anti ratio of 15:85 and 94% ee 
(Scheme 2.30). The product was subsequently hydrolyzed under acidic conditions and the 
liberated amine was protected with Boc2O to afford protected diamine 141. Aza-
Achmatowicz reaction of 141 with NBS furnished a 5:1 mixture of epimers 142 and 143 
indicating that epimerization had occurred under the reaction conditions. 
 
2.4 Application of the aza-Achmatowicz reaction in the total synthesis 
of natural products 
The piperidinone products accessed by the aza-Achmatowicz reaction contain multiple 
functional groups that allow further modification, which therefore renders the reaction very 
useful for the synthesis of different types of alkaloids. For example, containing the 3-oxo 
moiety, the aza-Achmatowicz products are direct precursors to the 3-hydroxypiperidine 
scaffold, a class of compounds that has received much attention by the synthetic community. 
This interest is underlined by the large number of reported total syntheses of natural products 
bearing this motif, as delineated by Rutjes et al.42 Along with several other approaches, the 
aza-Achmatowicz reaction offers a quick and versatile route to these versatile 3-
hydroxypiperidines. It is therefore not surprising that many total syntheses that rely on the 
aza-Achmatowicz reaction aim at natural products bearing the 3-hydroxypiperidine motif or a 
derivative thereof. Although not limited to 3-hydroxypiperidines, this section will provide a 
comprehensive overview of total syntheses of natural products exploiting the aza-
Achmatowicz reaction. 
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Scheme 2.31 Total synthesis of (+)-deoxoprosopinine (148) by Ciufolini and co-workers. 
The first total synthesis of a natural product with a pivotal role for the aza-Achmatowicz 
reaction was published by the group of Ciufolini in 1989.43 They described the total synthesis 
of (+)-deoxoprosopinine starting from bicyclic carbamate ent-113 which was prepared 
following the methodology that was previously described by the same authors (vide supra, 
Scheme 2.25). Thus, starting from ent-113, ketone reduction and acetylation of the resulting 
alcohol afforded 144, which was allylated via the N-acyliminium ion intermediate upon 
treatment with TiCl4. Acetyl hydrolysis and benzylation afforded olefin 145 as the desired 
2,6-trans-isomer. The requisite aliphatic side chain was introduced via a Wittig reaction 
ultimately leading to (+)-deoxoprosopinine (147). 
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Scheme 2.32 Total syntheses of (+)-deoxoprosophylline (151) and prosophylline (154) by Zhou et al. 
The structurally related alkaloids (+)-deoxoprosophylline (151) and prosophylline (154), 
which contain the 2,6-cis-disubstituted 3-hydroxypiperine moiety, were synthesized utilizing 
the aza-Achmatowicz reaction by Zhou and co-workers (Scheme 2.32).44 The earlier 
described Sharpless dihydroxylation approach to generate enantiopure α-furanyl amines (see 
Scheme 2.29) was applied to prepare starting material 137. The required N-sulfonyliminium 
ion precursor 148 was prepared in three synthetic steps from 137 and subsequent allylation 
furnished olefin 149 as a single 2,6-cis-diastereoisomer. For the introduction of the aliphatic 
chain in (+)-deoxoprosophylline (151), the authors relied on a copper mediated coupling of 
nonylmagnesium bromide with tosylated alcohol 150, which was prepared via a 
hydroboration reaction of olefin 149. Upon introduction of the side chain, two deprotection 
steps led to (+)-deoxoprosophylline (151). Similarly, ozonolysis of olefin 149 and subsequent 
reduction and sulfonylation furnished the tosylated primary alcohol 152. The side chain was 
introduced under the same conditions with Grignard reagent 153 and Li2CuCl4. Subsequent 
deprotection then led to the synthesis of prosophylline (154).44b 
 
Scheme 2.33 Total synthesis of (−)-prosophylline by Haroutounian and Koulocheri. 
Haroutounian and Koulocheri reported the total synthesis of the other enantiomer of 
prosophylline (ent-154) to demonstrate the applicability of their methodology for the 
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preparation of enantiopure aza-Achmatowicz products starting from D-glucal.28c The synthesis 
commenced with 82 (Scheme 2.33) of which the preparation was presented in Scheme 2.19. 
Although the synthetic pathway is analogous to the synthesis by Zhou and co-workers, 
Haroutounian and Koulocheri chose to introduce the side chain via a Wittig olefination of 
aldehyde 155 with the in situ generated triphenylphosphonium ylide of 156. The resulting 
olefin 157 then afforded (−)-prosophylline (ent-154) in four additional synthetic 
transformations. 
 
Scheme 2.34 Total syntheses of alkaloids from the Cassia and Prosopis family. 
By starting from racemic 95, Padwa and co-workers prepared 3-hydroxypiperidine building 
block 160 via the addition of methyl 3-(trimethylsilyl)-4-pentenoate (159) to the N-
sulfonyliminium ion derived from 158 (Scheme 2.34).32,45 Further manipulation of the side 
chain gave the authors access to four members of the Cassia and Prosopis alkaloid families 
(161–164). Additionally, since the authors demonstrated the preparation of enantiomerically 
pure 95 by stereoselective reduction of a chiral sulfinylimine (see Scheme 2.22), a formal 
enantioselective synthesis of 161–164 was thereby also provided. 
 
Scheme 2.35 Synthesis of (−)-dihydropinidine (166) by Zhou and Lu. 
Although the intended product is not a 3-hydroxypiperidine, the synthesis of (−)-
dihydropinidine (166) as reported by Lu and Zhou closely resembles the previously discussed 
syntheses.46 However, for this synthesis, the authors introduced the desired stereochemistry 
by kinetic resolution using the Sharpless asymmetric epoxidation as depicted in Scheme 2.26. 
This gave access to enantiopure 115a, which was smoothly converted in a few steps into 2,6-
cis-disubstituted piperidine 165 (Scheme 2.35). The superfluous hydroxyl was then removed 
via a Barton–McCombie deoxygenation and subsequent desulfonylation using sodium–
naphthalene furnished (−)-dihydropinidine (166). 
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Scheme 2.36 Synthesis of indolizidine alkaloid 171 by Shimizu et al. 
The aza-Achmatowicz reaction has also repeatedly been applied in the total syntheses of 
indolizidine alkaloids. This family of alkaloids share a distinctive 1-azabicyclo[4.3.0]nonane 
moiety and retrosynthetic breakdown shows that its 2,6-disubstituted six-membered ring 
should be accessible via the aza-Achmatowicz reaction. This has been exercised by Shimizu 
and co-workers in the total synthesis of indrizidine 223AB (171).31 Enantiomerically pure 
aza-Achmatowicz product 92 was available via diastereoselective addition of 
allyltrimethylsilane to a chiral sulfinylimine as shown in Scheme 2.21. Conventional 
functional group interconversions led to a diastereomeric mixture of alcohol 167 (Scheme 
2.36). Next, Barton–McCombie deoxygenation gave 2,6-disubstituted piperidine 168, which 
was converted into 169 in four consecutive steps including N-sulfonyliminium ion addition of 
allyltrimethylsilane. After conversion of 169 to its HCl salt, addition of sulfenyl chloride to 
the olefin and subsequent ring-closure under basic conditions furnished indolizidine 170. The 
synthesis of indrizidine 223AB (171) was finished by cleavage of the sulfenyl group with 
Raney nickel. 
 
Scheme 2.37 Total synthesis of 6-epi-indolizidine 223A (176) by Padwa and Harris. 
Prompted by the densely functionalized substitution pattern and the uncertainty surrounding 
its structure, Padwa and Harris reported the total synthesis of 6-epi-indolizidine 223A (176).12 
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the resulting hemiaminal using BF3·Et2O and allyltrimethylsilane. Stereoselective 1,4-addition 
of Et2CuMgBr proceeded in good yield and subsequent conversion of the ketone to its 
corresponding vinyl triflate furnished 173 in 95% yield (Scheme 2.37). A Stille coupling was 
used to introduce the vinyl substituent, which was in the next step hydrogenated over Adam’s 
catalyst. Desilylation of the primary alcohol then smoothly afforded 174 in 90% yield. 
Removal of the tosyl group with sodium–naphthalene rendered the amine susceptible for 
cyclization upon halogenation of the primary hydroxyl under Appel conditions to give 
dehydroindolizidine 175. Finally, hydrogenation of the trisubstituted olefin led to the product 
of which the analytical data were in accordance with literature values of 6-epi-indolizidine 
223A (176). 
 
Scheme 2.38 Formal total synthesis of (−)-swainsonine (182) by Zhou and co-workers. 
In order to further exploit their achievements on aza-Achmatowicz reactions, a formal total 
synthesis of (–)-swainsonine (182) was disclosed by Zhou and co-workers.47 This 
polyhydroxylated indolizidine alkaloid, that was first isolated from Rhizoctonia leguminicola, 
is a potent inhibitor of mannosidase and hence glycoprotein processing. The synthesis 
commenced with an aza-Achmatowicz reaction of 177 using the Sharpless asymmetric 
epoxidation reagent followed by treatment of the resulting hemiaminal with (EtO)3CH and 
BF3·Et2O to give piperidinone 178. Interestingly, the olefin was hardly affected since 178 was 
obtained in 42% yield along with 46% of the unreacted enantiomer of 177. Reduction of the 
enone with NaBH4 followed by benzylation and reduction of the N-sulfonyliminium ion that 
was formed by treatment with formic acid led to piperidine 179. 8-Benzyloxy-swainsonine 
(180) was then prepared by olefin dihydroxylation and removal of the tosyl and the MOM-
group in 179, followed by cyclization of the five-membered ring under Appel conditions. 
Unfortunately, debenzylation of 180 was not successful and the authors therefore disclosed a 
formal total synthesis of (−)-swainsonine (182) by preparing acetonide 181, which has been 
an intermediate in a previous synthesis of 182. 
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Scheme 2.39 Synthesis of 8a-epi-swainsonine (187) by Bi and Aggarwal. 
As part of their work on the formation of enantiopure epoxides by the reaction of aldehydes 
with a chiral sulfur ylide, Bi and Aggarwal published a concise synthesis of 8a-epi-
swainsonine (187) making minimal use of protecting groups.30 Piperidinone 88, which was 
obtained via an aza-Achmatowicz reaction as described in Scheme 2.20, was reacted with p-
toluenesulfonic acid to effect the intramolecular simultaneous protection of the alcohol and 
the hemiaminal moiety as bicyclic hemiaminal ether 183. Additionally, the resulting bridged 
framework of 183 was expected to enhance the diastereoselectivity of the attack of NaBH4 in 
the ketone reduction step. Indeed, allylic alcohol 184 was smoothly obtained in 95% yield 
upon reduction of 183 with NaBH4/CeCl3. Concomitant hydrogenolysis of the Cbz-group and 
the hemiaminal ether and hydrogenation of the double bond afforded 185, which was 
subsequently liberated from the acetonide protecting group by the action of p-toluenesulfonic 
acid. Intramolecular N-alkylation of 186 was accomplished under Appel conditions to furnish 
8a-epi-swainsonine (187) in 82% yield. 
 
Figure 2.1 Natural alkaloids 188 and 189 from the Castanospermum australe and non-natural analogue 190. 
Xu and Zhou reported the synthesis of (+)-6-epicastanospermine (189, Figure 2.1), a 
polyhydroxylated indolozidine alkaloid that is closely related to swainsonine. It has been 
isolated together with castanospermine (188) from the Castanospermum australe legume and 
is a powerful amyloglucosidase inhibitor. Xu and Zhou initially investigated the synthesis of 
190, the unnatural 1-deoxy derivative of 189, of which the synthetic route is depicted in 
Scheme 2.40.48 Via an aza-Achmatowicz reaction using the Sharpless asymmetric epoxidation 
reagent (see Scheme 2.26), piperidinone 191 was readily prepared in enantiopure form. 
Stereoselective reduction of the ketone and subsequent inversion of the resulting stereocenter 
using the Mitsunobu reaction gave the desired stereochemistry of the C-8 hydroxyl. Exchange 
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of the silyl protective group and reduction of the hemiaminal ether functionality consequently 
led to piperidine 192. Sharpless asymmetric dihydroxylation using the DHQ-CLB 
(dihydroquinine p-chlorobenzoate) ligand smoothly afforded 193 in 91% yield and the 
synthesis was finished by removal of the protective groups and subsequent Mitsunobu 
cyclization to furnish (+)-1-deoxy-6-epi-castanospermine (190). 
 
Scheme 2.40 Synthesis of 1-deoxy-6-epi-castanospermine (190) by Xu and Zhou. 
The same authors also synthesized structurally related (+)-6-epi-castanospermine (189).49 By 
having prepared α-furanyl amine 194 (Scheme 2.41), which was accomplished via the 
Sharpless asymmetric aminohydroxylation of the corresponding olefinic furan (see Scheme 
2.28), aza-Achmatowicz reaction and subsequent protection of the hemiaminal gave access to 
piperidinone 195. The conversion of 195 into piperidine 196 was subsequently realized 
following a similar route as for the synthesis of 192. However, in contrast to the synthesis of 
1-deoxy derivative 190, the indolizidine skeleton was in this case established using the Appel 
reaction upon which the resulting halogenated product immediately cyclized to form (+)-6-
epicastanospermine (189). 
 
Scheme 2.41 Total synthesis of 6-epicastanospermine 189 by Xu and Zhou. 
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In addition to the syntheses of 3-hydroxypiperidines and indolizidines, the aza-Achmatowicz 
reaction has been exceptionally useful for the synthesis of iminosugars such as the natural 
diastereoisomers (198–200) of 1-deoxynojirimycin (197, Figure 2.2). 
 
Figure 2.2 (+)-1-Deoxynojirimycin (197) and diastereoisomers 198–200. 
The groups of Zhou and O’Doherty have both reported a total synthesis of (−)-1-
deoxymannonojirimycin (198) in which the aza-Achmatowicz played a crucial role. Since 
both syntheses rely on the same key-step, the synthetic pathways are similar and differ only in 
the exact order of steps, the protecting groups and the specific conditions under which the 
transformations were conducted. To obtain the required optically active piperidinone 201, 
Haukaas and O’Doherty employed the Sharpless asymmetric aminohydroxylation as shown in 
Scheme 2.28, followed by the aza-Achmatowicz reaction.39b A Luche reduction of 
piperidinone 201 then gave allylic alcohol 204 with complete stereocontrol in 86% yield. 
Dihydroxylation of 204 with OsO4 and NMO, reduction of the hemiaminal ether and 
subsequent removal of the protecting groups furnished (−)-1-deoxygulonojirimycin (200). 
When allylic alcohol 204 was inverted using the Mitsunobu reaction, piperidine 206 was 
obtained bearing the desired C-4 stereochemistry for the synthesis of mannonojirimycin. 
Indeed, dihydroxylation of 206, reduction of the hemiaminal ether and deprotection smoothly 
led to (−)-1-deoxymannonojirimycin (198). 
 
Scheme 2.42 Synthesis of (–)-200 and (–)-198 by the groups of Zhou and O’Doherty. 
Xu and Zhou commenced their synthesis of (−)-198 with piperidinone 202, which was 
obtained in enantiopure form via kinetic resolution of the corresponding α-furanyl amine with 
the Sharpless asymmetric epoxidation reagent (see Scheme 2.26).50 Luche reduction afforded 
allylic alcohol 205 that was subsequently inverted under Mitsunobu conditions to give 207 
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(Scheme 2.42). With 207 in hand, olefin dihydroxylation, hemiaminal ether reduction and 
removal of the protecting groups furnished (−)-1-deoxymannonojirimycin (198). 
Additionally, the authors succeeded in establishing the stereochemistry that was required for 
the synthesis of (+)-1-deoxyaltronojirimycin (199).50b To achieve this, 208, which was 
prepared by dihydroxylation of 207, was subsequently reacted with thionyl chloride and 
sodium periodate/ruthenium chloride to afford cyclic sulfate 209 (Scheme 2.43). Hydrolysis 
with H2SO4 afforded piperidine 210, which upon a three-step protection/deprotection 
sequence smoothly provided (+)-1-deoxyaltronojirimycin (199). 
 
Scheme 2.43 Synthesis of 210 bearing the altro-stereochemistry that is required for the synthesis of (+)-199. 
In addition to the herein discussed synthesis of naturally occurring 1-deoxynojirimycin 
derivatives, Altenbach and Wischnat reported a short synthesis of protected 
mannonojirimycin.51 This was achieved by Luche reduction of 203 (Scheme 2.42) followed 
by dihydroxylation and protection of the free alcohols. Protected mannonojirimycin was 
according to this reaction sequence obtained and at least 95% diastereomerically pure. 
As a part of their studies towards the total synthesis of madangamine A, Weinreb and co-
workers employed the aza-Achmatowicz reaction of N-β-(trimethylsilyl)ethanesulfonyl (SES) 
protected furanyl amine 211.52 Subsequent reduction of the hemiaminal with Et3SiH and 
BF3·Et2O afforded enone 212 in 68% yield over two steps. Keystep in their synthesis was the 
[4+2]-cycloaddition of 212 with 1,3-butadiene to construct the desired cis-azadecalin 213. 
This could however not be realized under thermal conditions, but when the reaction was 
performed under high pressure (12 kbar), 213 was smoothly obtained in 75% yield. Further 
synthetic elaboration eventually furnished the “eastern” macrocyclic ring fragment of (±)-
madangamine 214.  
 
Scheme 2.44 Synthesis of the “eastern” macrocyclic ring fragment 214 of madangamine A by Weinreb et al. 
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2.5 Aza-Achmatowicz approaches to pyridines and pyridinium ions 
The earliest reports of oxidative rearrangements of α-furanyl amines suffered from highly 
unstable intermediates that were prone to aromatization resulting in the corresponding 
pyridine products. The groups of Ciufolini7,15 and Zhou9 reported different approaches to 
suppress the pyridine formation and hence opened the door to the aza-Achmatowicz reaction 
as a tool for the preparation of piperidines from furanyl amines (vide supra). Although each 
example that has been discussed in this chapter aims at the synthesis of functionalized 
piperidines, the late-stage aromatization of aza-Achmatowicz products, in other words 
aromatization after isolation can also be beneficial for specific purposes. 
As an example, Nelson et al. investigated the Lewis acid-mediated aromatization of 
piperidinones 216a–c, which were readily accessible via aza-Achmatowicz reaction of α-
furanyl amines 215a–c (Scheme 2.45).53 Interestingly, when piperidinones 216a–c were 
treated with AlCl3 and subsequently quenched by addition of Et3N, O-tosylated 3-
hydroxypyridines 218a–c were obtained indicating that a N→O sulfonyl transfer reaction had 
occurred. It is expected that this proceeds intermolecularly through the intermediacy of the 
sulfonyl pyridinium ions 217a–c. Furthermore, this reaction offers a convenient route to O-
tosylated 3-hydroxypyridines which are potentially good reaction partners in palladium-
catalyzed cross-coupling reactions.54 
 
Scheme 2.45 Synthesis of 2-substituted-3-sulfonyloxypyridines via the aza-Achmatowicz reaction. 
Closely related to the work by Nelson, Shaw and co-workers unexpectedly obtained pyridines 
224a–d while investigating the acetylation of aza-Achmatowicz products 221a–d (Scheme 
2.46).55 Recognizing this unexpected reaction as a novel approach to 2,4-disubstituted 3-
acetoxypyridines, the authors extended the scope by preparing 4-iodopyridine 225 starting 
from piperidinone 223, which was readily obtained by treatment of 222 with iodine and base. 
The iodide in pyridine 225 offers a versatile handle for further functionalization, for example 
via palladium-catalyzed cross-coupling reactions, such as a Sonogashira reaction. The 
required substrates 219a–d and 220 were obtained as single enantiomers starting from 
commercially available D-glucal. 
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Scheme 2.46 An aza-Achmatowicz approach to 2,4-disubstituted 3-acetoxypyridines by Shaw et al. 
Owing to their antimicrobial activity, potential as intercalating DNA-binding agents in 
chemotherapy and activity against the Epstein–Barr virus, 2-aza-anthraquinones (e.g. 231a–g, 
Scheme 2.47) have attracted much attention by the chemical community. In order to have 
access to new members of this class, De Kimpe and co-workers employed the aza-
Achmatowicz reaction in a synthesis of various 2-aza-1-cyano-4-hydroxyanthraquinones 
(231a–f).56 The required piperidinones 227a–g were readily available by aza-Achmatowicz 
reaction of the corresponding α-furanyl-amines, which were prepared by addition of a 
nucleophile to the imine derived from furfural and tosyl amide. With 227a–g in hand, the 
envisioned annulation reaction with compound 226 smoothly gave 2-aza-1-cyano-4-
hydroxyanthraquinones 231a–f in the presence if LiOt-Bu. It is hypothesized that introduction 
of the cyanide in intermediate 229 proceeds via a retro-Michael/Michael addition to 228. 
Tautomerization of the ketone and tosyl removal via β-elimination resulted in 230, which was 
readily oxidized by oxygen from the air to form the targeted 2-aza-anthraquinone species. 
 
Scheme 2.47 Synthesis of 2-aza-1-cyano-4-hydroxyanthraquinones from aza-Achmatowicz products 227a–g. 
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The previous examples clearly show that aza-Achmatowicz products can be transformed into 
the corresponding pyridines without much effort. The nitrogen atom should however be 
protected with a cleavable group (e.g. tosyl) in order to obtain the intended neutral pyridine 
product. Alkylated amines would otherwise result in pyridinium ions upon aza-Achmatowicz 
reaction, which can in fact be isolated, either as a salt or zwitterion. Since the aza-
Achmatowicz reaction forms 3-hydroxypyridines upon aromatization, zwitterions can be 
readily obtained by deprotonation of the resulting hydroxyl moiety. Such so-called 
oxidopyridinium ions were exploited by Curtis and co-workers in the intermolecular 1,3-
dipolar cycloaddition of acrylates or vinyl sulfone 235.57 First, the reaction of α-furanyl amine 
232 with bromine led to piperidinone 233, which instantaneously aromatized to form 
oxidopyridinium ion 234 (Scheme 2.48). By reacting 234 with vinyl sulfone 235 at elevated 
temperature, 8-azabicyclo[3.2.1]octane 236 was obtained as a single diastereoisomer in 31% 
yield. 
 
Scheme 2.48 1,3-Dipolar cycloaddition of 3-oxidopyridinium ion 234 by Curtis and co-workers. 
An intramolecular variant of this reaction was explored by Peese and Gin in their studies on 
the synthesis of (+)-nominine.58 Although the authors have prepared different substrates 
similar to 238, the example delineated in Scheme 2.49 gave the highest yield of the desired 
product. Thus, aza-Achmatowicz reaction of α-furanyl amine 237 furnished oxidopyridinium 
ion 238, which was isolated in 77% yield. The 1,3-dipolar cycloaddition was effected by 
refluxing a dilute solution of 238 in toluene, which ultimately led to 240, a fragment of the 
structural framework of nomine. 
 
Scheme 2.49 Intramolecular 1,3-dipolar cycloaddition of oxidopyridinium species 238. 
Instead of solely as reactive intermediates, pyridinium salts can actually be the targeted 
compounds. As an example, the group of Blank reported the synthesis of pyridinium salt 243 
(alapyridaine), which was isolated and identified from the Maillard reaction of D-glucose and 
L-alanine.59 It was found that 243 has an enhancing effect on the sweet taste of glucose, 
sucrose, L-alanine and the artificial sweetener aspartame, while being tasteless on its own. In 
order to further investigate the effects of 243, the authors started its synthetic preparation by 
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reductive amination of 241 with L-alanine. Subsequent aza-Achmatowicz reaction of the 
resulting ammonium salt 242, furnished alapyridaine (243) as a single enantiomer. 
 
Scheme 2.50 Synthesis of taste enhancing pyridinium salt 243. 
2.6 Conclusions 
In summary, the publications that were discussed herein give a comprehensive overview of 
the chemistry and applications of aza-Achmatowicz reactions. It has become evident from the 
examples that the aza-Achmatowicz products are indeed versatile building blocks that can be 
further functionalized using different modes of action. Furthermore the broad application of 
the reaction in a large number of natural product syntheses and in the synthesis of a variety of 
other molecules indicates its power and versatility. Finally, although various methods for the 
generation of optically pure aza-Achmatowicz substrates have been reported, only a few are 
catalytic. 
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3.1 Introduction 
Considering the applications of the aza-Achmatowicz reaction (see Chapter 2) in organic 
synthesis, it appears that relatively few examples are based on enantiomerically pure 
substrates that are obtained via asymmetrically catalyzed reactions. Considering the potential 
pharmaceutical relevance of the resulting piperidin-3-ones, being for example direct 
precursors for 3-hydroxypiperidines,1 we envisaged that there is demand for methodology to 
prepare enantiomerically pure aza-Achmatowicz substrates. Moreover, piperidin-3-ones 
contain multiple reactive sites for further synthetic elaboration, which render them 
exceptionally versatile for the synthesis of a wide array of substituted piperidines. We 
therefore wished to develop new entries into enantiopure aza-Achmatowicz substrates, in 
particular by applying the proline-catalyzed asymmetric Mannich reaction, which was 
previously investigated in our group.2 
3.2 Retrosynthetic plan 
We envisioned that 2,6-disubstituted piperidin-3-ones 29 could be selectively prepared via 
addition of suitable nucleophiles to N-acyliminium ion 30, derived from building blocks 20–
23. The 6-hydroxypiperidin-3-one moiety of 20–23 (Scheme 3.1), typical products of the aza-
Achmatowicz reaction, should be readily accessible from γ-amino alcohols 13–16, 19. Based 
on previous experience in our group, we anticipated that the asymmetric Mannich reaction 
would afford the desired γ-amino alcohols with high diastereo- and enantioselectivities from 
furanyl imines 8–11. Starting from furfural (31), the desired imines can be generated in situ or 
they can be prepared prior to the Mannich reaction depending on the nature of R3. 
 
Scheme 3.1 Retrosynthetic analysis of piperidinones 29. 
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3.3 Preparation of enantiopure aza-Achmatowicz substrates via the 
proline-catalyzed Mannich reaction 
In the approach to the Achmatowicz substrates, we had to decide on the nitrogen protecting 
group. In view of the examples discussed in Chapter 2, it is clear that sulfonyl- and 
carbamoyl-protected amines generally provide the best results in aza-Achmatowicz reactions. 
Of the two, N-sulfonyl amines tend to be less sensitive towards side reactions in the aza-
Achmatowicz process and allow further modification of the anticipated building blocks via N-
sulfonyliminium ion chemistry.3 However, Mannich reactions of N-sulfonyl imines have been 
scantly described using proline as the catalyst and only chiral metal-based Lewis acids have 
been successfully applied to obtain the desired selectivities. On the other hand, N-carbamoyl 
imines are also suitable substrates for the aza-Achmatowicz reaction and allow further 
modification via N-acyliminium ion chemistry.4–5 Furthermore, precedent on the synthesis of 
N-carbamoyl amines via the proline-catalyzed Mannich reaction exists, especially of N-Boc 
protected amines. For example, the groups of List and Córdova independently published in 
2007 the first proline-catalyzed asymmetric Mannich reactions with preformed N-Boc 
imines.6 We decided to screen across a range of protecting groups by applying the conditions 
described therein to furfural-derived imines for the asymmetric synthesis of the desired aza-
Achmatowicz substrates. 
We commenced by preparing the requisite imine 11 (Scheme 3.1), taking into consideration 
that the acid-labile character of the Boc-group might be unfavorable for eventual further 
modification of the building blocks 20–23 via N-acyliminium ion chemistry. We therefore 
planned to additionally investigate the proline-catalyzed Mannich reaction of N-Cbz, N-Ts 
and N-4-Ns imines, since ample precedent has shown the suitability of these protective groups 
for N-acyl- and sulfonyliminium ion addition. 
N-carbamoyl imines were prepared by in situ β-elimination of benzenesulfinic acid from α-
amidosulfones 4 and 5, which in turn were synthesized from furfural (1) and carbamates 2 
and 3 following the procedure by Wenzel and Jacobsen (Scheme 3.2).7 Because N-carbamoyl 
imines are rather moisture sensitive and tend to deteriorate upon storage, we had to freshly 
prepare them prior to the Mannich reaction from the corresponding α-amidosulfones. N-
Sulfonyl imines 8 and 9, which were obtained by crystallization after acid-catalyzed 
condensation of furfural (1) with sulfonamides 6 and 7, could be stored at low temperatures 
for prolonged periods of time (Scheme 3.2).  
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Scheme 3.2 Synthesis of α-amidosulfones (4 and 5) and N-sulfonyl imines (8 and 9). 
Having prepared the desired substrates, the stage was set to investigate the proline-catalyzed 
asymmetric Mannich reaction. List and Córdova reported outstanding results on proline-
catalyzed Mannich reactions of N-Boc imines with various aldehydes. However, we initiated 
our studies investigating less acid-labile protective groups by reacting N-sulfonyl imines 8 
and 9 with L-proline (20 mol %) and phenylacetaldehyde according to the conditions 
described by List et al. The resulting β-amino aldehydes were reduced in situ and γ-amino 
alcohols 13 and 14 were isolated in moderate and good yield resp. (Table 3.1, entries 1–2). 
Nonetheless, the diastereoisomeric selectivity of both reactions was rather poor and we 
therefore decided to focus our efforts on the synthesis of N-carbamoyl-protected γ-amino 
alcohols. Because of its higher stability towards acidic conditions, we first prepared N-Cbz-
protected imine 10 by eliminating the appropriate α-amidosulfone under basic conditions. We 
noticed that the resulting imine was highly moisture sensitive, necessitating elimination in the 
presence of molecular sieves. Having established suitable conditions to prepare imine 10, 
treatment with L-proline and phenylacetaldehyde (12e) furnished 15 in a discouraging 15% 
yield (Table 3.1, entry 3). Although the diastereoselectivity of the reaction was slightly higher 
compared to the reactions with N-sulfonyl imines, the low yield compelled us to use the N-
Boc-protected imines as described by List and Córdova for the asymmetric Mannich reaction. 
Thus, elimination of 5 under basic conditions afforded the corresponding crude imine (11), 
which was then immediately treated with L-proline (20 mol %) and an aldehyde to give the 
corresponding β-amino aldehydes (Table 3.1, entries 4–8). The crude Mannich products were 
reduced in situ resulting in γ-amino alcohols 16a–e, which were isolated by precipitation from 
n-heptane. Aliphatic (entries 4–6), allylic (entry 7) and aromatic substituents (entry 8) were 
smoothly introduced in reasonable yields and with excellent selectivities. 
 
Scheme 3.3 Preparation of aldehyde 12f. 
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Table 3.1 Asymmetric organocatalytic Mannich reaction. 
 
entry substrate product R1 R2 yielda (%) d.r.b eeb (%) 
1 8 13 Ts Ph 81 1:1.5d n.d. 
2 9 14 4-Ns Ph 64 1:1d n.d. 
3c 4 15 Cbz Ph 15 1:5d n.d. 
4 5 16a Boc Me 54 >1:20 >99 
5 5 16b Boc Pr 57 >1:20 >99 
6 5 16c Boc i-Pr 58 >1:20 97 
7 5 16d Boc Allyl 71 >1:20 99 
8 5 16e Boc Ph 50 >1:20 >99 
9 5 16f Boc 4-BrC6H4 43 >1:20 95e 
a Isolated yield. b Determined after precipitation from n-heptane. c Conditions for sulfone 
elimination: K2CO3, Na2SO4, 4Å MS, rt. d Determined after flash chromatography. e Absolute 
stereochemistry determined by X-ray structure analysis. 
The crystals of γ-amino alcohol 16e were of sufficient quality for single crystal X-ray 
structure analysis. Despite the fact that the relative configuration was readily determined, the 
absolute configuration of 16e could not be directly resolved. We therefore prepared aldehyde 
12f via hydrolysis of enol ether 18, which was obtained by a Wittig reaction of 4-
bromophenylacetaldehyde (17) and methoxymethyltriphenylphosphonium chloride (Scheme 
3.3).8 Aldehyde 12f was then subjected to the Mannich reaction affording 16f in 43% yield 
(Table 3.1, entry 9) and the absolute configuration of amino alcohol 16f was successfully 
determined to be (S,S) by single crystal X-ray structure analysis (Figure 3.1).9 
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Figure 3.1 X-ray structure analysis of 16f. 
3.4 Synthesis of N,O-acetals via the aza-Achmatowicz reaction 
The next step was the aza-Achmatowicz reaction, which according to literature, in case of 
carbamoylated amines with NBS/MeOH is likely to result in formation of significant amounts 
of side products.10 By using m-CPBA as the oxidant, side product formation may to a large 
extent be suppressed.11 Indeed, aza-Achmatowicz reactions induced with m-CPBA of γ-amino 
alcohols 16a–e afforded the intended hemiaminals, which due to the anticipated lability, were 
directly converted with CH(OEt)3 and BF3·Et2O into the N,O-acetals 21a–e in moderate to 
good yields (Table 3.2, entries 1–4 and 6). Nevertheless, we observed that 20e was more 
stable than expected and could be purified by flash chromatography (Table 3.2, entry 5). 
NMR analysis revealed that N,O-acetals 21a–e and 20e were isolated as bicyclic hemiacetals 
rather than the corresponding hydroxyketones. The monocyclic piperidinone 22 was prepared 
by acetylation of the primary alcohol prior to the aza-Achmatowicz reaction. Thus, reacting 
13e with Ac2O, Et3N and DMAP furnished acetylated γ-amino alcohol 19 in 98% yield, which 
was subsequently subjected to the aza-Achmatowicz reaction affording piperidinone 22 in 
70% yield (Table 3.2, entry 7). While we did not observe any lactam formation in the aza-
Achmatowicz reaction of substrates 16a–e due to overoxidation, we observed small amounts 
of 23 during the reaction of 19. 
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Table 3.2 Aza-Achmatowicz reactions 
 
entry substrate product R1 R2 R3 yield (%)a d.r.b 
1 16a 21a Me H Et 88 1:1.1 
2 16b 21b Pr H Et 89 1:1.2 
3 16c 21c i-Pr H Et 45 1:1.1 
4 16d 21d Allyl H Et 79 1:1.0 
5 16e 20e Ph H H 84c 1:4 
6 20e 21e Ph H Et 78c,d 1:1.2 
7 19 22 Ph Ac H 70c 1:6 
a Isolated yield. b Determined after precipitation from n-heptane. c Purified by flash 
chromatography. d Starting from 20e. Conditions: (a) Ac2O, Et3N, DMAP; (b) m-CPBA; (c) 
BF3·Et2O, CH(OEt)3. 
3.5 Functionalization of the N,O-acetals via N-acyliminium ion 
chemistry 
With the enantiopure N,O-acetal scaffolds in hand, we studied their further functionalization 
via N-acyliminium ion chemistry.3e-h,4a,5b,5c We initially examined the influence of the leaving 
group on the N-acyliminium ion additions to bicyclic building blocks 20e, 21e and acetylated 
24e, which was prepared by acetylation of 20e (Scheme 3.4). 
 
Scheme 3.4 Acetylation of 20e. 
Initially, we attempted to generate the N-acyliminium ion from N,O-acetal 21e, but reacting 
21e with BF3·Et2O in the presence of allyltrimethylsilane (25) at −78 to −40 °C did not show 
any conversion (Table 3.3, entry 1). Allowing the temperature to warm to 0 °C and 
subsequently raising it to 40 °C did not result in product formation either, but instead we 
observed decomposition of the starting material which is probably caused by the acid labile 
character of the Boc-group. When N,O-hemiacetal 20e (R = H) was treated with BF3·Et2O and 
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allyltrimethylsilane and the temperature was allowed to rise to 0 °C (entry 2), the product was 
formed in 39% yield as a 1:3 mixture of diastereoisomers which could be separated by 
column chromatography (entry 2). In the case of substrate 24e (R = Ac) under similar 
conditions, the product was obtained in a slightly increased yield, but remarkably, the 
diastereoselectivity of the reaction appeared to be inverted with 26a being the major isolated 
isomer (entry 3). We then switched to tin(II)triflate as the Lewis acid, which can be used in 
catalytic amounts.5b Thus, reacting 20e with tin(II)triflate (10 mol %) and allyltrimethylsilane 
in MeCN at −30 °C afforded addition product 26, albeit in low yield (entry 4). The 
unsatisfying yield could be improved by changing the leaving group to OAc (substrate 24e) 
resulting in a combined yield of diastereoisomers 26a and 26b of 35% (entry 5). In addition, 
we observed that the diastereoselectivity of the reaction also significantly increased to a 1:10 
ratio in favor of 26b. 
Table 3.3 Lewis acid and leaving group optimization for N-acyliminium ion chemistry. 
 
entry substrate Lewis acid conditions R yielda (%) ratio 26a/26bb 
1 21e BF3·Et2O (3 equiv) −78 → 40 °C, CH2Cl2 Et 0 — 
2 20e BF3·Et2O (3 equiv) −78 → 0 °C, CH2Cl2 H 39 1:3 
3 24e BF3·Et2O (3 equiv) −78 → 0 °C, CH2Cl2 Ac 55 3:1 
4 20e Sn(OTf)2 (10 mol %) −30 °C, MeCN H 11 n.d. 
5 24e Sn(OTf)2 (10 mol %) −30 → 0 °C, MeCN Ac 35 1:10 
a Combined yield of both diastereoisomers after chromatography. b Based on 1H NMR of the crude product. 
Structural assignment of the diastereoisomers is tentatively based on NOESY analysis of 26b. 
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The mediocre yields and selectivities of the allyltrimethylsilane additions to the N-
acyliminium ion derived from 20e and 24e did not meet our expectations. As an explanation 
for the low selectivities that we observed, we hypothesize that preferred axial attack of the 
nucleophile is hampered because this most likely occurs from the concave side of the 
molecule. Furthermore, we observed the formation of significant amounts of side product 29, 
of which a mechanistic rationale for its formation is shown in Scheme 3.5. Tautomerization of 
bicyclic hemiacetal 20e to monocyclic N,O-acetal 27 and subsequent Lewis acid-facilitated 
iminium ion formation results in intermediate 28. Subsequent attack of the primary hydroxyl 
would then furnish bicyclic side product 29. We showed that 29 could also be deliberately 
synthesized in 63% yield by reacting 20e with TFA in the absence of an external nucleophile 
(Scheme 3.5). 
  
Scheme 3.5 Formation of side product 29. 
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It was anticipated that better yields and selectivities would evolve from subjecting 
monocyclic piperidinone 22 to N-acyliminium ion chemistry. Indeed, reacting 22 with 
allyltrimethylsilane and catalytic tin(II)triflate, followed by deprotection of the crude product 
with TFA, resulted in formation of 2,6-disubstituted piperidinone 30a as a single cis-
diastereoisomer (Table 3.4, entry 1). Similar results were obtained when BF3·Et2O was used 
as the Lewis acid. Consequently, we observed that increasing the steric bulk of the 
nucleophiles by using methallyltrimethylsilane (entry 2) or 2-
(chloromethyl)allyltrimethylsilane (entry 3) had a large effect on the selectivity of the 
reaction due to hindrance of the axially positioned C-2 substituent, while addition of the 
smaller 3-trimethylsilyl-1,2-butadiene afforded 30d again as a single diastereoisomer (entry 
4). Addition of 2-(trimethylsiloxy)propene yielded an inseparable 1:1 mixture of 
diastereoisomers (entry 5) and the addition of α-(trimethylsiloxy)styrene surprisingly gave 
inversion of the selectivity to give the trans-isomer as the major product (entry 6). The cis- 
and trans-relationships of compounds 30a and 30f were determined by NOESY analysis. A 
NOE interaction between the C-7 and C-12 protons in 31 prior to deprotection with TFA 
indicated a cis-relationship of 30a (Scheme 3.6), while for compound 30f an interaction 
between the C-2 and C-12 protons allowed us to establish the trans-relationship. Additional 
evidence for the cis-relationship of 30a was gathered by olefin hydrogenation of 31 and 
subsequent Boc-deprotection with TFA providing 32, which has a proper chair conformation 
and hence two 2,6-diaxially positioned protons. NOESY analysis clearly showed this diaxial 
interaction between the C-2 and C-6 protons confirming the cis-relationship of compound 32 
and hence 30a. 
 
Scheme 3.6 Determination of configuration by NOESY analyses of 30f, 31 and 32. 
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Table 3.4 N-Acyliminium ion addition reactions. 
 
entry nucleophile product R yield (%)a cis/trans ratiob 
1  30a  85 >20:1 
2  30b  69 3:1 
3 
 
30c 
 
62 4.5:1 
4 
 
30d 
 
77 >20:1 
5 
 
30e 
 
62c 1:1 
6d  30f  69 1:15 
7e Et3SiH 30g —H 70 — 
a Isolated yield of major diastereoisomer after two steps. b Based on 1H NMR of crude 
product. c Isolated as a mixture of diastereoisomers. d Reaction in CH2Cl2 at −50 °C. e With 
BF3·Et2O (3 equiv) in CH2Cl2 at −78 °C. 
3.6 Conclusions 
In summary, we have established a route to enantiomerically pure building blocks starting 
from furfural by successively applying the proline-catalyzed asymmetric Mannich reaction 
and the aza-Achmatowicz reaction. The γ-amino alcohols resulting from the Mannich 
reactions were obtained in reasonable yields and excellent selectivities. Consecutive oxidation 
with m-CPBA afforded the corresponding aza-Achmatowicz products as bicyclic hemiacetals, 
of which functionalization via the N-acyliminium ion appeared to be difficult. However, an 
analogues monocyclic aza-Achmatowicz product was prepared and reacted with various 
nucleophiles under the same conditions. Although this afforded the desired products in 
reasonable to good yields, the diastereoselectivity of these reactions showed to be largely 
dependent on the size of the incoming nucleophile resulting in cis/trans ratios varying from 
>20:1 to 1:15. 
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3.8 Experimental section 
General remarks 
Dry solvents were obtained from a MBRAUN MB-SPS-800. Chemicals were purchased from Sigma-
Aldrich or AlfaAesar and used as received. Reactions were carried out in flame-dried glassware under 
an inert atmosphere of dry argon. Standard syringe techniques were applied for the transfer of dry 
solvents and air- or moisture-sensitive reagents. Reactions were followed and Rf values are obtained 
using thin layer chromatography (TLC) on silica gel-coated plates (Merck 60 F254) with the indicated 
solvent mixture. Detection was performed with UV-light, and/or by charring at ~150 °C after dipping 
into a solution of either 2% anisaldehyde in ethanol/H2SO4, KMnO4/Na2CO3/NaOH in water or 
ninhydrin/AcOH in n-butanol. Melting points were analyzed with a Büchi melting point B-545. IR 
spectra were recorded on an ATI Mattson Genesis Series FTIR spectrometer or a Bruker Tensor 27 
FTIR spectrometer. NMR spectra were recorded on a Bruker DMX 300 (300 MHz), Varian Inova 400 
(400 MHz) or Bruker Avance III (500 MHz) spectrometer in CDCl3 solutions (unless otherwise 
reported). Chemical shifts are given in ppm with respect to CDCl3 (1H NMR: 7.26 ppm, 13C NMR: 
77.16 ppm) as internal standard. Coupling constants are reported as J-values in Hz. Peak assignment in 
13C spectra are based on 2D-HSQC and HMBC spectra. Column or flash chromatography was carried 
out using ACROS silica gel (0.035–0.070 mm, and ca 6 nm pore diameter). Optical rotations were 
determined with a Perkin Elmer 241 polarimeter. High-resolution mass spectra were recorded on a 
JEOL AccuTOF JMS-T100CS (ESI) or a JEOL AccuTOF JMS-100GCv (EI, CI). HPLC 
measurements were carried out on a Shimadzu LC-2010 using the stated columns and eluents. 
Chromatograms were recorded using a two-channel UV detector at 215 and 254 nm. 
Benzyl [furan-2-yl(phenylsulfonyl)methyl]carbamate (4) 
A solution of benzyl carbamate (5.00 g, 33.1 mmol) and sodium benzenesulfinate 
(10.9 g, 66.2 mmol) in MeOH (34 mL) was diluted with water (68 mL). Freshly 
distilled furfural (4.11 mL, 49.6 mmol) and formic acid (5.5 mL, 0.14 mol) were 
subsequently added and the reaction mixture was stirred for ten days at room 
temperature. The precipitate was filtered off and washed with cold water. The 
residue was dried in vacuo to afford sulfone 4 (6.29 g, 16.9 mmol, 51%) as white powder. 1H NMR 
(300 MHz, CDCl3) δ 7.86–7.78 (m, 2H), 7.66–7.58 (m, 1H), 7.50–7.41 (m, 3H), 7.38–7.32 (m, 3H), 
7.29–7.21 (m, 2H), 6.55 (d, J = 3.4 Hz, 1H), 6.42 (dd, J = 1.9, 3.4 Hz, 1H), 6.07 (br s, 2H), 4.98 (s, 
2H). The spectral data is in accordance with earlier reported values.12 
tert-Butyl [furan-2-yl(phenylsulfonyl)methyl]carbamate (5) 
A solution of tert-butyl carbamate (26.1 g, 0.222 mol) and sodium benzenesulfinate 
(73.0 g, 0.445 mol) in MeOH (250 mL) was diluted with water (500 mL). Freshly 
distilled furfural (25.7 mL, 0.310 mol) and formic acid (17.2 mL, 0.374 mol) were 
subsequently added and the reaction mixture was stirred for six days at room 
temperature. The precipitate was filtered off and subsequently washed with cold 
water (100 mL) and Et2O (3 × 50 mL). The residue was dried in vacuo to afford sulfone 5 (34.6 g, 
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0.103 mol, 46%) as white powder. Rf 0.40 (EtOAc/heptane, 1:1). IR (ATR) ν 3339, 2976, 1714, 1515, 
1321, 1135, 728 cm−1. 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 7.5 Hz, 2H), 7.65 (t, J = 7.4 Hz, 1H), 
7.57–7.50 (m, 2H), 7.48 (br s, 1H), 6.58 (d, J = 3.4 Hz, 1H), 6.44 (dd, J = 1.9, 3.4 Hz, 1H), 6.02 (d, J = 
10.5 Hz, 1H), 5.81 (d, J = 10.5 Hz, 1H), 1.28 (s, 9H). 13C NMR (125 MHz, CDCl3) δ 153.4, 144.4, 
143.1, 136.7, 134.2, 129.7,129.2, 112.4, 111.3, 81.5, 69.1, 28.2. The spectral data is in accordance with 
earlier reported values.7 
N-(furan-2-ylmethylene)-4-methylbenzenesulfonamide (8) 
To a solution of freshly distilled furfural (4.14 mL, 50.0 mmol) and 4-
methylbenzenesulfonamide (8.56 g, 50.1 mmol) in dry toluene (250 mL) were added 
Amberlyst Xn-1010 (1.7 g) and 4 Å molecular sieves (4.0 g). After refluxing for 15 
hours under an inert atmosphere, the resulting suspension was filtered over Celite® and 
the residue was washed with CH2Cl2. The filtrate was concentrated under reduced pressure furnishing 
the crude imine, which was purified by recrystallization from toluene to afford imine 8 (6.73 g, 27.0 
mmol, 54%) as a yellow solid. 1H NMR (300 MHz, CDCl3) δ 8.81 (s, 1H), 7.87 (d, J = 8.1 Hz, 2H), 
7.73 (s, 1H), 7.33 (m, 3H), 6.64 (dd, J = 1.7, 3.7 Hz, 1H), 2.43 (s, 3H). The spectral data is in 
accordance with the values reported in literature.3f 
N-(furan-2-ylmethylene)-4-nitrobenzenesulfonamide (9) 
To a solution of freshly distilled furfural (172 µL, 2.08 mmol) and 4-
nitrobenzenesulfonamide (383 mg, 1.89 mmol) in dry toluene (15 mL) were added 
Amberlyst Xn-1010 (9.5 mg) and 4 Å molecular sieves (308 mg). After refluxing for 14 
hours under an inert atmosphere, the resulting suspension was filtered over Celite® and 
the residue was washed with toluene. The filtrate was concentrated under reduced pressure to furnish 
the crude imine, which was purified by recrystallization from toluene to afford sufficiently pure imine 
9 (180 mg, 0.643 mmol, 31%). 1H NMR (300 MHz, CDCl3) δ 8.87 (s, 1H), 8.40–8.35 (m, 2H), 8.21–
8.16 (m, 2H), 7.81 (dt, J = 0.7, 1.7 Hz, 1H), 7.44 (dd, J = 0.7, 3.7 Hz, 1H), 6.70 (dd, J = 1.7, 3.7 Hz, 
1H). 
2-(4-Bromophenyl)acetaldehyde (12f) 
To a suspension of (methoxymethyl)triphenylphosphonium chloride (1.66 g, 5.40 
mmol) in anhydrous THF (5.4 mL) at 0 °C was added KOt-Bu (5.95 mL, 5.95 
mmol, 1 M in THF) in portions. After stirring for 30 min at 0 °C, the mixture was 
allowed to warm to room temperature and a solution of 4-bromobenzaldehyde (1.0 g, 5.4 mmol) in 
anhydrous THF (5.4 mL) was slowly added via syringe. The resulting mixture was stirred for 46 h at 
room temperature until the reaction was quenched by addition of saturated aqueous NH4Cl (5.4 mL). 
The resulting white suspension was filtered and the product was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated under reduced 
pressure. To the resulting yellow solid was added n-pentane and after the triphenylphosphine oxide was 
removed by filtration, the solvent was removed under reduced pressure. This treatment was repeated 
three times. The combined residues were dissolved in CH2Cl2 (8.1 mL) and treated with formic acid 
(2.7 mL, 5.4 mmol) and the mixture was stirred in the dark at room temperature for 5 days. Water (4.0 
mL) was then added and the layers were separated. The aqueous layer was extracted with CH2Cl2 (8 
mL) and the combined organic layers were washed with brine, dried over Na2SO4 and concentrated in 
vacuo. The crude aldehyde was purified by vacuum-distillation (bp 80 °C, 0.45 mbar) affording 2-(4-
bromophenyl)acetaldehyde (12f) (290 mg, 1.46 mmol, 27%) as a white solid. Rf 0.44 (EtOAc/heptane, 
1:1). Mp 47–48 °C. IR (ATR) ν 2837, 2729, 1731, 1493, 1066, 1009, 815, 607, 517 cm–1. 1H NMR 
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(300 MHz, CDCl3) δ 9.74 (t, J = 2.1 Hz, 1H), 7.50 (d, J = 8.5 Hz, 2H), 7.09 (d, J = 8.5 Hz, 2H), 3.66 
(d, J = 2.1 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 198.6, 132.2, 131.4, 130.9, 121.7, 50.0. The 
spectral data is in accordance with earlier reported values.13 
3-[N-(4-methylbenzenesulfonyl)amino]-3-(furan-2-yl)-2-phenylpropanol (13) 
To a solution of imine 8 (150 mg, 0.602 mmol) in MeCN (5 mL) at −5 °C was 
added freshly distilled phenylacetaldehyde (140 µL, 1.26 mmol) and L-proline (14 
mg, 0.12 mmol). The mixture was stirred at −5 °C for 16 h under an inert 
atmosphere. The reaction was then quenched by addition of water (20 mL) and the 
product was extracted with Et2O (3 × 20 mL). The combined organic layers were washed with brine, 
dried over MgSO4 and concentrated in vacuo to afford the crude amino aldehyde, which was 
subsequently dissolved in MeOH (6.0 mL). The mixture was cooled to −78 °C and NaBH4 (88 mg, 2.3 
mmol) was added. The reaction mixture was allowed to stir for a period of 2.5 h while allowing it to 
warm to room temperature. The reaction was quenched by addition of water (20 mL). The product was 
extracted with CH2Cl2 (2 × 20 mL) and the combined organic layers were washed with brine and dried 
over MgSO4. Removal of the volatiles under reduced pressure afforded the crude amino alcohol, which 
was purified by flash chromatography (silica gel, EtOAc/heptane, 1:2) to afford 13 (181 mg, 0.490 
mmol, 81%) as a 1:1.5 mixture of diastereoisomers. Rf 0.32 (EtOAC/heptane, 1:1). IR (ATR) ν 3296, 
3028, 2928, 1528, 1346, 1165 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.3 Hz, 2H), 7.60–7.52 
(m, 4H), 7.30–6.95 (m, 9H), 6.07 (dd, J = 1.9, 3.3 Hz, 1H), 5.92 (dd, J = 1.8, 3.3 Hz, 1H), 5.72 (d, J = 
3.3 Hz, 1H), 5.48 (d, J = 3.0 Hz, 1H), 4.94 (m, 3H), 4.78 (t, J = 9.22 Hz, 2H), 3.75 (m, 2H), 3.30 (m, 
2H), 3.18 (dd, J = 4.9, 9.4 Hz, 1H), 2.40 (s, 7H), 2.31 (m, 3H), 2.04 (s, 1H), 1.59 (s, 2H), 1.26 (t, J = 
7.1 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 141.6, 130.0–125.0, 110.1, 109.9, 107.9, 107.3, 53.7, 52.5, 
52.2, 52.1. 
3-[N-(4-nitrobenzenesulfonyl)amino]-3-(furan-2-yl)-2-phenylpropanol (14) 
To a solution of imine 9 (100 mg, 0.357 mmol) in MeCN (3.75 mL) at −5 °C was 
added freshly distilled phenylacetaldehyde (80 µL, 0.71 mmol) and L-proline (8.2 
mg, 0.071 mmol). The mixture was stirred for 16 h at −5 °C under an inert 
atmosphere. The reaction was then quenched by addition of water (20 mL) and the 
product was extracted with Et2O (3 × 20 mL). The combined organic layers were washed with brine, 
dried over Na2SO4 and concentrated in vacuo to afford the crude amino aldehyde, which was 
subsequently dissolved in MeOH (2.5 mL). The mixture was cooled to −78 °C and NaBH4 (38 mg, 1.0 
mmol) was added. The reaction mixture was allowed to stir for a period of 2.5 h while allowing it to 
warm to room temperature. The reaction was quenched by addition of saturated aqueous NH4Cl (5 
mL). The product was extracted with Et2O (3 × 5 mL) and the combined organic layers were washed 
with brine and dried over Na2SO4. Removal of the volatiles under reduced pressure afforded the crude 
amino alcohol, which was purified by flash chromatography (silica gel, EtOAc/heptane, 1:2) furnishing 
γ-amino alcohol 14 (93 mg, 0.23 mmol, 64%) as a 1:1 mixture of diastereoisomers. Rf 0.32 
(EtOAC/heptane, 1:1). IR (ATR) ν 3287, 2928, 1528, 1346, 1308, 1165, 1009, 737 cm–1. 1H NMR (500 
MHz, CDCl3) δ 8.07 (d, J = 8.9 Hz, 2H), 7.69 (d, J = 8.9 Hz, 2H), 7.36–7.10 (m, 3H), 7.02–6.98 (m, 
1H), 6.97–6.92 (m, 2H), 6.01 (dd, J = 1.9 3.2 Hz, 1H), 5.75 (d, J = 3.2 Hz, 1H), 5.50–5.25 (m, 1H), 
4.94 (d, J = 6.1 Hz, 1H), 3.94–3.87 (m, 1H), 3.70–3.63 (m, 1H), 3.30–3.20 (m, 1H). 13C NMR (125 
MHz, CDCl3) δ 150.8, 149.6, 145.9, 142.1, 128.8, 127.9, 123.9, 110.3, 108.5, 63.0, 53.0, 51.9. 
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3-[N-(Benzyloxycarbonyl)amino]-3-(furan-2-yl)-2-phenylpropanol (15) 
To a flask that was charged with K2CO3 (0.67 g, 4.9 mmol) and 4 Å molecular 
sieves (360 mg) were added THF (9 mL) and sulfone 4 (0.30 g, 0.81 mmol). The 
resulting suspension was stirred for 20 min at room temperature and was 
subsequently filtered over Celite®. Concentration of the filtrate under reduced 
pressure afforded the crude imine, which was immediately dissolved in dry MeCN (1.9 mL). The 
resulting solution was cooled to −8 °C and phenylacetaldehyde (48 µL, 0.43 mmol) and L-proline (5.0 
mg, 0.043 mmol) were added. The reaction mixture was stirred for 17 h at −8 °C and the reaction was 
then quenched by addition of water (10 mL). The product was extracted with Et2O (3 ×) and the 
combined organic layers were washed with brine and dried over Na2SO4. Concentration in vacuo 
furnished the crude aldehyde which was subsequently brought into MeOH (1.4 mL) at −78 °C. Sodium 
borohydride (21 mg, 0.54 mmol) was added and the reaction mixture was allowed to warm to room 
temperature and was stirred for another 2.5 h until TLC indicated full conversion of the starting 
material. The reaction was quenched with saturated aqueous NH4Cl (5 mL) and the product was 
extracted with Et2O (3 × 5 mL). The combined organic layers were washed with brine, dried over 
Na2SO4 and the solvents were removed under reduced pressure. Purification of the resulting crude 
product by flash chromatography (silica gel, EtOAc/heptane, 1:2) furnished γ-amino alcohol 15 (42 
mg, 0.12 mmol, 15%) as a 1:5 mixture of diastereoisomers. Rf 0.41 (EtOAC/heptane, 1:1). IR (ATR) ν 
3399, 3028, 2924, 1697, 1052 cm–1. 1H NMR (500 MHz, CDCl3, mixture of diastereoisomers A and B) 
δ 7.40–7.00 (m, 20HA+B), 6.98–6.92 (m, 2HA+B), 6.82 (s, 1HB), 6.18 (s, 1HA), 6.06 (s, 1HB), 5.97–5.93 
(m, 1HA), 5.37–5.29 (m, 1HA), 5.22–5.10 (m, 1HB), 5.18 (s, 4HA+B), 4.70–4.55 (m, 2HA+B), 3.85–3.75 
(m, 2HA+B), 3.70–3.60 (m, 1HA), 3.36–3.24 (m, 1HA), 3.14–3.04 (m, 1HB). 13C NMR (125 MHz, 
CDCl3) δ 156.7, 141.7, 128.8–128.0, 127.4, 126.5, 110.3, 106.7, 67.3, 63.7, 52.2, 50.0. 
General procedure for the asymmetric Mannich reaction 
A 500 mL flask was charged with Na2SO4 (27.1 g, 191 mmol) and K2CO3 (25.4 g, 184 mmol). A 
vacuum was applied to the flask and the solids were flame-dried. When the flask and its contents were 
cooled to room temperature, sulfone 5 (10.1 g, 30.0 mmol) and THF (250 mL) were added. The flask 
was equipped with a reflux condenser and the mixture was refluxed for 20 h. After the reaction was 
finished, the mixture was allowed to cool to room temperature and the solids were filtered off. The 
filtrate was concentrated in vacuo affording the crude imine (5.76 g, 29.5 mmol, 99%) as a pale yellow 
oil. 
A flame-dried Schlenk tube was charged with a solution of a weighed amount of freshly prepared 
imine in MeCN (~0.1 M) and immersed in a cooling bath at −20 °C. The appropriate aldehyde (12a–f) 
and L-proline (~20 mol %) were added and the mixture was stirred for 36 h at that temperature. After 
the reaction was quenched with water, the product was extracted with Et2O (3 ×) and the combined 
organic layers were washed with brine and dried over Na2SO4. After removal of the solvents under 
reduced pressure, the residue was dissolved in MeOH (~0.1 M) and cooled to −78 °C on a dry 
ice/acetone bath. NaBH4 (1.75–2.00 equiv) was added and after stirring the resulting mixture for 15 
min at −78 °C, the cooling bath was removed to allow the reaction mixture to warm to room 
temperature. The mixture was stirred for another 1–4 h until TLC showed full conversion of the 
starting material. The reaction was then quenched by addition of saturated aqueous NH4Cl and the 
product was extracted with Et2O (3 ×). The combined organic layers were washed with brine, dried 
over Na2SO4 and concentrated in vacuo to afford the crude product, which was purified by 
recrystallization from n-heptane. 
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(2S,3S)-3-[N-(tert-Butoxycarbonyl)amino]-3-(furan-2-yl)-2-methylpropanol (16a) 
According to the general procedure for the asymmetric Mannich reaction, freshly 
prepared imine (1.01 g, 5.17 mmol) was reacted with propionaldehyde (12a, 0.41 g, 
7.1 mmol) and L-proline (122 mg, 1.06 mmol) in MeCN (50 mL). Reduction of the 
resulting aldehyde with NaBH4 (349 mg, 9.22 mmol) in MeOH (50 mL) furnished γ-
amino alcohol 16a (718 mg, 2.81 mmol, 54%) as a white solid. Rf 0.53 (EtOAc/heptane, 1:1). Mp 90–
91 °C. [α]!!" = −32.5 (c 1.0, CH2Cl2). IR (ATR) ν 3347, 2971, 2924, 1679, 1502, 1164, 733 cm–1. 1H 
NMR (500 MHz, CDCl3) δ 7.35 (dd, J = 0.9, 1.9 Hz, 1H), 6.33 (dd, J = 1.9, 3.2 Hz, 1H), 6.17 (d, J = 
3.2 Hz, 1H), 5.14 (br s, 2H), 3.57 (dd, J = 4.7, 9.1 Hz, 1H), 3.49 (ddd, J = 4.9, 9.1, 11.7 Hz, 1H), 3.33 
(td, J = 4.7, 11.0 Hz, 1H), 2.29–2.16 (m, 1H), 1.46 (s, 9H), 0.73 (d, J = 6.9 Hz, 3H). 13C NMR (125 
MHz, CDCl3) δ 156.8, 153.9, 141.8, 110.4, 106.0, 80.5, 64.7, 49.2, 40.4, 28.4, 10.9. HRMS (ESI+) 
calcd for C13H21NO4Na [M+Na]+ 278.1368, found 278.1380. HPLC: ee: >99%, Chiralpak AD-H (250 × 
4.6 mm), flow: 1.0 mL/min, n-heptane/2-propanol 80/20, retention times: 16a: 5.5 min, ent-16a: 12.0 
min. 
(2S,3S)-3-[N-(tert-Butoxycarbonyl)amino]-3-(furan-2-yl)-2-propylpropanol (16b) 
According to the general procedure for the asymmetric Mannich reaction, freshly 
prepared imine (0.93 g, 4.8 mmol) was reacted with pentanal (12b, 0.81 g, 9.4 
mmol) and L-proline (121 mg, 1.05 mmol) in MeCN (50 mL). Reduction of the 
resulting aldehyde with NaBH4 (337 mg, 8.91 mmol) in MeOH (50 mL) furnished γ-
amino alcohol 16b (780 mg, 2.75 mmol, 57%) as a white solid. Rf 0.63 (EtOAc/heptane, 1:1). Mp 82–
84 °C. [α]!!" = −20.0 (c 1.0, CH2Cl2). IR (ATR) ν 3378, 2963, 2924, 1689, 1503, 1366, 1250, 1169, 
1047, 1009, 734 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.35 (dd, J = 0.7, 1.7 Hz, 1H), 6.32 (dd, J = 1.9, 
3.2 Hz, 1H), 6.16 (d, J = 3.2 Hz, 1H), 5.25 (d, J = 9.2 Hz, 1H), 5.13 (d, J = 7.2 Hz, 1H), 3.72–3.58 (m, 
1H), 3.43–3.27 (m, 2H), 2.14–2.04 (m, 1H), 1.45 (s, 9H), 1.36–1.25 (m, 1H), 1.23–1.10 (m, 2H), 1.09–
0.96 (m, 1H), 0.83 (t, J = 7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 156.6, 153.9, 141.7, 110.4, 
106.1, 80.4, 63.1, 49.5, 45.1, 28.6, 28.5, 20.7, 14.4. HRMS (ESI+) calcd for C15H25NO4Na [M+Na]+ 
306.1681, found 306.1688. HPLC: ee: >99%, Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 mL/min, n-
heptane/2-propanol 90/10, retention times: 16b: 8.2 min, ent-16b: 9.1 min. 
(2S,3S)-3-[N-(tert-Butoxycarbonyl)amino]-3-(furan-2-yl)-2-(2-propyl)propanol (16c) 
According to the general procedure for the asymmetric Mannich reaction, freshly 
prepared imine (98 mg, 0.50 mmol) was reacted with isovaleraldehyde (12c, 56 mg, 
0.65 mmol) and L-proline (12 mg, 0.10 mmol) in MeCN (5 mL). Reduction of the 
resulting aldehyde with NaBH4 (38 mg, 1.0 mmol) in MeOH (5 mL) furnished γ-
amino alcohol 16c (82 mg, 0.29 mmol, 58%) as a white solid. Rf 0.63 (EtOAc/heptane, 1:1). Mp 54–56 
°C. [α]!!" = −42.0 (c 1.0, CH2Cl2). IR (ATR) ν 3378, 2967, 1689, 1502, 1367, 1169, 1009, 733 cm–1. 1H 
NMR (300 MHz, CDCl3) δ 7.34 (dd, J = 0.8, 1.8 Hz, 1H), 6.31 (dd, J = 1.8, 3.2 Hz, 1H), 6.19 (dt, J = 
0.7, 3.2 Hz, 1H), 5.59 (d, J = 9.1 Hz, 1H), 5.20–4.96 (m, 1H), 3.72 (ddd, J = 4.3, 6.4, 11.5 Hz, 1H), 
3.54 (ddd, J = 5.3, 9.1, 11.5 Hz, 1H), 2.60 (br s, 1H), 1.97–1.76 (m, 1H), 1.75–1.57 (m, 1H), 1.42 (s, 
9H), 0.96 (d, J = 6.8 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 155.9, 154.3, 
141.6, 110.5, 106.5, 79.9, 61.5, 50.8, 49.7, 28.5, 26.8, 22.1, 19.7. HRMS (ESI+) calcd for C15H26NO4 
[M+H]+ 284.1862, found 284.1879. HPLC: ee: 97%, Phenomenex Lux 3u Amylose-2 (250 × 4.6 mm), 
flow: 1.0 mL/min, n-heptane/2-propanol 90/10, retention times: 16c: 9.6 min, ent-16c: 8.0 min. 
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(2S,3S)-3-[N-(tert-Butoxycarbonyl)amino]-3-(furan-2-yl)-2-(2-propenyl)propanol (16d) 
According to the general procedure for the asymmetric Mannich reaction, freshly 
prepared imine (980 mg, 5.02 mmol) was reacted with pent-4-enal (12d, 852 mg, 
10.1 mmol) and L-proline (123 mg, 1.07 mmol) in MeCN (50 mL). Reduction of the 
resulting aldehyde with NaBH4 (280 mg, 7.40 mmol) in MeOH (50 mL) furnished γ-
amino alcohol 16d (1.00 g, 3.55 mmol, 71%) as a white solid. Rf 0.61 
(EtOAc/heptane, 1:1). Mp 54–57 °C. [α]!!" = −13.0 (c 1.0, CH2Cl2). IR (ATR) ν 3381, 2978, 1690, 
1503, 1367, 1250, 1169, 1010, 736 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.36 (dd, J = 0.8, 1.8 Hz, 1H), 
6.33 (dd, J = 1.8, 3.2 Hz, 1H), 6.19 (dt, J = 0.8, 3.2 Hz, 1H), 5.76–5.62 (m, 1H), 5.24 (d, J = 8.9 Hz, 
1H), 5.14 (dd, J = 2.8, 9.0 Hz, 1H), 5.00 (d, J = 5.0 Hz, 1H), 4.98 (d, J = 8.8 Hz, 1H), 3.68–3.58 (m, 
1H), 3.44–3.34 (m, 1H), 3.19 (dd, J = 5.4, 7.8 Hz, 1H), 2.24–2.14 (m, 1H), 2.11–2.00 (m, 1H), 1.90–
1.77 (m, 1H), 1.46 (s, 9H). 13C NMR (125 MHz, CDCl3) δ 156.5, 153.5, 141.9, 136.2, 116.6, 110.5, 
106.4, 80.5, 62.8, 49.3, 45.1, 31.4, 28.5. HRMS (ESI+) calcd for C15H24NO4 [M+H]+ 282.1705, found 
282.1712. HPLC: ee: >99%, Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 mL/min, n-heptane/2-
propanol 90/10, retention times: 16d: 9.5 min, ent-16d: 11.8 min. 
(2S,3S)-3-[N-(tert-Butoxycarbonyl)amino]-3-(furan-2-yl)-2-phenylpropanol (16e) 
According to the general procedure for the asymmetric Mannich reaction, freshly 
prepared imine (3.20 g, 16.4 mmol) was reacted with phenylacetaldehyde (12e, 2.36 
g, 19.7 mmol) and L-proline (377 mg, 3.28 mmol) in MeCN (150 mL). Reduction of 
the resulting aldehyde with NaBH4 (1.24 g, 32.8 mmol) in MeOH (115 mL) 
furnished γ-amino alcohol 16e (2.58 g, 8.13 mmol, 50%) as a white solid. Rf 0.46 (EtOAc/heptane, 
1:1). Mp 111–112 °C. [α]!!" = −44.6 (c 1.0, CH2Cl2). IR (ATR) ν 3425, 2976, 1688, 1493, 1169, 1061, 
1018, 737, 698 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.33–7.20 (m, 4H), 7.06–6.99 (m, 2H), 6.24 (br s, 
1H), 5.99 (d, J = 2.5 Hz, 1H), 5.37 (br s, 1H), 4.96 (d, J = 7.3 Hz, 1H), 3.89 (dd, J = 9.4, 11.6 Hz, 1H), 
3.74 (dd, J = 5.5, 11.6 Hz, 1H), 3.51–3.11 (br s, 1H), 3.36 (dt, J = 5.2, 9.2 Hz, 1H), 1.45 (s, 9H). 13C 
NMR (125 MHz, CDCl3) δ 156.5, 153.3, 141.6, 137.8, 128.8, 128.5, 127.4, 110.3, 106.4, 80.6, 63.0, 
52.6, 49.4, 28.4. HRMS (ESI+) calcd for C18H23NO4Na [M+Na]+ 340.1525, found 340.1532. HPLC: ee: 
>99%, Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 mL/min, n-heptane/2-propanol 80/20, retention 
times: 16e: 7.0 min, ent-16e: 8.3 min. 
(2S,3S)-3-[N-(tert-Butoxycarbonyl)amino]-3-(furan-2-yl)-2-(4-bromophenyl)propanol (16f) 
According to the general procedure for the asymmetric Mannich reaction, freshly 
prepared imine (87 mg, 0.44 mmol) was reacted with 2-(4-
bromophenyl)acetaldehyde (12f, 150 mg, 0.754 mmol) and L-proline (10 mg, 0.087 
mmol) in MeCN (4 mL). Reduction of the resulting aldehyde with NaBH4 (67 mg, 
1.8 mmol) in MeOH (4.4 mL) furnished γ-amino alcohol 16f (74 mg, 0.19 mmol, 
43%) as an off-white solid. Rf 0.44 (EtOAc/heptane, 1:1). Mp 106–110 °C. [α]!!" = 
−26.1 (c 1.0, CH2Cl2). IR (ATR) ν 3412, 2976, 2928, 1701, 1489, 1169, 1018, 741, 612 cm–1. 1H NMR 
(300 MHz, CDCl3) δ 7.37 (d, J = 8.4 Hz, 2H), 7.30–7.23 (br s, 1H), 6.89 (d, J = 8.4 Hz, 2H), 6.25 (dd, 
J = 1.8, 3.2 Hz, 1H), 6.00 (d, J = 3.2 Hz, 1H), 5.42–5.22 (m, 1H), 4.95 (d, J = 8.8 Hz, 1H), 3.91–3.77 
(m, 1H), 3.76–3.60 (m, 1H), 3.44 (br s, 1H), 3.31 (dt, J = 5.2, 9.0 Hz, 1H), 1.44 (s, 9H). 13C NMR (75 
MHz, CDCl3) δ 156.4, 152.9, 141.8, 136.9, 131.6, 130.5, 121.4, 110.4, 106.5, 80.8, 62.8, 52.2, 49.3, 
28.4. HRMS (ESI+) calcd for C18H22BrNO4Na [M+Na]+ 418.0630, found 418.0634. HPLC: ee: 95%, 
Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 mL/min, n-heptane/2-propanol 80/20, retention times: 16f: 
9.9 min, ent-16f: 11.7 min. 
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(2S,3S)-3-[N-(tert-Butoxycarbonyl)amino]-3-(furan-2-yl)-2-phenylpropyl acetate (19) 
Amino alcohol 16e (1.50 g, 4.73 mmol) was reacted with triethylamine (1.45 mL, 
1.05 mmol), 4-dimethylaminopyridine (231 mg, 1.89 mmol) and acetic anhydride 
(981 µL, 10.4 mmol) in CH2Cl2 (4.7 mL) at room temperature for 10 min. The 
reaction mixture was diluted with Et2O (5 mL) followed by addition of 1 M 
aqueous HCl (5 mL). The layers were separated and the organic layer was washed with 1 M aqueous 
NaOH (10 mL), dried over Na2SO4 and the solvents were removed under reduced pressure. The crude 
product was purified by flash chromatography (silica gel, EtOAc/heptane, 1:1) affording 19 (1.66 g, 
4.62 mmol, 98%) as a white powder. Rf 0.58 (EtOAc/heptane, 1:1). Mp 92–93 °C. [α]!!" = −44.6 (c 1.0, 
CH2Cl2). IR (ATR) ν 2978, 1735, 1684, 1519, 1234, 1169, 1009, 616 cm–1. 1H NMR (300 MHz, 
CDCl3) δ 7.37 (dd, J = 0.8, 1.7 Hz, 1H), 7.31–7.21 (m, 3H), 7.08 (d, J = 1.6 Hz, 1H), 7.06 (br s, 1H), 
6.28 (dd, J = 1.9, 3.2 Hz, 1H), 6.04 (d, J = 3.2 Hz, 1H), 5.22 (br s, 1H), 4.70 (br s, 1H), 4.36 (dd, J = 
7.0, 11.2 Hz, 1H), 4.24 (dd, J = 6.3, 11.2 Hz, 1H), 3.54 (q, J = 6.6 Hz, 1H), 2.00 (s, 3H), 1.36 (s, 9H). 
13C NMR (75 MHZ, CDCl3) δ 170.0, 154.1, 152.3, 140.9, 136.4, 127.6, 127.5, 126.5, 109.5, 106.1, 
79.0, 63.7, 49.2, 47.5, 27.4, 20.0. HRMS (ESI+) calcd for C20H25NO5Na [M+Na]+ 382.1630, found 
382.1625. 
tert-Butyl (1S,3RS,6S,9S)-3,6-dihydroxy-9-phenyl-7-oxa-2-azabicyclo[4.3.0]non-4-ene-2-
carboxylate (20e) 
A solution of 16e (1.50 g, 4.73 mmol) in anhydrous CH2Cl2 (47 mL) was cooled to 0 
°C before m-CPBA (1.63 g, 7.27 mmol) was added. The resulting mixture was stirred 
for 2 h while the temperature was slowly allowed to rise to room temperature by 
removal of the ice bath after 15 min. The reaction mixture was then diluted with 
CH2Cl2 (50 mL) and subsequently washed with 20% aqueous KI solution (100 mL), 30% aqueous 
Na2S2O5 solution (100 mL), saturated aqueous NaHCO3 (100 mL), water (100 mL) and brine (100 mL). 
The combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude product 
was purified by flash chromatography (silica gel, EtOAc/heptane, 1:2) affording 20e (1.32 g, 3.96 
mmol, 84%) as a white solid. Rf 0.21 (EtOAC/heptane, 1:1). Mp 52–54 °C. IR (ATR) ν 3378, 2971, 
1688, 1511, 1169, 1001, 698 cm–1. 1H NMR (500 MHz, CDCl3, 1:4 mixture of diastereoisomers and 
rotamers) δ 7.38–7.23 (m, 6.25H), 6.26–5.80 (m, 3.75H), 5.36–4.16 (m, 4.21H), 4.09–3.82 (m, 1.27H), 
3.66–3.39 (m, 1.71H), 3.26–3.10 (m, 0.31H), 1.31 (s, 8H), 1.18 (s, 3.25H). 13C NMR (125 MHz, 
CDCl3, mixture of diastereoisomers and rotamers) δ 155.5, 138.0, 137.3, 135.3, 134.6, 134.0, 131.9, 
131.5, 130.8, 129.1, 128.9, 127.9, 127.8, 127.49, 127.45, 115.0, 102.0, 101.7, 79.9, 72.4, 67.6, 62.7, 
60.5, 60.3, 49.7, 48.4, 28.35, 28.28, 28.0, 21.2, 14.3. HRMS (ESI+) calcd for C18H23NO5Na [M+Na]+ 
356.1474, found 356.1468. 
General procedure for the aza-Achmatowicz reactions 
To a solution of substrate 16 in CH2Cl2 (~0.1 M) was added m-CPBA (~2.0–2.2 equiv, 77 wt%). The 
reaction mixture was stirred for approximately 3 h until TLC indicated the reaction to be completed. 
The reaction mixture was diluted with CH2Cl2 (~0.1 M) and successively washed with 20% aqueous KI 
solution, 30% aqueous Na2S2O5 solution, saturated aqueous NaHCO3, water and brine. The combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The hemiaminal was dissolved in 
THF (~0.1 M) and brought to −78 °C on a dry ice/acetone bath. Triethylorthoformate (~4 equiv) and 
BF3·Et2O (0.05–0.2 equiv, 48%) were added and the reaction mixture was stirred for approximately 3 h 
until TLC indicated full conversion of the starting material. The reaction was quenched with water (to a 
concentration of ~0.05 M) and the product was extracted with Et2O (3 ×). The combined organic layers 
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were washed with brine and dried over Na2SO4. The crude product was purified by flash 
chromatography over silica gel. 
tert-Butyl (1S,3RS,6S,9S)-3-ethoxy-6-hydroxy-9-methyl-7-oxa-2-azabicyclo[4.3.0]non-4-ene-2-
carboxylate (21a) 
Substrate 16a (205 mg, 0.803 mmol) was reacted with m-CPBA (364 mg, 1.62 
mmol), triethylorthoformate (0.70 mL, 4.2 mmol) and BF3·Et2O (40 µL, 0.15 mmol) 
following the general procedure to afford 21a (211 mg, 0.705 mmol, 88%) as a 
colorless oil. Rf 0.58 (EtOAc/heptane, 1:1). IR (ATR) ν 3378, 2971, 2933, 1710, 
1507, 1366, 1170, 1004 cm–1. 1H NMR (500 MHz, CDCl3, mixture of diastereoisomers) δ 6.02 (dd, J = 
1.0, 2.5 Hz, 1H), 6.01 (dd, J = 0.9, 2.4 Hz, 1H), 5.97 (dd, J = 0.9, 5.8 Hz, 1H), 5.92 (dd, J = 1.0, 5.8 
Hz, 1H), 5.81 (br s, 1H), 5.70 (br s, 1H), 5.07 (d, J = 8.9 Hz, 1H), 4.61 (d, J = 10.0 Hz, 1H), 4.18 (t, J = 
8.3 Hz, 1H), 4.17 (t, J = 8.3 Hz, 1H), 3.88–3.78 (m, 2H), 3.73 (dd, J = 9.1, 10.8 Hz, 1H), 3.66–3.56 (m, 
3H), 3.53–3.44 (m, 2H), 2.33–2.19 (m, 2H), 1.42 (s, 9H), 1.41 (s, 9H), 1.14 (d, J = 6.6 Hz, 3H), 1.11 
(d, J = 6.6 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 156.4, 156.0, 132.3, 132.2, 132.1, 131.9, 117.5, 
114.8, 107.0, 106.1, 79.8, 79.4, 72.9, 72.7, 64.9, 61.6, 61.5, 60.9, 38.3, 37.9, 28.4, 15.5, 15.4, 14.69, 
14.67. HRMS (ESI+) calcd for C15H25NO5Na [M+Na]+ 322.1630, found 322.1638. 
tert-Butyl (1S,3RS,6S,9S)-3-ethoxy-6-hydroxy-9-propyl-7-oxa-2-azabicyclo[4.3.0]non-4-ene-2-
carboxylate (21b) 
Substrate 16b (255 mg, 0.901 mmol) was reacted with m-CPBA (449 mg, 2.00 
mmol), triethylorthoformate (0.75 mL, 4.4 mmol) and BF3·Et2O (23 µL, 0.087 mmol) 
following the general procedure to afford 21b (263 mg, 0.802 mmol, 89%) as a 
colorless oil. Rf 0.67 (EtOAc/heptane, 1:1). IR (ATR) ν 3356, 2975, 2930, 1716, 
1507, 1365, 1246, 1169, 1100, 1003 cm–1. 1H NMR (500 MHz, CDCl3, mixture of diastereoisomers) δ 
6.02 ( br s, 1H), 6.01 (br s, 1H), 5.97 (dd, J = 0.9, 5.7 Hz, 1H), 5.92 (dd, J = 1.0, 5.8 Hz, 1H), 5.82 (br 
s, 1H), 5.71 (br s, 1H), 5.05 (d, J = 9.2 Hz, 1H), 4.62 (d, J = 10.1 Hz, 1H), 4.20 (td, J = 1.7, 8.3 Hz, 
2H), 3.93–3.77 (m, 3H), 3.68–3.49 (m, 6H), 2.27–2.15 (m, 2H), 1.78–1.70 (m, 1H), 1.70–1.62 (m, 1H), 
1.42 (s, 9H), 1.41 (s, 9H), 1.35–1.26 (m, 6H), 1.29 (t, J = 7.0 Hz, 3H), 1.21 (t, J = 7.1 Hz, 3H), 0.91 
(td, J = 2.5, 7.2 Hz, 6H). 13C NMR (125 MHz, CDCl3, mixture of diastereoisomers) δ 156.3, 155.9, 
132.2, 132.04, 131.95, 117.5, 114.9, 107.1, 106.1, 79.8, 79.4, 72.0, 71.8, 64.8, 61.5, 60.4, 59.83, 59.77, 
43.2, 42.8, 33.5, 33.4, 28.4, 21.4, 21.3, 15.5, 15.4, 14.43, 14.40. HRMS (ESI+) calcd for C17H29NO5Na 
[M+Na]+ 350.1943, found 350.1952. 
tert-Butyl (1S,3RS,6S,9S)-3-ethoxy-6-hydroxy-9-(2-propyl)-7-oxa-2-azabicyclo[4.3.0]non-4-ene-2-
carboxylate (21c) 
Substrate 16c (512 mg, 1.81 mmol) was reacted with m-CPBA (861 mg, 3.84 
mmol), triethylorthoformate (1.50 mL, 9.02 mmol) and BF3·Et2O (23 µL, 0.087 
mmol) following the general procedure to afford 21c (265 mg, 0.809 mmol, 45%) 
as a colorless oil. Rf 0.68 (EtOAc/heptane, 1:1). IR (ATR) ν 3369, 2974, 2889, 
1715, 1506, 1366, 1168, 1105, 1005 cm–1. 1H NMR (500 MHz, CDCl3, mixture of 
diastereoisomers) δ 6.014 (dd, J = 1.0, 5.8 Hz, 1H), 6.009 (dd, J = 1.1, 5.8 Hz, 1H), 5.97 (dd, J = 1.1, 
5.8 Hz, 1H), 5.91 (dd, J = 1.2, 5.8 Hz, 1H), 5.82 (t, J = 1.1 Hz, 1H), 5.70 (br s, 1H), 4.98 (d, J = 9.6 Hz, 
1H), 4.63 (d, J = 10.2 Hz, 1H), 4.14 (t, J = 8.7 Hz, 1H), 4.12 (t, J = 8.7 Hz, 1H), 4.03 (t, J = 10.6 Hz, 
1H), 3.96 (dd, J = 9.9, 10.6 Hz, 1H), 3.86 (dd, J = 7.1, 9.3 Hz, 1H), 3.72–3.55 (m, 5H), 2.14–2.02 (m, 
2H), 1.84 (dq, J = 6.8, 13.5 Hz, 1H), 1.78 (dq, J = 6.8, 13.6 Hz, 1H), 1.404 (s, 9H), 1.395 (s, 9H), 1.28 
(t, J = 7.1 Hz, 3H), 1.21 (t, J = 7.1 Hz, 3H), 0.98 (dd, J = 5.9, 6.7 Hz, 6H), 0.92 (dd, J = 6.8, 9.8 Hz, 
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6H). 13C NMR (125 MHz, CDCl3, mixture of diastereoisomers) δ 156.1, 155.5, 132.4, 132.1, 132.0, 
131.8, 118.0, 115.5, 107.2, 106.1, 79.7, 79.4, 69.6, 69.3, 64.7, 61.6, 58.2, 57.6, 48.6, 48.5, 29.7, 29.2, 
28.5, 21.0, 20.8, 20.0, 19.5, 15.54, 15.46. HRMS (ESI+) calcd for C17H29NO5Na [M+Na]+ 350.1943, 
found 350.1949. 
tert-Butyl (1S,3RS,6S,9S)-3-ethoxy-6-hydroxy-9-(2-propenyl)-7-oxa-2-azabicyclo[4.3.0]non-4-ene-
2-carboxylate (21d) 
Substrate 16d (260 mg, 0.924 mmol) was reacted with m-CPBA (423 mg, 1.89 
mmol), triethylorthoformate (0.75 mL, 4.4 mmol) and BF3·Et2O (23 µL, 0.087 
mmol) following the general procedure to afford 21d (239 mg, 0.734 mmol, 79%) 
as a colorless oil. Rf 0.66 (EtOAc/heptane, 1:1). IR (ATR) ν 3382, 2971, 1715, 
1507, 1364, 1168, 1104, 1000 cm–1. 1H NMR (500 MHz, CDCl3, mixture of 
diastereoisomers) δ 6.03 (d, J = 5.8 Hz, 2H), 5.97 (d, J = 5.7 Hz, 1H), 5.92 (d, J = 5.8 Hz, 1H), 5.82 (s, 
1H), 5.82–5.71 (m, 2H), 5.71 (s, 1H), 5.10 (d, J = 9.2 Hz, 1H), 5.06 (dd, J = 1.0, 17.1 Hz, 2H), 5.00 (d, 
J = 10.2 Hz, 2H), 4.63 (d, J = 10.0 Hz, 1H), 4.18 (t, J = 8.4 Hz, 2H), 3.94 (t, J = 10.5 Hz, 1H), 3.91–
3.81 (m, 2H), 3.68–3.53 (m, 5H), 2.59–2.50 (m, 1H), 2.49–2.41 (m, 1H), 2.38–2.27 (m, 2H), 2.18–2.06 
(m, 2H), 1.418 (s, 9H), 1.410 (s, 9H), 1.29 (t, J = 7.1 Hz, 3H), 1.21 (t, J = 7.1 Hz, 3H). 13C NMR (125 
MHz, CDCl3, mixture of diastereoisomers) δ 156.2, 155.7, 135.8, 135.6, 132.4, 132.1, 132.0, 131.9, 
117.4, 116.6, 116.4, 114.8, 107.1, 106.2, 79.8, 79.5, 71.3, 71.1, 64.9, 61.7, 59.7, 59.2, 42.9, 42.6, 35.2, 
28.4, 15.5, 15.4. HRMS (ESI+) calcd for C17H27NO5Na [M+Na]+ 348.1787, found 348.1790. 
tert-Butyl (1S,3RS,6S,9S)-3-ethoxy-6-hydroxy-9-phenyl-7-oxa-2-azabicyclo[4.3.0]non-4-ene-2-
carboxylate (21e) 
To a solution of hemiaminal 20e (200 mg, 0.60 mmol) in THF (6 mL) at −78 °C was 
added triethylorthoformate (0.40 mL, 2.40 mmol) and BF3·Et2O (8.0 µL, 0.03 
mmol). The reaction was quenched after 2.5 h by addition of water (6 mL) and the 
product was extracted with Et2O (3 × 6 mL). The combined organic layers were 
washed with brine, dried over Na2SO4 and concentrated in vacuo. The crude product was purified by 
flash chromatography (silica gel, EtOAc/heptane, 1:4) affording 21e (170 mg, 0.47 mmol, 78%) as a 
white solid. Rf 0.54 (EtOAc/heptane, 1:1). Mp 100–102 °C. IR (ATR) ν 3404, 2976, 2894, 1718, 1498, 
1364, 1169, 996 cm–1. 1H NMR (500 MHz, CDCl3, mixture of diastereoisomers) δ 7.36–7.22 (m, 10H), 
6.15–5.97 (m, 4H), 5.90 (br s, 1H), 5.77 (br s, 1H), 5.02–4.86 (m, 0.53H), 4.96 (d, J = 9.8 Hz, 1H), 
4.67 (d, J = 10.2 Hz, 1H), 4.55–4.36 (m, 4H), 4.04–3.85 (m, 3H), 3.75–3.60 (m, 3H), 3.53–3.30 (m, 
2H), 1.33 (s, 6.5H), 1.31 (s, 7.5H), 1.29 (t, J = 7.1 Hz, 3H), 1.25 (t, J = 7.1 Hz, 3H), 1.17 (br s, 2.5H), 
1.09 (br s, 1.5H). 13C NMR (125 MHz, CDCl3, mixture of diastereoisomers) δ 155.9, 155.5, 137.73, 
137.66, 132.6, 132.2, 132.0, 131.7, 128.9, 128.8, 127.8, 127.7, 127.4, 127.3, 117.5, 114.9, 107.3, 106.3, 
79.8, 79.4, 72.5, 72.4, 64.7, 61.6, 60.6, 60.2, 48.7, 48.6, 28.30, 28.28, 28.0, 15.6, 15.5. HRMS (ESI+) 
calcd for C18H22NO4 [M–OEt]+ 316.1549, found 316.1542. HPLC: d.r. 1:1.2, Chiralpak AD-H (250 × 
4.6 mm), flow: 1.0 mL/min, n-heptane/2-propanol 80/20, retention times: minor: 4.4 min, major: 6.2 
min. 
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tert-Butyl (6RS,2S)-2-[(1S)-2-(acetoxy)-1-phenylethyl]-6-hydroxy-3-oxo-1,2,3,6-tetrahydro-
pyridine-1-carboxylate (22) 
A solution of 19 (1.50 g, 4.17 mmol) in anhydrous CH2Cl2 (42 mL) was cooled 
to 0 °C before m-CPBA (2.06 g, 9.19 mmol) was added. The mixture was stirred 
for 30 min at 0 °C and was then allowed to warm to room temperature. After 
stirring for 22 h, the reaction mixture was diluted with CH2Cl2 (50 mL) and 
subsequently washed with 20% aqueous KI solution (100 mL), 30% aqueous Na2S2O5 solution (100 
mL), saturated aqueous NaHCO3 (100 mL), water (100 mL) and brine (100 mL). The combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The crude product was purified by 
flash chromatography (silica gel, EtOAc/heptane, 1:3) affording 22 (1.09 g, 2.90 mmol, 70%) as an 
orange solid. Rf 0.33 (EtOAc/heptane, 1:1). Mp 37–38 °C. [α]!!" = −57.0 (c 1.0, CH2Cl2). IR (ATR) ν 
3430, 2980, 1740, 1684, 1364, 1230, 1165, 1040, 988, 703 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.33–
7.22 (m, 5H), 6.94 (dd, J = 4.1, 10.3 Hz, 1H), 6.18 (dd, J = 1.2, 10.3 Hz, 1H), 6.01 (t, J = 3.7 Hz, 1H), 
4.71 (d, J = 10.0 Hz, 1H), 4.26 (dd, J = 7.7, 11.5 Hz, 1H), 4.16 (dd, J = 5.6, 11.5 Hz, 2H), 3.59 (ddd, J 
= 5.6, 7.7, 10.0 Hz, 1H), 1.91 (s, 3H), 1.11 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 194.4, 170.4, 154.5, 
144.3, 138.5, 129.4, 128.6, 127.6, 127.4, 82.0, 72.4, 64.8, 63.3, 49.1, 27.8, 20.8. HRMS (ESI+) calcd 
for C20H25NO6Na [M+Na]+ 398.1580, found 398.1572. 
tert-Butyl (1S,3RS,6S,9S)-3-acetoxy-6-hydroxy-9-phenyl-7-oxa-2-azabicyclo[4.3.0]non-4-ene-2-
carboxylate (24e) 
To a stirred solution of hemiaminal 20e (200 mg, 0.600 mmol) in CH2Cl2 was added 
acetic anhydride (125 µL, 1.32 mmol), triethylamine (184 µL, 1.32 mmol) and 4-
dimethylaminopyridine (29 mg, 0.24 mmol). After stirring for 45 minutes at room 
temperature, the mixture was diluted with Et2O (10 mL) and subsequently washed 
with 1 M aqueous HCl (10 mL) and 1 M aqueous NaOH (10 mL). The organic layer was dried over 
Na2SO4 and concentrated under reduced pressure to afford the crude product, which was purified by 
flash chromatography (silica gel, EtOAc/heptane, 1:3) to furnish 24e (206 mg, 0.549 mmol, 92%) as a 
white solid. Rf 0.60 (EtOAc/heptane, 1:1). Mp 50–52 °C. IR (ATR) ν 3373, 2976, 2894, 1748, 1714, 
1502, 1355, 1234, 1169, 988, 703 cm–1. 1H NMR (500 MHz, CDCl3, mixture of diastereoisomers A and 
B) δ 7.30–7.15 (m, 10HA+B), 6.87 (s, 1HB), 6.64 (s, 1HA), 6.15–6.01 (m, 4HA+B), 4.76 (d, J = 10.2 Hz, 
1HB), 4.70 (d, J = 10.2 Hz, 1HA), 4.53–4.41 (m, 2HA+B), 4.36 (dd, J = 11.7, 5.6 Hz, 2HA+B), 3.95–3.77 
(m, 2HA+B), 3.50–3.34 (m, 2HA+B), 2.06 (s, 2HA+B), 1.26 (d, J = 17.8 Hz, 9HA), 1.11 (d, J = 5.4 Hz, 
9HB). 13C NMR (75 MHz, CDCl3, mixture of diastereoisomers) δ 170.4 (major), 170.0 (minor), 155.5 
(minor), 155.3 (major), 137.2 (minor), 136.9 (major), 133.0 (minor), 132.7 (major), 130.8 (minor), 
130.5 (major), 128.8 (major+minor), 127.6 (major+minor), 127.4 (major), 127.3 (minor), 118.7 
(minor), 116.7 (major), 100.4 (minor), 98.9 (major), 79.8 (major), 79.5 (minor), 72.61 (minor), 72.58 
(major), 60.2 (major), 59.9 (minor), 48.0 (major), 47.7 (minor), 28.3 (minor), 28.1 (major), 21.3 
(major), 21.2 (minor). 
tert-Butyl (1R,4S,5S)-6-oxo-4-phenyl-2-oxa-9-azabicyclo[3.3.1]non-7-ene-9-carboxylate (29) 
To a flame-dried Schlenk tube containing a solution of hemiaminal 20e (260 mg, 0.780 
mmol) in CH2Cl2 (13 mL) was added TFA (72 µL, 0.94 mmol). The resulting mixture 
was stirred for 3 h at room temperature until TLC indicated full conversion of the 
starting material. The mixture was concentrated in vacuo and the residue was purified 
by flash chromatography (silica gel, EtOAc/heptane, 1:5) to afford 29 as a white solid (154 mg, 0.488 
mmol, 63%). Rf 0.76 (EtOAc/heptane, 1:1). Mp 108–110 °C. [α]!!" = −181.8 (c 1.0, CH2Cl2). IR (ATR) 
ν 2976, 2924, 1697, 1403, 1316, 1251, 1156, 1040, 910, 759, 703 cm–1. 1H NMR (500 MHz, CDCl3, 
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mixture of rotamers A and B) δ 7.37–7.22 (m, 3HA+B), 7.04 (dd, J = 23.1, 6.8 Hz, 2HA+B), 6.94 (ddd, J 
= 24.9, 9.4, 5.2 Hz, 1HA+B), 6.49 (dd, J = 9.9, 0.7 Hz, 1HA+B), 6.20 (d, J = 4.6 Hz, 0.5HA), 6.13–5.98 
(m, 0.5HB), 4.77 (d, J = 3.9 Hz, 0.5HA), 4.64 (d, J = 3.8 Hz, 0.5HB), 4.30 (t, J = 12.5 Hz, 1HA+B), 4.07–
3.95 (m, 1HA+B), 3.55–3.38 (m, 1HA+B), 1.54 (s, 9HA+B). 13C NMR (125 MHz, CDCl3, mixture of 
rotamers) δ 193.3, 193.2, 171.1, 152.7, 152.5, 140.7, 140.1, 136.0, 132.8, 132.7, 128.7, 128.6, 127.9, 
127.8, 82.0, 74.6, 73.3, 62.8, 61.4, 60.9, 60.4, 44.7, 43.8, 28.3. 
General procedure for the N-acyliminium ion additions 
A flame-dried Schlenk tube was charged with a solution of substrate 22 in MeCN (0.1 M) and cooled 
to −30 °C. The nucleophile (5 equiv) and Sn(OTf)2 (0.1 equiv) were subsequently added and the 
mixture was stirred at −30 °C until TLC indicated full conversion of the starting material. The reaction 
was quenched by addition of saturated aqueous NaHCO3 (to a concentration of 0.05 M) and the product 
was extracted with EtOAc (3 ×). The combined organic layers were dried over Na2SO4, concentrated in 
vacuo and the residue was dissolved in CH2Cl2 (0.5 M). TFA (14 equiv) was added and the mixture 
was stirred for 1 h at room temperature. The reaction was carefully quenched by addition of 10% 
aqueous Na2CO3 until the pH of the aqueous layer was ~10. The product was extracted with CH2Cl2 (5 
×) and the combined organic layers were dried of over Na2SO4 and concentrated in vacuo. The crude 
product was purified by flash chromatography over silica gel. 
(2S)-2-[(2S,6R)-3-oxo-6-(prop-2-en-1-yl)-1,2,3,6-tetrahydropyridin-2-yl]-2-phenylethyl acetate 
(30a) 
Substrate 22 (50 mg, 0.13 mmol) was reacted according to the general 
procedure with Sn(OTf)2 (5.5 mg, 0.01 mmol) and allyltrimethylsilane (105 
µL, 0.66 mmol) to afford the crude N-Boc protected piperidinone. Subsequent 
deprotection with TFA (142 µL, 1.85 mmol) afforded 30a (33 mg, 0.11 mmol, 
85%) as a yellow oil after flash chromatography (silica gel, EtOAc/heptane, 1:2). Rf 0.36 
(EtOAc/heptane, 2:1). [α]!!" = −37.1 (c 0.6, CH2Cl2). IR (ATR) ν 3032, 1735, 1684, 1238, 1035, 845, 
711 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.28–7.19 (m, 5H), 6.87 (dd, J = 1.6, 10.1 Hz, 1H), 5.99 (dd, 
J = 2.6, 10.1 Hz, 1H), 5.65 (dddd, J = 6.4, 7.9, 10.2, 16.7 Hz, 1H), 5.08–5.01 (m, 2H), 4.60 (dd, J = 
8.5, 10.8 Hz, 1H), 4.45 (dd, J = 6.4, 10.8 Hz, 1H), 3.91 (ddd, J = 3.7, 6.4, 8.5 Hz, 1H), 3.64–3.59 (m, 
1H), 3.58 (dd, J = 1.5, 3.7 Hz, 1H), 2.34–2.21 (m, 2H), 2.00 (s, 3H), 1.55–1.37 (m, 1H, NH). 13C NMR 
(125 MHz, CDCl3) δ 197.0, 171.1, 152.8, 137.1, 133.3, 129.5, 128.8, 128.4, 127.4, 118.9, 65.0, 62.2, 
54.1, 42.9, 39.4, 21.1. HRMS (ESI+) calcd for C18H22NO3 [M+H]+ 300.1600, found 300.1603. 
(2S)-2-[(2S,6R)-6-(2-methylprop-2-en-1-yl)-3-oxo-1,2,3,6-tetrahydropyridin-2-yl]-2-phenylethyl 
acetate (30b) 
Substrate 22 (50 mg, 0.13 mmol) was reacted according to the general 
procedure with Sn(OTf)2 (5.5 mg, 0.01 mmol) and methallyltrimethylsilane 
(116 µL, 0.66 mmol) to afford the crude N-Boc protected piperidinone. 
Subsequent deprotection with TFA (143 µL, 1.86 mmol) afforded 30b (29 mg, 
0.09 mmol, 69%) as a yellow oil after flash chromatography (silica gel, EtOAc/heptane, 1:1). Rf 0.60 
(EtOAc/heptane, 2:1). [α]!!" = +63.3 (c 0.6, CH2Cl2). IR (ATR) ν 3075, 2919, 1731, 1243, 1048, 698, 
607 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.30–7.19 (m, 5H), 6.86 (dd, J = 1.6, 10.1 Hz, 1H), 5.99 (dd, 
J = 2.6, 10.1 Hz, 1H), 4.81–4.76 (m, 1H), 4.68–4.65 (m, 1H), 4.61 (dd, J = 8.1, 10.8 Hz, 1H), 4.45 (dd, 
J = 6.6, 10.8 Hz, 1H), 3.88 (ddd, J = 4.1, 6.6, 8.1 Hz, 1H), 3.70–3.64 (m, 1H), 3.56 (dd, J = 1.6, 4.1 Hz, 
1H), 2.18 (d, J = 7.3 Hz, 2H), 2.00 (s, 3H), 1.70 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 197.0, 171.1, 
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153.0, 141.1, 137.3, 129.5, 128.5, 128.4, 127.4, 114.1, 65.2, 62.4, 52.8, 43.4, 43.1, 22.5, 21.1. HRMS 
(ESI+) calcd for C19H23NO3Na [M+Na]+ 336.1576, found 336.1572. 
(2S)-2-[(2S,6R)-6-[2-(chloromethyl)prop-2-en-1-yl]-3-oxo-1,2,3,6-tetrahydropyridin-2-yl]-2-
phenylethyl acetate (30c) 
Substrate 22 (50 mg, 0.13 mmol) was reacted according to the general 
procedure with Sn(OTf)2 (5.5 mg, 0.01 mmol) and 2-(chloromethyl)allyl-
trimethylsilane (119 µL, 0.66 mmol) to afford the crude N-Boc protected 
piperidinone. Subsequent deprotection with TFA (143 µL, 1.86 mmol) 
afforded 30c (29 mg, 0.08 mmol, 62%) as a yellow oil after flash chromatography (silica gel, 
EtOAc/heptane, 1:3). Rf 0.38 (EtOAc/heptane, 1:1). IR (ATR) ν 3036, 2941, 1740, 1679, 1450, 1390, 
1230, 1048, 910, 763, 703 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.31–7.21 (m, 5H), 6.85 (dd, J = 1.6, 
10.1 Hz, 1H), 6.01 (dd, J = 2.5, 10.1 Hz, 1H), 5.20 (d, J = 0.6 Hz, 1H), 4.98 (d, J = 0.9 Hz, 1H), 4.62 
(dd, J = 8.5, 10.8 Hz, 1H), 4.43 (dd, J = 6.4, 10.8 Hz, 1H), 4.06 (s, 2H), 3.91 (ddd, J = 3.8, 6.4, 8.4 Hz, 
1H), 3.78 (br s, 1H), 3.57 (d, J = 2.4 Hz, 1H), 2.47 (dd, J = 5.8, 14.4 Hz, 1H), 2.32 (dd, J = 8.5, 14.4 
Hz, 1H), 2.01 (s, 3H), 1.78–1.34 (br s, 1H, NH). 13C NMR (125 MHz, CDCl3) δ 196.6, 171.1, 152.3, 
141.1, 137.0, 129.5, 128.9, 128.5, 127.5, 118.3, 64.9, 62.3, 53.0, 48.1, 43.0, 38.7, 21.1. HRMS (ESI+) 
calcd for C19H22ClNO3Na [M+Na]+ 370.1186, found 370.1185. 
(2S)-2-[(2S,6R)-6-(but-2-yn-1-yl)-3-oxo-1,2,3,6-tetrahydropyridin-2-yl]-2-phenylethyl acetate 
(30d) 
Substrate 22 (50 mg, 0.13 mmol) was reacted according to the general 
procedure with Sn(OTf)2 (5.5 mg, 0.01 mmol) and 3-(trimethylsilyl)-1,2-
butadiene (110 µL, 0.66 mmol) to afford the crude N-Boc protected 
piperidinone. Subsequent deprotection with TFA (143 µL, 1.86 mmol) 
afforded 30d (30 mg, 0.10 mmol, 77%) as a yellow oil after flash chromatography (silica gel, 
EtOAc/heptane, 1:2). Rf 0.27 (EtOAc/heptane, 1:1). [α]!!" = −94.8 (c 0.5, CH2Cl2). IR (ATR) ν 2915, 
1735, 1684, 1450, 1225, 1040, 707 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.30–7.27 (m, 4H), 7.25–7.20 
(m, 1H), 6.90 (dd, J = 1.6, 10.1 Hz, 1H), 6.03 (dd, J = 2.5, 10.1 Hz, 1H), 4.61 (dd, J = 8.4, 10.8 Hz, 
1H), 4.48 (dd, J = 6.5, 10.8 Hz, 1H), 3.92 (ddd, J = 4.0, 6.5, 8.4 Hz, 1H), 3.67–3.62 (m, 1H), 3.61 (dd, 
J = 1.4, 3.9 Hz, 1H), 2.38 (dq, J = 2.5, 5.1 Hz, 2H), 2.00 (s, 3H), 1.75 (br s, 1H), 1.58 (t, J = 2.5 Hz, 
3H). 13C NMR (125 MHz, CDCl3) δ 196.9, 171.1, 152.3, 137.1, 129.5, 129.4, 128.5, 127.4, 79.6, 73.8, 
65.0, 62.1, 53.7, 43.2, 25.3, 21.1, 3.4. HRMS (ESI+) calcd for C19H21NO3Na [M+Na]+ 334.1419, found 
334.1422. 
(2S)-2-[(2S,6RS)-3-oxo-6-(2-oxopropyl)-1,2,3,6-tetrahydropyridin-2-yl]-2-phenylethyl acetate 
(30e) 
Substrate 22 (50 mg, 0.13 mmol) was reacted according to the general 
procedure with Sn(OTf)2 (5.5 mg, 0.01 mmol) and trimethyl(prop-1-en-2-
yloxy)silane (111 µL, 0.66 mmol) to afford the crude N-Boc protected 
piperidinone. Subsequent deprotection with TFA (143 µL, 1.86 mmol) 
afforded 30e (25 mg, 0.08 mmol, 62%) after flash chromatography (silica gel, EtOAc/heptane, 1:2) as a 
mixture of diastereoisomers (d.r. 1:1). Rf 0.21 and 0.16 (EtOAc/heptane, 3:1). IR (ATR) ν 2920, 1727, 
1705, 1688, 1355, 1243, 1040, 711 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.38–7.24 (m, 10H), 6.79 (dd, 
J = 2.8, 10.2 Hz, 1H), 6.77 (dd, J = 1.6, 10.1 Hz, 1H), 6.01 (dd, J = 2.2, 10.2 Hz, 1H), 6.00 (dd, J = 2.7, 
10.1 Hz, 1H), 4.57 (dd, J = 8.1, 10.8 Hz, 1H), 4.51 (dd, J = 6.0, 12.4 Hz, 1H), 4.44 (dd, J = 2.8, 6.7 Hz, 
1H), 4.42 (dd, J = 3.1, 6.4 Hz, 1H), 4.27 (dd, J = 6.1, 11.1 Hz, 1H), 4.07–3.99 (m, 2H), 3.84 (ddd, J = 
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4.2, 6.5, 8.0 Hz, 1H), 3.69–3.61 (m, 3H), 2.70–2.57 (m, 4H), 2.15 (s, 3H), 2.11 (s, 3H), 2.02 (s, 3H), 
1.97 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 206.2, 206.1, 196.6, 196.5, 171.1, 170.8, 151.9, 151.0, 
137.9, 137.3, 129.4, 129.0, 128.8, 128.6, 128.5, 127.8, 127.5, 127.2, 65.2, 65.0, 62.7, 61.2, 51.4, 48.2, 
47.3, 47.2, 43.8, 43.3, 30.5, 30.4, 21.1, 21.0. HRMS (ESI+) calcd for C18H21NO4Na [M+Na]+ 338.1368, 
found 338.1369. 
(2S)-2-[(2S,6S)-3-oxo-6-(2-oxo-2-phenylethyl)-1,2,3,6-tetrahydropyridin-2-yl]-2-phenylethyl 
acetate (30f) 
To a solution of substrate 22 (50 mg, 0.13 mmol) in dry CH2Cl2 (1.3 mL) at 
−78 °C was added trimethyl[(1-phenylvinyl)oxy]silane (137 µL, 0.67 mmol) 
and Sn(OTf)2 (5.7 mg, 0.01 mmol). The reaction was then slowly allowed to 
warm to −50 °C and was stirred at this temperature for 4.5 h. The reaction 
was then quenched by addition of saturated aqueous NaHCO3 (5 mL) and the product was extracted 
with EtOAc (3 × 5 mL). The combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. The crude product was redissolved in CH2Cl2 (1.3 mL) and trifluoroacetic acid (143 µL, 1.86 
mmol) was added. After stirring the mixture for 25 min at room temperature, the reaction was carefully 
quenched by addition of 10% aqueous Na2CO3 until the pH of the aqueous layer was 10. The product 
was extracted with CH2Cl2 (5 × 5 mL) and the combined organic layers were dried of over Na2SO4 and 
concentrated in vacuo. Purification of the crude product by flash chromatography (silica gel, 
EtOAc/heptane, 1:1.5) afforded 30f (35 mg, 0.09 mmol, 69%) as a yellow solid. Rf 0.28 
(EtOAc/heptane, 1:1). Mp 80–82 °C. [α]!!" = −100.3 (c 1.0, CH2Cl2). IR (ATR) ν 3075, 3023, 1744, 
1683, 1454, 1364, 1247, 1040, 694 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.88 (dd, J = 1.2, 8.4 Hz, 2H), 
7.57 (tt, J = 7.4, 1.2 Hz, 1H), 7.46 (t, J = 7.8 Hz, 2H), 7.36–7.24 (m, 5H), 6.93 (dd, J = 2.8, 10.2 Hz, 
1H), 6.05 (dd, J = 2.2, 10.2 Hz, 1H), 4.41 (dd, J = 7.0, 11.1 Hz, 1H), 4.28 (dd, J = 6.6, 11.1 Hz, 1H), 
4.25 (ddd, J = 2.7, 5.4, 10.6 Hz, 1H), 3.72 (d, J = 7.6 Hz, 1H), 3.66 (dd, J = 7.0, 14.2 Hz, 1H), 3.23 
(dd, J = 7.9, 17.1 Hz, 1H), 3.13 (dd, J = 5.7, 17.1 Hz, 1H), 1.94 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
197.4, 196.7, 170.8, 151.4, 137.9, 136.5, 133.7, 128.9, 128.85, 128.82, 128.1, 127.7, 127.2, 65.0, 61.4, 
47.6, 43.9, 42.6, 20.9. HRMS (ESI+) calcd for C23H23NO4Na [M+Na]+ 400.1525, found 400.1525. 
(2S)-2-[(2S)-3-oxo-1,2,3,6-tetrahydropyridin-2-yl]-2-phenylethyl acetate (30g) 
Substrate 22 (50 mg, 0.13 mmol) was reacted with BF3·Et2O (34 µL, 0.27 mmol) and 
triethylsilane (22 µL, 0.14 mmol) in dry CH2Cl2 (1.3 mL) at −78 °C. After 40 min, 
the reaction was quenched by addition of saturated aqueous NaHCO3 (5 mL) and the 
product was extracted with EtOAc (3 × 5 mL). The combined organic layers were 
dried over Na2SO4 and concentrated in vacuo. The crude product was brought in dry CH2Cl2 (1.3 mL) 
and TFA (143 µL, 1.86 mmol) was added. After stirring the mixture for 1 h at room temperature, the 
reaction was carefully quenched by addition of 10% aqueous Na2CO3 until the pH of the aqueous layer 
was 10. The product was extracted with CH2Cl2 (5 × 5 mL) and the combined organic layers were dried 
of over Na2SO4 and concentrated in vacuo. Purification of the crude product by flash chromatography 
(silica gel, EtOAc/heptane, 5:1) afforded 30g (26 mg, 0.093 mmol, 70%) as a yellow oil.  Rf 0.25 
(EtOAc/heptane, 11:1). [α]!!" = −23.5 (c 1.0, CH2Cl2). IR (ATR) ν 3032, 1740, 1675, 1238, 1040, 698 
cm–1. 1H NMR (500 MHz, CDCl3) δ 7.33–7.23 (m, 5H), 6.96 (dt, J = 3.3, 10.2 Hz, 1H), 6.03 (dt, J = 
2.0, 10.2 Hz, 1H), 4.54 (dd, J = 8.2, 10.9 Hz, 1H), 4.39 (dd, J = 6.5, 10.9 Hz, 1H), 3.85 (ddd, J = 5.2, 
6.4, 8.1 Hz, 1H), 3.60 (d, J = 5.0 Hz, 1H), 3.54–3.51 (m, 2H), 1.99 (s, 3H). 13C NMR (125 MHz, 
CDCl3) δ 196.9, 171.0, 149.6, 137.5, 129.2, 128.7, 128.3, 127.6, 64.9, 62.9, 44.2, 42.8, 21.0. HRMS 
(ESI+) calcd for C15H18NO3 [M+H]+ 260.1287, found 260.1278. 
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(S)-2-[(2S,6R)-3-oxo-6-propylpiperidin-2-yl]-2-phenylethyl acetate (32) 
A flame-dried Schlenk tube was charged with a solution of hemiaminal 22 
(50 mg, 0.133 mmol) in MeCN (1.3 mL). The solution was cooled to −30 
°C and Sn(OTf)2 (5.5 mg, 0.013 mmol) was added. The mixture was stirred 
for 3 h at the same temperature until TLC indicated full conversion of the 
starting material. The reaction mixture was diluted with EtOAc (5 mL) and saturated aqueous NaHCO3 
(5 mL) was added. The layers were separated and the aqueous layer was extracted twice with EtOAc (5 
mL). The combined organic layers were dried over Na2SO4 and concentrated under reduced pressure. 
The crude piperidinone was redissolved in MeOH (1.0 mL) and the reaction flask was evacuated and 
refilled with N2 (3 ×) before Pd/C (4.1 mg, 10 wt %) was added. Hydrogen was bubbled through the 
solution for one minute and the reaction mixture was then stirred for 3 h under a hydrogen atmosphere. 
The catalyst was removed by filtration over Celite® and the filtrate was concentrated in vacuo. The 
resulting crude saturated piperidinone was dissolved in CH2Cl2 (200 µL) and deprotected by treatment 
with TFA (110 µL, 1.44 mmol) for 1 h at room temperature. The reaction was quenched by addition of 
10% aqueous Na2CO3 and the product was extracted with CH2Cl2 (5 ×). The combined organic layers 
were dried over Na2SO4 and concentrated in vacuo to afford the crude product. Purification by flash 
chromatography (silica gel, EtOAc/heptane, 2:1) afforded 32 (15 mg, 0.064 mmol, 48%) as a yellow 
oil.  Rf 0.75 (EtOAc/heptane, 3:1). 1H NMR (500 MHz, CDCl3) δ 7.34–7.21 (m, 5H), 4.45 (dd, J = 6.0, 
10.8 Hz, 1H), 4.38 (dd, J = 7.0, 10.8 Hz, 1H), 3.55 (dd, J = 7.0, 13.3 Hz, 1H), 3.50 (dd, J = 0.5, 7.2 Hz, 
1H), 2.85 (ddd, J = 3.0, 6.4, 9.9 Hz, 1H), 2.46–2.34 (m, 2H), 2.04–1,94 (m, 5H), 1.52–1.42 (m, 2H), 
1.34–1.13 (m, 2H), 0.86–0.80 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 208.0, 170.9, 137.9, 129.1, 
128.5, 127.3, 65.6, 65.0, 55.8, 44.3, 40.0, 38.0, 33.9, 20.9, 19.3, 14.0. 
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4.1 Introduction 
The 6-aza-8-oxa[3.2.1]bicyclooctane moiety (1) is a structural motif, containing an N,O-
acetal functional group, which is encountered in a number of natural products as shown in 
Figure 4.1. Each of these natural products has its own distinct biological activity indicating 
that the bicyclic N,O-acetal moiety does not lead to recognition by specific types of receptors. 
For example, cadambine (2), a natural product isolated from the leaves of Nauclea latifolia 
S.M. (Rubiaceae)1 can be used in the treatment of malaria, while samandarine (4) is a highly 
toxic steroidal alkaloid obtained from the skin glands of the fire salamander.2 Interestingly, 
ribasine (3), which is isolated from Fumariaceae plants,3 does not exhibit any relevant 
medicinal activity. We were, however, primarily interested in the N,O-acetal motif that these 
natural products have in common, especially because we envisioned that this moiety should 
be accessible via the Achmatowicz reaction. Furthermore, we anticipated that the N,O-acetal 
would be amenable to further functionalization, either as a scaffold as described for the aza-
Achmatowicz products in Chapter 3, or upon opening of the reactive N,O-acetal structure. 
 
Figure 4.1 Examples of natural products containing the bicyclic N,O-acetal moiety 1. 
4.2 Retrosynthetic plan 
Cyclization of the secondary amine onto the oxycarbenium ion derived from hemiacetals 6 
was thought to lead to the desired 6-aza-8-oxa[3.2.1]bicyclooctane skeletons 5. We 
envisioned that acetals 6, in turn, would be readily accessible via an Achmatowicz reaction of 
N-protected amino furanyl alcohols 7. The requisite furanyl alcohols will be prepared by 
reduction of the cyanohydrin derived from furfural (8) to the corresponding amino alcohol. 
Subsequent protection of the primary amine with TsCl or CbzCl would result in 7. 
 
Scheme 4.1 Retrosynthetic analysis of bicyclic scaffold 5. 
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4.3 Synthesis of bicyclic bridged N,O-acetals 
The synthesis of the desired bicyclic N,O-acetals 14 and 15 started by reacting furfural (8) 
with potassium cyanide to form the corresponding cyanohydrin (Scheme 4.2). The crude 
cyanohydrin was reduced with LiAlH4 furnishing racemic amino alcohol 9 in 56% yield. 
Subsequent protection with either CbzCl or TsCl afforded the corresponding N-protected 
amino alcohols 10 and 11 so that the stage was set for the Achmatowicz reaction. Thus, 
treatment of compounds 10 and 11 with m-CPBA in CH2Cl2 at room temperature smoothly 
resulted in the formation of pyranones 12 and 13, which were obtained as mixtures of 
diastereoisomers at the anomeric position in a 1:2.1 and 1:3 ratio, respectively. Formation of 
the oxycarbenium ion and subsequent cyclization to the bicyclic N,O-acetals 14 and 15 was 
accomplished by refluxing a solution of 12 or 13 in benzene using a Dean–Stark trap in the 
presence of a catalytic amount of TsOH. The resulting N-tosylated bicyclic acetal 14 was 
obtained as a crystalline solid, which was analyzed by single-crystal X-ray diffraction 
spectroscopy to confirm its bicyclic structure. Although the bicyclic N,O-acetals 14 and 15 
were synthesized as racemic mixtures, they should be available in enantiomerically pure form 
starting from enantiopure amino alcohol 9. This material may be prepared on preparative (up 
to kilogram) scale via enzyme-catalyzed cyanohydrin formation using recombinant 
hydroxynitrile lyase from Hevea brasiliensis (HbHNL) followed by reduction of the 
cyanohydrin.4 
 
Scheme 4.2 Synthesis of bicyclic scaffolds 14 and 15. 
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4.4 Functionalization of the N,O-acetal  
Having established a feasible route for the preparation of bicyclic N,O-acetals 14 and 15, we 
wished to explore their pertinence as heterocyclic building blocks by investigating pathways 
for further functionalization. Since building blocks 14 and 15 bear multiple sites for 
modification (Figure 4.2), subsequent elaboration could be compassed by reduction or 
alkylation of the ketone, Michael addition to the enone or by epoxidation or dihydroxylation 
of the olefin. 
 
Figure 4.2 Reactive sites of bicyclic N,O-acetals 14 and 15 for synthetic elaboration. 
We were, however, particularly interested in opening and subsequent functionalization of the 
N,O-acetal moiety, which depending on the mode of cleavage of the acetal would either lead 
to the corresponding pyranones or azepanes. Opening of bicyclic acetals has been widely 
investigated and several groups have reported the formation of azepanes via this strategy.5-7 
Husson and co-workers developed methodology for the facile preparation of bicyclic 
hemiaminal ethers, which could be opened either under reductive conditions or by the action 
of a Grignard reagent to afford substituted azepanes.5,8 Another elegant approach to azepanes 
was reported by Blériot et al. who applied a tandem Staudinger/aza-Wittig reaction for the 
synthesis of bicyclic N,O-acetals 18, which likewise were subsequently opened under 
reductive conditions or by the action of a Grignard reagent to afford the corresponding 
azepanes 19 (Scheme 4.3).6  
 
Scheme 4.3 Formation and opening of bicyclic N,O-acetal 18 by Blériot and co-workers. 
Moreover, additional examples have been published where similar bicyclic N,O-acetals, with 
an unprotected nitrogen atom, were opened under reductive conditions to produce azepanes.7 
A common aspect in these examples is that the acetal nitrogen atoms are unprotected, while 
we would be interested in directly functionalizing N-protected N,O-acetals. Opening via the 
iminium ion derived from N-protected [3.2.1]-bicyclic N,O-acetals 20 leading to the 
corresponding piperidines 21 has also been described, although only for substrates where the 
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nitrogen forms the single atom bridge (Scheme 4.4).9 In addition, 2-aza-3-oxa[2.2.1]-bicyclic 
N,O-acetals have been opened to the corresponding piperidines via the N-acyliminium or N-
sulfonyliminium ion (e.g. opening of 22 by Padwa and co-workers).10 
 
Scheme 4.4 Opening of N-protected bicyclic N,O-acetals 20 and 22 by Brauer or Padwa, respectively. 
The N,O-acetal opening reactions in the previously described precedents have in common that 
they proceed via an intermediate iminium ion upon leaving of the acetal oxygen atom. It is, 
however, also possible that bicyclic N,O-acetals open via an intermediate oxycarbenium ion 
upon departure of the nitrogen atom. Fuentes et al. reported the opening of N-
diethoxycarbonylvinyl-protected [2.2.1]-bicyclic N,O-acetals (24) via such an oxycarbenium 
ion intermediate (25, Scheme 4.5)11 and the group of Muthusamy observed that the character 
of the Lewis acid has an influence on the pathway via which [2.2.1]-bicyclic N,O-acetals are 
opened.10e This allowed the authors to obtain furanones via BF3·Et2O-mediated oxycarbenium 
ion formation, while reactions of the same substrates with TiCl4 afforded the corresponding 
piperidines via an N-sulfonyliminium ion intermediate. 
 
Scheme 4.5 Opening of bicyclic N,O-acetal 24 by Fuentes et al. 
With these results in mind, we wished to investigate whether the opening of our bicyclic N,O-
acetals would proceed via an intermediate iminium (29) or oxycarbenium ion (27) and hence 
provide access to either substituted azepanes (30) or pyrans (28), respectively (Scheme 4.6). 
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Scheme 4.6 Possible pathways for the opening of bicyclic N,O-acetals 5. 
We commenced our investigations by reacting N-tosylated N,O-acetal 14 with BF3·Et2O and 
allyltrimethylsilane (31) to trap the intermediate iminium or oxycarbenium ion (Scheme 4.7). 
Initial experiments showed that the acetal moiety was more stable than expected towards 
Lewis acidic conditions so that we observed the formation of a side product instead of acetal 
opening. 2D NMR analysis and single crystal X-ray analysis (Figure 4.3) showed that 
cyclobutane 34 was formed with a d.r. of 1:11 via a [2+2]-cycloaddition reaction, a mode of 
reaction that is occasionally encountered in Sakurai reactions resulting in similar cyclobutane 
side products.12 We hypothesized that the observed selectivity of the reaction is induced by 
diastereoselective formation of the intermediate siliranium ion 33, which undergoes 
intramolecular attack of the enolate resulting in the cyclobutane moiety.12a,12f-h,12j When the 
reaction was performed using Me3SiOTf instead of BF3·Et2O, the 1,4-adduct (36) was 
obtained in 32% yield as a single diastereoisomer (d.r. >1:20), likely via in situ desilylation of 
the putative intermediate 35 by the triflate anion. 
 
Figure 4.3 Single crystal X-ray structure analysis of 34.13 
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Scheme 4.7 Formal [2+2]-cycloaddition to give 34 and Me3SiOTf-mediated formation of Michael adduct 36. 
We reasoned that compound 37, formed by hydrogenation of the double bond in 14, would 
display suppressed [2+2]-cycloaddition. However, instead of acetal opening, we observed 
1,2-addition when saturated bicyclic N,O-acetal 37 was treated with BF3·Et2O and 
allyltrimethylsilane resulting in the formation of tertiary alcohol 38 (Scheme 4.8). 
 
Scheme 4.8 Hydrogenation of enone 14 and subsequent reaction with BF3·Et2O and allyltrimethylsilane (31). 
These results indicated that ketone activation is more favored than N,O-acetal opening and 
hence we decided on reducing the ketone functionality. Thus, reacting unsaturated ketones 14 
and 15 with NaBH4 in the presence of CeCl3·7H2O afforded allylic alcohols 39 and 40 as 
single diastereoisomers of which the relative configuration was confirmed by single crystal 
X-ray analysis of N-tosylated allylic alcohol 39 (Scheme 4.9). 
 
 
Scheme 4.9 Reduction of enones 14 and 15 and single crystal X-ray structure analysis of 39.14 
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With allylic alcohols 39 and 40 in hand, we set out to investigate the opening of the acetal 
moieties by reacting N-tosylated N,O-acetal 39 with BF3·Et2O in the presence of 
allyltrimethylsilane (31) at −78 °C (Table 4.1, entry 1). While at this temperature only little 
product formation was observed, at room temperature, the reaction went to full conversion 
and pyran 41 was isolated in 75% yield as a 1:1.4 mixture of diastereoisomers. Apparently, 
the reaction proceeded via an intermediate oxycarbenium ion when BF3·Et2O was used as the 
Lewis acid. Since we were also interested in the formation of azepanes, we planned 
conducting the same reaction using TiCl4, which in a paper by Muthusamy and co-workers 
was shown to be selective for opening of [2.2.1]-bicyclic N,O-acetals via the N-
sulfonyliminium ion.10e When bicyclic acetal 39 was treated with TiCl4 and 
allyltrimethylsilane, we again obtained pyran 41, however in this case in only 25% yield and 
as a mixture of diastereoisomers while the missing material seemed to be degraded into 
multiple side products (Table 4.1, entry 2). 
Table 4.1 Opening of bicyclic N,O-acetals 39 and 40.a 
 
entry substrate nucleophile product R2 Lewis acid T (°C) yield
b 
(%) 
2,6-cis/trans 
ratioc 
1 39  41  
BF3·Et2O 
(3 equiv) −78→20 75
d 1:1.4 
2     TiCl4 (1 equiv) 0 25
d 1:1.1 
3 40  42  
BF3·Et2O 
(3 equiv) −78 46 >1:20 
4     BF3·Et2O (3 equiv) 
−30 75 >1:20 
5     BF3·Et2O (3 equiv) 0 57 >1:20 
6e     Sn(OTf)2 (10 mol %) −30 40 >1:20 
7e     Sn(OTf)2 (10 mol %) 0 59 >1:20 
8 40 
 
43 
 
BF3·Et2O 
(3 equiv) −30 74 >1:20 
9 40 
 
44 
 
BF3·Et2O 
(3 equiv) −30 80 >1:20 
10 40 
 
45  
BF3·Et2O 
(3 equiv) 
−30 59 >1:20 
a Conditions: Nucleophile (5 equiv) and Lewis acid (3 equiv) in CH2Cl2. b Isolated yield. c Based on 1H NMR or 
13C NMR of crude product. d Isolated as a mixture of diastereoisomers. e Reaction in MeCN. 
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We envisioned that changing, based on the perception that the protective group on the 
nitrogen determines the stability of the intermediate iminium ion, would have a direct 
influence on the outcome of the reaction. Thus, reacting N-Cbz N,O-acetal 40 with BF3·Et2O 
and allyltrimethylsilane at −78 °C furnished pyran 42 as a single diastereoisomer in 46% 
yield (Table 4.1, entry 3). This result indicates that the carbamate functionality was more 
readily activated at lower temperatures for oxycarbenium ion formation compared to the N-
tosyl-protected substrates. Furthermore, we believe that the high diastereoselectivity of the 
reaction is a result of the low temperature at which the reaction was performed. Repeating the 
reaction at −30 °C afforded pyran 42 with high diastereoselectivity and an isolated yield of 
75% (entry 4), while conducting the reaction at 0 °C resulted in a slightly lower yield 
indicating an optimal temperature around −30 °C (entry 5). When the Lewis acid was 
changed to Sn(OTf)2, which could be used in catalytic amounts (see Section 3.5), and the 
reaction was conducted in MeCN at −30 °C, the bicyclic acetal was again opened via the 
oxycarbenium ion affording pyran 42 in 40% yield (entry 6). Increasing the reaction 
temperature to 0 °C only had a slight effect on the yield (entry 7) and we therefore decided to 
continue our efforts using BF3·Et2O in CH2Cl2 at −30 °C as reaction conditions for the 
introduction of different substituents. Using these conditions, methallyl (entry 8), 2-
(chloromethyl)allyl (entry 9) and 2-butyne (entry 10) substituents were successfully 
introduced with moderate to good yields and excellent selectivities.  
The results in Table 4.1 show that opening of N-protected bicyclic N,O-acetals 39 and 40 
under Lewis acidic conditions preferably proceed via an intermediate oxycarbenium ion. We 
hypothesize that the ring-strain present in our scaffold might impede N-acyl- or N-
sulfonyliminium ion formation. This hypothesis is underlined by the example from Brauer 
(Scheme 4.4) in which bicyclic N,O-acetal 20 was opened via the six-membered N-
sulfonyliminium ion. In addition, 24 (Scheme 4.5) was opened via a five-membered 
oxycarbenium ion upon departure of the nitrogen, which was, comparably to our scaffold, 
protected with an electron-withdrawing group. Since Blériot and Husson used non-protected 
N,O-acetals (18) or hemiaminal ethers for the formation of azepanes (Scheme 4.3), it might 
be necessary to deprotect bicyclic N,O-acetals 39 or 40 in order to form the intermediate 
iminium ion that would lead to the anticipated seven-membered rings. 
4.5 Characterization 
To establish the relative configuration of pyrans 42–45, we aimed at using single crystal X-
ray analysis by converting the oily pyran into a crystalline derivative. We therefore 
hydrogenated 42 over Pd/C in order to reduce both olefins and deprotect the amine (Scheme 
4.10). It was anticipated that subsequent conversion of the primary amine into a 4-
nitrobenzene sulfonamide would result in a crystalline product, but unfortunately, this did not 
happen. We hence proceeded by reacting the sulfonamide with 4-nitrobenzoyl chloride 
resulting in crystalline dibenzoylated pyran 46, of which the 2,6-trans configuration was 
unequivocally established using single crystal X-ray analysis. 
Chapter 4 
 
86 
 
Scheme 4.10 Derivatization of 42 to crystalline 46. 
 
Figure 4.4 Single crystal X-ray structure analysis of 46.15 
4.6 Conclusions 
In summary, we have successfully prepared racemic bicyclic scaffolds in a five-step 
procedure starting from furfural. Although these scaffolds could be readily decorated via 
standard functional group interconversions, we have focused our efforts on investigating their 
functionalization via Lewis acid-mediated N,O-acetal opening, followed by nucleophilic 
trapping of the resulting intermediate cation. The acetal opening could in principle proceed 
via the oxycarbenium ion or via the iminium ion giving access to either pyrans or azapanes, 
but we only observed the corresponding pyrans. By using different nucleophiles, we have 
synthesized several 2,6-trans-disubstituted pyrans in good yields and in a highly 
diastereoselective manner. 
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4.8  Experimental section 
For general remarks see Section 3.8. 
2-Amino-1-(2-furanyl)ethanol (9) 
To a solution of furfural (9.61 g, 100 mmol) in glacial acetic acid (49 mL) at 0 °C 
was dropwise added a solution of potassium cyanide (15.6 g, 240 mmol) in water (49 
mL). The reaction mixture was stirred for 16 h at room temperature after which it was 
diluted with water (50 mL). The product was extracted with Et2O (3 × 60 mL) and the 
combined organic layers were dried over Na2SO4. Toluene (100 mL) was added and the solvents were 
removed under reduced pressure and the resulting oil was coevaporated with toluene (100 mL) to 
remove residual water affording the crude cyanohydrin as a yellow oil. This was then dissolved in dry 
THF (147 mL) and dropwise added to a solution of LiAlH4 (9.11 g, 240 mmol) in dry THF (588 mL) at 
0 °C. The reaction mixture was stirred for 2 h while keeping the internal temperature below 20 °C with 
the aid of an ice bath. The reaction was quenched by slow addition of subsequently water (9.1 mL), 
15% aqueous NaOH (9.1 mL) and water (27 mL) while monitoring the internal temperature and 
keeping it below 25 °C using an ice bath. Na2SO4 was then added and the mixture was stirred for 30 
minutes at room temperature. Filtration over Celite® and removal of the volatiles under reduced 
pressure afforded the crude amino alcohol as an orange solid (10.17 g). Recrystallization from hot 
MeCN then afforded 9 (7.07 g, 55.6 mmol, 56%) as an off-white crystalline solid. Mp 87–88 °C. IR 
(ATR) ν 3348, 3278, 3106, 2929, 1206, 1163, 1098, 1065, 939, 748 cm−1. 1H NMR (500 MHz, CDCl3) 
δ 7.37 (dd, J = 0.8, 1.8 Hz, 1H), 6.33 (dd, J = 1.8, 3.2 Hz, 1H), 6.26 (dt, J = 0.8, 3.2 Hz, 1H), 4.65–
4.61 (m, 1H), 3.03 (dd, J = 2.2, 5.7 Hz, 2H), 2.08 (br s, 3H). 13C NMR (125 MHz, CDCl3) δ 155.5, 
142.2, 110.3, 106.5, 68.3, 46.0. HRMS (ESI+) calcd for C6H10NO2 [M+H]+ 128.0712, found 128.0725. 
N-[2-(2-Furanyl)-2-hydroxyethyl]-4-methylbenzenesulfonamide (10) 
Amino alcohol 9 (4.29 g, 33.7 mmol) was dissolved in dry CH2Cl2 (170 mL) and the 
resulting solution was cooled to 0 °C before TsCl (6.53 g, 34.3 mmol), Et3N (14.0 
mL, 0.101 mmol) and DMAP (824 mg, 6.74 mmol) were added. The cooling bath 
was removed and the resulting mixture was stirred for 1 h at room temperature under 
an argon atmosphere. The reaction was quenched by addition of water (150 mL) and the layers were 
separated. The product was extracted with Et2O (3 × 100 mL) and the combined organic layers were 
dried over Na2SO4 and concentrated im vacuo to afford the crude product. Purification by flash 
chromatography (silica gel, EtOAc/heptane, 0%→50% EtOAc) afforded the desired tosylated amino 
alcohol 10 (7.74 g, 27.5 mmol, 82%) as an off-white solid. IR (ATR) ν 3477, 3283, 1325, 1161, 1091, 
659, 547 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.76–7.73 (m, 2H), 7.35 (dd, J = 0.8, 1.8 Hz, 1H), 7.33–
7.29 (m, 2H), 6.33 (dd, J = 1.8, 3.3 Hz, 1H), 6.28 (dt, J = 0.8, 3.3 Hz, 1H), 4.89 (dd, J = 5.1, 7.4 Hz, 
1H), 4.83–4.74 (m, 1H), 3.37 (ddd, J = 4.2, 8.0, 13.2 Hz, 1H), 3.25 (ddd, J = 4.9, 7.8, 13.2 Hz, 1H), 
2.43 (s, 4H). 
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Benzyl [2-(2-furanyl)-2-hydroxyethyl]carbamate (11) 
To a solution of amino alcohol 9 (4.45 g, 35.0 mmol) in water (175 mL) was added 
Na2CO3 (4.08 g, 38.5 mmol) and benzyl chloroformate (5.50 mL, 38.5 mmol) at 0 
°C. After the reaction mixture was stirred for 2 h at 0 °C, an additional amount of 
benzyl chloroformate (1.00 mL, 7.00 mmol) and Na2CO3 (742 mg, 7.00 mmol) was 
added, which drove the reaction to completion within 30 minutes at 0 °C. The product was then 
extracted with EtOAc (3 × 200 mL) and the combined organic layers were dried over Na2SO4 and 
concentrated in vacuo affording the crude product. This was then further purified by flash 
chromatography (silica gel, EtOAc/heptane, 1:4 to 1:1) furnishing Cbz-protected amino alcohol 11 
(8.58 g, 32.8 mmol, 94%) as a colorless oil. Rf 0.28 (EtOAc/heptane, 1:1). IR (ATR) ν 3413, 3339, 
2944, 1695, 1521, 1248, 1145, 1067, 1006, 734, 696 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.38–7.29 
(m, 6H), 6.33 (dd, J = 1.8, 3.2 Hz, 1H), 6.30–6.27 (m, 1H), 5.24 (br s, 1H), 5.10 (s, 2H), 4.86–4.72 (m, 
1H), 3.66 (ddd, J = 4.2, 6.5, 13.6 Hz, 1H), 3.50 (ddd, J = 5.7, 7.0, 13.6 Hz, 1H), 2.97 (s, 1H). 13C NMR 
(125 MHz, CDCl3) δ 157.2, 154.2, 142.5, 136.4, 128.7, 128.32, 128.26, 110.4, 107.0, 67.4, 67.1, 45.6. 
HRMS (ESI+) calcd for C14H15NO4Na [M+Na]+ 284.0899, found 284.0898. 
N-[(6-Hydroxy-3-oxo-3,6-dihydro-2H-pyran-2-yl)methyl]-4-methylbenzenesulfonamide (12) 
To a stirred solution of 10 (64 mg, 0.23 mmol) in CH2Cl2 (3 mL) was added m-
CPBA (62 mg, 0.25 mmol, 70 wt %) at 0 °C and, after 10 minutes at the same 
temperature, the mixture was stirred at room temperature for 3 h. The insoluble 
material was removed by filtration through a Celite® pad and the filtrate was concentrated under 
reduced pressure. The crude pyranone was directly purified by flash chromatography (silica gel, 
EtOAc/heptane, 1:2 to 1:1) affording 12 (52 mg, 0.18 mmol, 78%) as a colorless oil, which was a 
mixture of anomeric diastereoisomers in a 1:2.1 cis/trans ratio. Trans-diastereoisomer: Rf 0.25 
(EtOAc/heptane, 1:1). Cis-diastereoisomer: Rf 0.33 (EtOAc/heptane, 1:1). IR (ATR) ν 3274, 2924, 
1688, 1321, 1152, 1091, 1031, 664 cm−1. 1H NMR (500 MHz, CDCl3, 1:2.1 cis/trans mixture) δ 7.80–
7.72 (m, 2Htrans+2Hcis), 7.35–7.28 (m, 2Htrans+2Hcis), 6.95 (dd, J = 1.7, 10.3 Hz, 1Hcis), 6.90 (dd, J = 3.4, 
10.3 Hz, 1Htrans), 6.11 (dd, J = 1.5, 10.3 Hz, 1Hcis), 6.05 (d, J = 10.3 Hz, 1Htrans), 5.74 (t, J = 6.4 Hz, 
1Hcis), 5.71–5.67 (m, 1Hcis), 5.63 (d, J = 3.4 Hz, 1Htrans), 5.57–5.49 (m, 1Htrans), 4.72 (dd, J = 4.0, 7.8 
Hz, 1Htrans), 4.24 (ddd, J = 0.6, 4.0, 8.1 Hz, 1Hcis), 3.54 (ddd, J = 4.0, 7.9, 13.0 Hz, 1Htrans), 3.47 (ddd, J 
= 4.0, 7.8, 13.4 Hz, 1Hcis), 3.26 (ddd, J = 5.3, 8.1, 13.4 Hz, 1Hcis), 3.14 (ddd, J = 5.0, 7.8, 13.0 Hz, 
1Htrans), 2.42 (s, 3Htrans+3Hcis). 13C NMR (125 MHz, CDCl3, mixture of cis/trans diastereoisomers) δ 
194.5 (trans), 194.0 (cis), 148.4 (cis), 145.4 (trans), 144.0 (cis), 143.9 (trans), 136.52 (trans), 136.51 
(cis), 129.98 (cis), 129.97 (trans), 128.4 (cis), 127.3 (trans+cis), 127.2 (cis), 90.5 (cis), 87.8 (trans), 
77.0 (cis), 72.2 (trans), 43.8 (cis), 42.9 (trans), 21.7 (trans+cis). HRMS (ESI+) calcd for 
C13H15NO5SNa [M+Na]+ 320.0569, found 320.0578. 
Benzyl [(6-hydroxy-3-oxo-3,6-dihydro-2H-pyran-2-yl)methyl]carbamate (13) 
To a stirred solution of 11 (4.00 g, 15.3 mmol) in CH2Cl2 (77 mL) was added m-
CPBA (5.28 g, 21.4 mmol, 70 wt %) at 0 °C and, after 1 h at the same 
temperature, the mixture was stirred at room temperature for 2 h. The mixture 
was diluted with CH2Cl2 (75 mL) and washed with 20% aqueous KI solution (75 mL). The aqueous 
layer was washed with CH2Cl2 (5 × 75 mL) and the combined organic layers were washed with 10% 
aqueous Na2S2O5 solution (200 mL), saturated aqueous NaHCO3 and brine. The organic layer was 
dried over Na2SO4 and concentrated in vacuo furnishing the crude product, which was precipitated 
from hot toluene to give pyranone 13 (2.90 g, 10.5 mmol, 69%) as an off-white powder as a mixture of 
anomeric diastereoisomers in a 1:3 cis/trans ratio. Rf 0.26 (EtOAc/heptane, 2:1). Mp 115–116 °C. IR 
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(ATR) ν 3363, 1695, 1530, 1255, 1028 cm−1. 1H NMR (500 MHz, CDCl3, 1:3 cis/trans mixture) δ 
7.41–7.27 (m, 5Htrans+5Hcis), 6.96 (d, J = 10.3 Hz, 1Hcis), 6.90 (dd, J = 3.5, 10.3 Hz, 1Htrans), 6.13 (d, J = 
10.3 Hz, 1Hcis), 6.08 (d, J = 10.3 Hz, 1Htrans), 5.67 (br s, 1Hcis), 5.63 (br s, 1Htrans), 5.48–5.37 (m, 1Hcis), 
5.35–5.21 (m, 1Htrans), 5.20–5.01 (m, 2Htrans+2Hcis), 4.67 (t, J = 5.3 Hz, 1Htrans), 4.25–4.13 (m, 
1Htrans+1Hcis), 3.77–3.49 (m, 2Htrans+2Hcis). 13C NMR (125 MHz, CDCl3, mixture of cis/trans 
diastereoisomers) δ 195.6 (trans), 194.9 (cis), 157.0 (cis), 156.8 (trans), 148.3 (trans+cis), 145.3 
(trans+cis), 136.35 (trans), 136.28 (cis), 128.7 (trans+cis), 128.38 (cis), 128.35 (trans), 128.3 
(trans+cis), 127.4 (trans+cis), 90.3 (cis), 87.9 (trans), 77.6 (cis), 72.7 (trans), 67.23 (cis), 67.16 
(trans), 42.4 (cis), 41.0 (trans). HRMS (ESI+) calcd for C14H15NO5Na [M+Na]+ 300.0848, found 
300.0844. 
6-(4-Methylbenzenesulfonyl)-8-oxa-6-azabicyclo[3.2.1]oct-3-en-2-one (14) 
A flask containing a solution of pyranone 12 (24 mg, 81 µmol) and TsOH (2.5 mg, 13 
µmol) in dry benzene (3 mL) was equipped with a Dean–Stark apparatus and the setup 
was purged with argon. After refluxing for 1 h, the mixture was allowed to cool to room 
temperature and successively washed with 0.5 M aqueous NaHCO3 (3 mL), water (3 mL) 
and brine (3 mL). Drying the organic layer over MgSO4 and removal of the solvent under reduced 
pressure afforded the crude product. Purification by flash chromatography (silica gel, EtOAc/heptane, 
1:4 to 1:2) then afforded bicyclic N,O-acetal 14 (13 mg, 47 µmol, 58%) as a white crystalline solid. Rf 
0.46 (EtOAc/heptane, 1:1). Mp 155–160 °C. IR (ATR) ν 1694, 1341, 1161, 1088, 863, 663, 597 cm−1. 
1H NMR (500 MHz, CDCl3) δ 7.77–7.11 (m, 2H), 7.38–7.33 (m, 2H), 7.27 (dd, J = 4.1, 9.7 Hz, 1H), 
6.08 (dd, J = 1.2, 9.7 Hz, 1H), 5.98 (d, J = 4.1 Hz, 1H), 4.57 (d, J = 7.4 Hz, 1H), 3.60 (dd, J = 7.4, 11.0 
Hz, 1H), 3.26 (dd, J = 1.3, 11.0 Hz, 1H), 2.45 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 193.8, 147.4, 
144.9, 133.8, 130.2, 128.1, 126.8, 84.6, 80.8, 45.5, 21.8. HRMS (CI+) calcd for C13H14NO4S [M+H]+ 
280.0644, found 280.0655. 
Benzyl 2-oxo-8-oxa-6-azabicyclo[3.2.1]oct-3-ene-6-carboxylate (15) 
A flask containing a solution of pyranone 13 (2.76 g, 9.95 mmol) and TsOH (171 mg, 
0.900 mmol) in dry benzene (50 mL) was equipped with a Dean–Stark apparatus and the 
setup was purged with argon. After refluxing for 1 h, the mixture was allowed to cool to 
room temperature, diluted with benzene (50 mL) and 1 M aqueous NaHCO3 (100 mL) 
was added. After separating the layers, the product was extracted with benzene (2 × 100 mL) and the 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated in vacuo. 
Purification by flash chromatography (silica gel, EtOAc/heptane, 5%→30% EtOAc) then afforded 
bicyclic N,O-acetal 15 (1.42 g, 5.48 mmol, 55%) as a colorless oil. Rf 0.43 (EtOAc/heptane, 1:1). IR 
(ATR) ν 1697, 1412, 1355, 1110, 884, 755 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.50–7.29 (m, 6H), 
6.10 (d, J = 9.3 Hz, 1H), 6.03–5.82 (m, 1H), 5.21–5.09 (m, 2H), 4.81 (dt, J = 0.9, 7.0 Hz, 1H), 3.96–
3.82 (m, 1H), 3.29 (d, J = 10.3 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 194.3, 149.2, 135.9, 128.8, 
128.6, 128.3, 127.4, 81.3, 67.9, 43.9. HRMS (EI+) calcd for C14H13NO4 [M]+• 259.0845, found 
259.0842. 
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9-(4-Methylbenzenesulfonyl)-4-[(trimethylsilyl)methyl]-10-oxa-9-azatricyclo[5.2.1.02,5]decan-6-
one (34) 
To a stirred solution of bicyclic N,O-acetal 14 (52 mg, 0.19 mmol) in CH2Cl2 (1.8 
mL) at −78 °C was added allyltrimethylsilane (150 µL, 0.957 mmol) and BF3·Et2O 
(150 µL, 0.568 mmol, 48 wt %) and the reaction mixture was stirred for 2 h at that 
temperature under an argon atmosphere. The reaction was quenched by the addition 
of water (3 mL) and the product was extracted with CH2Cl2 (3 × 3 mL). The 
combined organic layers were washed with brine and dried over Na2SO4. Concentration under reduced 
pressure and purification of the crude product by flash chromatography (silica gel, EtOAc/heptane, 1:4) 
afforded cyclobutane 34 (38 mg, 97 µmol, 51%) as a 1 to 11 mixture of diastereoisomers. 
Recrystallization from EtOAc/heptane (1:4) afforded crystals that were suitable for single crystal X-ray 
analysis. Rf  0.62 (EtOAc/heptane, 1:1). Mp 175–177 °C. IR (ATR) ν 1709, 1350, 1252, 1166, 925, 
836, 665, 547 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.76–7.70 (m, 2H), 7.38–7.33 (m, 2H), 5.49 (d, J = 
0.6 Hz, 1H), 4.47 (d, J = 6.9 Hz, 1H), 3.35 (dd, J = 0.9, 9.6 Hz, 1H), 3.27 (dd, J = 6.9, 9.6 Hz, 1H), 
2.83–2.72 (m, 2H), 2.63–2.53 (m, 1H), 2.45 (s, 3H), 2.30–2.22 (m, 1H), 1.98–1.90 (m, 1H), 0.96 (dd, J 
= 5.2, 14.3 Hz, 1H), 0.84 (dd, J = 10.8, 14.3 Hz, 1H), −0.04 (s, 9H). 13C NMR (125 MHz, CDCl3) δ 
207.0, 144.6, 133.3, 130.2, 127.9, 90.8, 80.5, 50.0, 49.8, 35.2, 35.1, 31.2, 26.5, 21.7, −1.0. HRMS (CI+) 
calcd for C19H28NO4SSi [M+H]+ 394.1508, found 394.1510. 
4-Allyl-6-(4-methylbenzenesulfonyl)-8-oxa-6-azabicyclo[3.2.1]octan-2-one (36) 
To a solution of bicyclic N,O-acetal 14 (46 mg, 0.17 mmol) in CH2Cl2 (1.6 mL) at −78 °C 
was added Me3SiOTf (90 µL, 0.49 mmol) and allyltrimethylsilane (134 µL, 0.826 mmol). 
After having the reaction mixture stirred for 1 h at −78 °C under an argon atmosphere, the 
cooling bath was removed and the mixture was stirred for another 16 h at room 
temperature. The reaction was then quenched by addition of water (3 mL) and the product 
was extracted with CH2Cl2 (3 × 3 mL). The combined organic layers were subsequently washed with 
water and brine, and dried over MgSO4. Concentration under reduced pressure afforded the crude 
product, which was purified by flash chromatography (silica gel, EtOAc/heptane, 1:5 to 1:4) to furnish 
36 (17 mg, 53 µmol, 31%) as a white powder. Rf 0.47 (EtOAc/heptane, 1:1). Mp 126–128 °C. IR 
(ATR) ν 2915, 1731, 1346, 1161, 1091, 668 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.76–7.71 (m, 2H), 
7.39–7.34 (m, 2H), 5.77 (ddt, J = 6.9, 10.3, 17.2 Hz, 1H), 5.43 (s, 1H), 5.18–5.10 (m, 2H), 4.35 (d, J = 
6.5 Hz, 1H), 3.46 (d, J = 9.7 Hz, 1H), 3.28 (dd, J = 6.5, 9.7 Hz, 1H), 2.69 (dd, J = 7.9, 17.2 Hz, 1H), 
2.50–2.43 (m, 1H), 2.45 (s, 3H), 2.33 (ddt, J = 1.2, 7.2, 14.3 Hz, 1H), 2.30–2.24 (m, 1H), 2.22–2.13 
(m, 1H). 13C NMR (125 MHz, CDCl3) δ 205.0, 144.8, 134.6, 133.3, 130.3, 127.9, 118.4, 90.6, 81.4, 
49.2, 41.8, 37.7, 37.2, 21.8. HRMS (CI+) calcd for C16H20NO4S [M+H]+ 322.1113, found 322.1129. 
2-Allyl-6-(4-methylbenzenesulfonyl)-8-oxa-6-azabicyclo[3.2.1]octan-2-ol (38) 
Bicyclic N,O-acetal 14 (91 mg, 0.33 mmol) was dissolved in a 1:1 
MeOH/CH2Cl2 mixture (6 mL) and Pd/C (38 mg, 10 wt %) was added. 
Hydrogen was bubbled through the solution for 1 minute and the 
reaction mixture was stirred for 2 h at room temperature under a 
hydrogen atmosphere (1 atm). The reaction mixture was filtered over a 
plug of Celite® and the volatiles were removed under reduced pressure followed by purification over a 
short path of silica (EtOAc/heptane, 1:2 to 1:1). This afforded 37 (82 mg, 0.29 mmol, 88%) as a 
colorless oil of which a part was directly used in the next step. Thus, 37 (20 mg, 71 µmol) was 
dissolved in CH2Cl2 (0.8 mL) and the solution was brought to −20 °C. Allyltrimethylsilane (56 µL, 
0.35 mmol) and BF3·Et2O (56 µL, 0.21 mmol, 48 wt %) were added and the mixture was stirred for 1 h 
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under an argon atmosphere. The reaction was quenched by addition of water (1 mL) and the layers 
were separated. The product was extracted with CH2Cl2 (2 × 2 mL) and the combined organic layers 
were dried over MgSO4 and concentrated in vacuo. Purification by flash chromatography (silica gel, 
EtOAc/heptane, 0:1 to 1:2) furnished 38 (22 mg, 68 µmol, 84% over two steps from 14) as an 
inseparable mixture of diastereoisomers in a 1:1.7 allyl eq/ax ratio. Rf 0.37 (EtOAc/heptane, 1:1). IR 
(ATR) ν 3501, 2954, 1338, 1161, 1090, 1033, 911, 673 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.80–7.76 
(m, 2Heq), 7.75–7.69 (m, 2Hax), 7.36–7.28 (m, 2Heq+ax), 5.90 (d, J = 6.6 Hz, 1Heq), 5.81 (ddt, J = 7.7, 
9.7, 17.4 Hz, 1Hax), 5.59–5.49 (m, 1Heq+ax), 5.19 (ddd, J = 1.9, 13.6, 18.9 Hz, 2Hax), 5.03–4.93 (m, 
2Heq), 3.97 (dd, J = 1.2, 6.4 Hz, 1Hax), 3.72 (ddd, J = 1.3, 6.4, 14.2 Hz, 1Heq), 3.70 (d, J = 10.0 Hz, 
1Hax), 3.15 (dd, J = 6.4, 10.0 Hz, 1Hax), 3.15–3.08 (m, 1Heq), 2.87 (dd, J = 10.4, 14.2 Hz, 1Heq), 2.50–
2.43 (m, 1Hax), 2.44 (s, 3Heq), 2.43 (s, 3Hax), 2.41–2.36 (m, 1Heq), 2.36–2.30 (m, 1Hax), 2.27–2.18 (m, 
2Heq), 2.00 (ddd, J = 5.0, 9.8, 13.0 Hz, 1Heq), 1.89–1.70 (m, 4Hax+2Heq), 1.45 (tdd, J = 1.1, 4.6, 12.9 
Hz, 1Heq). 13C NMR (125 MHz, CDCl3) δ 144.1 (ax), 143.7 (eq), 136.8 (eq), 134.1 (ax), 133.5 (eq), 
132.4 (ax), 130.0 (ax), 129.6 (eq), 128.1 (eq), 127.9 (ax), 120.9 (ax), 118.1 (eq), 88.5 (ax), 85.7 (eq), 
85.1 (eq), 80.2 (ax), 69.5 (ax), 64.8 (eq), 47.0 (ax), 44.4 (eq), 41.3 (ax), 39.9 (eq), 30.8 (eq), 30.4 (ax), 
28.7 (ax), 26.4 (eq), 21.72 (ax), 21.67 (eq). HRMS (CI+) calcd for C16H22NO4S [M+H]+ 324.1270, 
found 324.1274. 
rac-(1R,2R,5R)-6-(4-Methylbenzenesulfonyl)-8-oxa-6-azabicyclo[3.2.1]oct-3-en-2-ol (39) 
A solution of 14 (568 mg, 2.03 mmol) and CeCl3·7H2O (916 mg, 2.46 mmol) in a 1:4 
mixture of CH2Cl2/MeOH (25 mL) was stirred for 5 minutes at 0 °C under an argon 
atmosphere. NaBH4 (96 mg, 2.5 mmol) was added and the reaction mixture was stirred 
at 0 °C until TLC indicated full conversion of the starting material after 1 h. The 
volatiles were removed under reduced pressure and the residue was brought in EtOAc (25 mL) and 
washed with water (25 mL). The aqueous layer was extracted with EtOAc (2 × 25 mL) and the 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated in vacuo. The 
crude product was purified by flash chromatography (silica gel, EtOAc/heptane, 1:2 to 1:1) to afford 
diastereoisomerically pure 39 (426 mg, 1.51 mmol, 74%) as a white powder. Rf 0.20 (EtOAc/heptane, 
1:1). Mp 137–138 °C. IR (ATR) ν 3504, 1323, 1155, 865, 811, 681, 600, 557 cm−1. 1H NMR (500 
MHz, CDCl3) δ 7.74–7.71 (m, 2H), 7.33–7.29 (m, 2H), 6.00 (ddd, J = 1.8, 3.9, 9.7 Hz, 1H), 5.71–5.66 
(m, 2H), 4.59 (t, J = 5.2 Hz, 1H), 4.28 (ddt, J = 1.8, 4.8, 6.8 Hz, 1H), 3.76 (dd, J = 1.8, 12.0 Hz, 1H), 
3.48 (dd, J = 7.0, 12.0 Hz, 1H), 2.43 (s, 3H), 1.70 (d, J = 5.7 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 
145.3, 135.6, 130.9, 130.3, 129.3, 129.2, 85.4, 77.1, 67.6, 45.6, 22.8. HRMS (CI+) calcd for 
C13H16NO4S [M+H]+ 282.0800, found 282.0801. 
rac-(1R,2R,5R)-Benzyl 2-hydroxy-8-oxa-6-azabicyclo[3.2.1]oct-3-ene-6-carboxylate (40) 
A solution of 15 (1.30 g, 5.01 mmol) and CeCl3·7H2O (2.33 g, 6.25 mmol) in a 1:4 
mixture of CH2Cl2/MeOH (50 mL) was stirred for 5 minutes at 0 °C under an argon 
atmosphere. NaBH4 (236 mg, 6.25 mmol) was added and the reaction mixture was 
stirred at 0 °C until TLC indicated full conversion of the starting material after 20 
minutes. The volatiles were removed under reduced pressure and the residue was brought in EtOAc 
(100 mL) and washed with water (100 mL). The aqueous layer was extracted with EtOAc (2 × 100 
mL) and the combined organic layers were washed with brine, dried over Na2SO4 and concentrated in 
vacuo. The crude product was purified by flash chromatography (silica gel, EtOAc/heptane, 25%→
40% EtOAc) to afford diastereoisomerically pure 40 (1.11 g, 4.25 mmol, 85%) as a colorless oil. Rf 
0.38 (EtOAc/heptane, 2:1). IR (ATR) ν 3419, 1681, 1420, 1359, 1117, 1068, 880, 723, 698 cm−1. 1H 
NMR (500 MHz, CDCl3) δ 7.40–7.29 (m, 5H), 6.21–5.91 (m, 1H), 5.79–5.59 (m, 1H), 5.68 (d, J = 9.7 
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Hz, 1H), 5.13 (s, 2H), 4.76 (br s, 1H), 4.63 (ddd, J = 1.6, 5.2, 8.5 Hz, 1H), 3.74 (br s, 2H), 2.13 (br s, 
1H). 13C NMR (125 MHz, CDCl3) δ 153.3, 136.4, 128.9, 128.7, 128.3, 128.1, 81.0, 77.4, 67.4, 66.9, 
53.6, 42.4. HRMS (EI+) calcd for C14H15NO4 [M]+• 261.1001, found 261.1001. 
N-[(6-allyl-3-hydroxy-3,6-dihydro-2H-pyran-2-yl)methyl]-4-methylbenzenesulfonamide (41) 
 To a solution of 39 (145 mg, 0.515 mmol) and 
allyltrimethylsilane (409 µL, 2.58 mmol) in CH2Cl2 (5.2 
mL) at −78 °C was added BF3·Et2O (408 µL, 1.55 
mmol, 48 wt %). The reaction mixture was stirred for 1.5 h at −78 °C under an argon atmosphere and 
was then slowly allowed to warm to room temperature. After stirring for another 2.5 h at room 
temperature, the reaction was quenched by addition of water (5 mL) and the product was extracted with 
CH2Cl2 (3 × 5 mL). The combined organic layers were dried over Na2SO4 and concentrated in vacuo to 
afford the crude product which was further purified by flash chromatography (silica gel, 
EtOAc/heptane, 30%→40% EtOAc) to furnish pyran 41 (125 mg, 0.387 mmol, 75%) as a mixture of 
diastereoisomers in a 1:1.4 2,6-cis/trans ratio. The isomers could be separated in an additional 
chromatographic step and were tentatively assigned. 2,6-trans-isomer: Rf 0.26 (EtOAc/heptane, 2:1). 
IR (ATR) ν 3305, 1334, 1156, 1099, 1056, 734, 658 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.73–7.70 
(m, 2H), 7.32–7.29 (m, 2H), 5.64 (ddd, J = 2.5, 3.2, 11.9 Hz, 1H), 5.51 (dddd, J = 6.4, 7.9, 10.2, 16.8 
Hz, 1H), 5.41–5.36 (m, 1H), 4.93–4.86 (m, 2H), 4.83–4.77 (m, 2H), 3.71–3.64 (m, 1H), 3.61–3.57 (m, 
2H), 3.50 (d, J = 10.1 Hz, 1H), 2.55 (d, J = 1.8 Hz, 1H), 2.43 (s, 3H), 2.15 (dt, J = 8.2, 13.9 Hz, 1H), 
2.01 (ddd, J = 5.6, 6.4, 13.9 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 143.9, 137.8, 133.4, 131.8, 129.9, 
127.8, 127.2, 118.7, 76.0, 72.7, 57.9, 48.2, 37.5, 21.7. HRMS (ESI+) calcd for C16H21NO4SNa [M+Na]+ 
346.1089, found 346.1094. 2,6-cis-isomer: Rf 0.35 (EtOAc/heptane, 2:1). IR (ATR) ν 3464, 3282, 
2922, 1326, 1157, 1090, 1045, 661 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.76–7.72 (m, 2H), 7.31–7.28 
(m, 2H), 5.99 (ddd, J = 2.0, 5.3, 10.2 Hz, 1H), 5.90 (dd, J = 3.1, 10.2 Hz, 1H), 5.79 (ddd, J = 6.8, 7.3, 
9.7 Hz, 1H), 5.18–5.12 (m, 2H), 4.85 (dd, J = 3.7, 8.9 Hz, 1H), 4.21 (dddd, J = 2.0, 3.1, 5.7, 8.7 Hz, 
1H), 3.84–3.77 (m, 2H), 3.21 (ddd, J = 4.5, 8.9, 13.4 Hz, 1H), 3.09 (ddd, J = 3.8, 8.5, 13.2 Hz, 1H), 
2.42 (s, 3H), 2.37 (dddt, J = 1.2, 7.5, 8.7, 14.3 Hz, 1H), 2.22 (dddt, J = 1.3, 5.7, 6.8, 14.3 Hz, 1H), 1.66 
(d, J = 9.7 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 143.6, 136.9, 134.3, 133.2, 129.9, 127.3, 126.0, 
118.1, 72.8, 70.5, 62.5, 44.0, 36.8, 21.7. 
General procedure for BF3·Et2O mediated N-acyliminium ion addition 
To a stirred solution of bicyclic N,O-acetal 40 in CH2Cl2 (0.2 M) at −30 °C was added the a silane (5 
equiv) and BF3·Et2O (3 equiv). The reaction mixture was stirred at the same temperature until TLC 
indicated full conversion of the starting material. The reaction was quenched by the addition of water 
and the product was extracted with CH2Cl2 (3 ×). The combined organic layers were washed with 
brine, dried over Na2SO4 and concentrated in vacuo. The crude product was purified by column 
chromatography as indicated. 
Benzyl [(6-allyl-3-hydroxy-3,6-dihydro-2H-pyran-2-yl)methyl]carbamate (42) 
 Bicyclic N,O-acetal 40 (101 mg, 0.387 mmol) was reacted with 
allyltrimethylsilane (306 µL, 1.93 mmol) and BF3·Et2O (306 µL, 1.16 mmol, 
48 wt %) following the general procedure. Flash chromatography (silica gel, 
EtOAc/heptane, 1:2 to 1:1) afforded pyran 42 (88 mg, 0.29 mmol, 75%) as a colorless oil. Rf 0.32 
(EtOAc/heptane, 2:1). IR (ATR) ν 3405, 2894, 1699, 1519, 1259, 1078, 745, 698 cm−1. 1H NMR (500 
MHz, CDCl3) δ 7.39–7.28 (m, 5H), 6.03 (ddd, J = 2.0, 5.5, 10.1 Hz, 1H), 5.93 (dd, J = 3.0, 10.1 Hz, 
1H), 5.81 (ddt, J = 7.1, 9.6, 16.8 Hz, 1H), 5.18–5.04 (m, 5H), 4.30–4.24 (m, 1H), 3.84–3.75 (m, 2H), 
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3.58 (ddd, J = 5.6, 7.8, 13.7 Hz, 1H), 3.30 (ddd, J = 4.6, 7.5, 13.7 Hz, 1H), 2.44–2.34 (m, 1H), 2.28–
2.20 (m, 1H), 2.12 (d, J = 8.5 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 156.0, 135.6, 133.5, 132.1, 127.7, 
127.3, 127.2, 125.2, 116.7, 71.9, 69.6, 66.0, 61.4, 40.8, 35.9. HRMS (ESI+) calcd for C18H23NO4Na 
[M+Na]+ 326.1368, found 326.1383. 
Benzyl {[3-hydroxy-6-(2-methylprop-2-en-1-yl)-3,6-dihydro-2H-pyran-2-yl]methyl}carbamate 
(43) 
 Bicyclic N,O-acetal 40 (41 mg, 0.16 mmol) was treated with 
methallyltrimethylsilane (145 µL, 0.78 mmol) and BF3·Et2O (124 µL, 0.470 
mmol, 48 wt %) as described in the general procedure. Flash chromatography 
(silica gel, EtOAc/heptane, 1:2 to 1:1) afforded pyran 43 (37 mg, 0.12 mmol, 75%) as a colorless oil. Rf 
0.21 (EtOAc/heptane, 1:1). IR (ATR) ν 3402, 2937, 1706, 1517, 1216, 1085, 1048, 747, 696 cm−1. 1H 
NMR (500 MHz, CDCl3) δ 7.40–7.28 (m, 5H), 6.03 (ddd, J = 1.9, 5.5, 10.2 Hz, 1H), 5.92 (dd, J = 3.2, 
10.2 Hz, 1H), 5.15 (br s, 1H), 5.10 (s, 2H), 4.82 (s, 1H), 4.73 (s, 1H), 4.44–4.35 (m, 1H), 3.85–3.73 (m, 
2H), 3.57 (ddd, J = 5.6, 7.6, 14.1 Hz, 1H), 3.29 (ddd, J = 4.4, 7.8, 14.1 Hz, 1H), 2.40 (dd, J = 9.7, 14.1 
Hz, 1H), 2.13 (dd, J = 5.0, 14.1 Hz, 1H), 1.77 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 157.0, 142.1, 
136.6, 133.5, 128.7, 128.3, 128.2, 126.1, 113.4, 71.3, 70.5, 66.9, 62.4, 41.9, 40.3, 22.2. HRMS (ESI+) 
calcd for C18H23NO4Na [M+Na]+ 340.1525, found 340.1536. 
Benzyl ({6-[2-(chloromethyl)prop-2-en-1-yl]-3-hydroxy-3,6-dihydro-2H-pyran-2-
yl}methyl)carbamate (44) 
 Bicyclic N,O-acetal 40 (66 mg, 0.25 mmol) was treated with 2-
(chloromethyl)allyltrimethylsilane (235 µL, 1.26 mmol) and BF3·Et2O (200 
µL, 0.758 mmol, 48 wt %) as described in the general procedure. Flash 
chromatography (silica gel, EtOAc/heptane, 1:2 to 1:1) afforded pyran 44 (71 mg, 0.20 mmol, 80%) as 
a colorless oil. Rf 0.17 (EtOAc/heptane, 1:1). IR (ATR) ν 3414, 2941, 1702, 1520, 1258, 1084, 744, 
611 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.39–7.29 (m, 5H), 6.05 (ddd, J = 2.0, 5.6, 10.1 Hz, 1H), 5.92 
(dd, J = 3.2, 10.2 Hz, 1H), 5.19 (s, 1H), 5.15–5.06 (m, 3H), 5.02 (s, 1H), 4.47–4.39 (m, 1H), 4.15–4.06 
(m, 2H), 3.85–3.73 (m, 2H), 3.58 (ddd, J = 6.3, 7.3, 13.8 Hz, 1H), 3.29 (ddd, J = 5.1, 7.3, 13.8 Hz, 1H), 
2.53 (dd, J = 10.3, 14.9 Hz, 1H), 2.38 (d, J = 8.6 Hz, 1H), 2.33 (dd, J = 3.8, 14.9 Hz, 1H). 13C NMR 
(125 MHz, CDCl3) δ 157.1, 141.9, 136.5, 133.0, 128.7, 128.33, 128.26, 126.4, 117.5, 71.6, 70.6, 67.1, 
62.1, 48.1, 41.7, 35.2. HRMS (ESI+) calcd for C18H22ClNO4Na [M+Na]+ 374.1135, found 374.1132. 
Benzyl {[6-(but-2-yn-1-yl)-3-hydroxy-3,6-dihydro-2H-pyran-2-yl]methyl}carbamate (45) 
 Bicyclic N,O-acetal 40 (48 mg, 0.18 mmol) was reacted with 3-
(trimethylsilyl)-1,2-butadiene (156 µL, 0.919 mmol) and BF3·Et2O (146 
µL, 0.553 mmol, 48 wt %) following the general procedure. Flash 
chromatography (silica gel, EtOAc/heptane, 1:2) afforded pyran 45 (34 mg, 0.11 mmol, 61%) as a 
colorless oil. Rf 0.19 (EtOAc/heptane, 1:1). IR (ATR) ν 3382, 2917, 1698, 1518, 1259, 1088, 1046, 
738, 697 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.38–7.27 (m, 5H), 6.08–6.04 (m, 1H), 6.03 (dd, J = 2.6, 
10.2 Hz, 1H), 5.34–5.23 (m, 1H), 5.10 (s, 2H), 4.36–4.30 (m, 1H), 3.84–3.78 (m, 1H), 3.77 (ddd, J = 
2.0, 5.6, 7.7 Hz, 1H), 3.57 (ddd, J = 5.9, 7.5, 13.6 Hz, 1H), 3.32 (ddd, J = 4.5, 7.6, 13.6 Hz, 1H), 2.49–
2.40 (m, 2H), 2.40–2.31 (m, 1H), 1.74 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 157.1, 136.6, 132.2, 
128.6, 128.3, 128.2, 126.7, 78.2, 74.9, 71.9, 71.1, 67.0, 62.0, 41.7, 23.1, 3.6. HRMS (ESI+) calcd for 
C18H21NO4Na [M+Na]+ 338.1368, found 338.1378. 
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2-({4-nitro-N-[(4-nitrophenyl)sulfonyl]benzamido}methyl)-6-propyltetrahydro-2H-pyran-3-yl 4-
nitrobenzoate (46) 
Through a suspension of 42 (66 mg, 0.22 mmol) and Pd/C (11 mg, 
10 wt %) in MeOH (1.1 mL) was bubbled hydrogen gas for a 
period of 5 minutes. The reaction mixture was then stirred for 3 h 
at room temperature under an atmosphere of hydrogen. Filtration 
over Celite® afforded the crude product (33 mg, 0.19 mmol) which 
was immediately used in the next step. Thus, the crude primary 
amine was dissolved in CH2Cl2 (1.7 mL) and Et3N (36 µL, 0.26 mmol) and 4-nitrobenzenesulfonyl 
chloride (77 mg, 0.35 mmol) were added. The reaction mixture was stirred for 24 h at room 
temperature under an argon atmosphere. Upon dilution with EtOAc (5 mL) and water (5 mL), the 
layers were separated and the organic layer was washed with aqueous 1 M HCl and dried over Na2SO4. 
Removal of the volatiles under reduced pressure furnished the crude sulfonamide (45 mg, 0.13 mmol), 
which was dissolved in CH2Cl2 (1.3 mL). Et3N (52 µL, 0.37 mmol), DMAP (3.6 mg, 29 µmol) and 4-
nitrobenzoyl chloride (61 mg, 0.33 mmol) were added at room temperature and the mixture was stirred 
for 3 h. The reaction was quenched by addition of saturated aqueous NH4Cl (1 mL) and the product 
was extracted with CH2Cl2 (3 × 1 mL). The combined organic layers were dried over Na2SO4 and 
concentrated in vacuo to afford the crude. Recrystallization from EtOAc afforded the 46 (55 mg, 83 
µmol, 38% from 42) as white needles. Rf 0.58 (EtOAc/heptane, 1:1). Mp 193–195 °C. IR (ATR) ν 
2953, 1717, 1696, 1521, 1347, 1317, 1270, 1173, 1011, 856, 704, 685, 602 cm−1. 1H NMR (500 MHz, 
CDCl3) δ 8.39–8.34 (m, 2H), 8.28–8.23 (m, 2H), 8.22–8.17 (m, 2H), 8.16–8.11 (m, 2H), 8.06–8.01 (m, 
2H), 7.66–7.62 (m, 2H), 5.15–5.09 (m, 1H), 4.15–3.98 (m, 3H), 3.87–3.78 (m, 1H), 2.01–1.84 (m, 3H), 
1.53 (dddd, J = 5.7, 8.1, 9.7, 13.4 Hz, 1H), 1.45–1.37 (m, 1H), 1.36–1.27 (m, 1H), 1.26–1.12 (m, 2H), 
0.87 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 169.6, 163.9, 151.0, 149.5, 144.1, 140.3, 
135.0, 130.7, 130.2, 129.5, 124.3, 123.8, 123.6, 72.2, 69.5, 69.4, 47.8, 33.0, 24.3, 23.6, 19.2, 14.1. 
HRMS (CI+) calcd for C29H29N4O12S [M+H]+ 657.1503, found 657.1504. 
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5.1 Introduction 
In the quest for finding new drugs, medicinal chemists strive to synthesize highly potent and 
selective candidate compounds against a biological target of interest, while keeping the 
adverse effects (e.g. toxicity) as low as possible. In many instances, these goals are pursued 
by using planar scaffolds. For example, the currently marketed drugs sildenafil (1) and 
diazepam (2) (Figure 5.1) are (nearly) flat and do not contain a rigid three-dimensional 
structure. On the other hand, Nature produces many natural products with relevant biological 
properties with particular 3D structural features (e.g. paclitaxel (3), morphine (4) and atropine 
(5)). This has been recognized in the medicinal chemistry field so that molecules of higher 
levels of spatial complexity have received increasing attention in recent years.1 This trend is 
underlined by projects that are supported by pharmaceutical enterprises like the European 
Lead Factory (ELF), which aims at creating a 500,000-membered library of non-planar 
compounds.2 It is anticipated that this increased complexity might reveal new compounds 
exhibiting more potent and selective biological activities. 
  
Figure 5.1 Examples of marketed drugs 1 and 2 and natural products 3–5. 
Recognizing the structural resemblance of the bicyclic N,O-acetals described in Chapter 4 
with tropane alkaloids (e.g. 5) and considering their biological activities, we planned to 
investigate a similar synthetic pathway for the synthesis of skeletal analogues of the tropane 
alkaloids. By placing the nitrogen in different positions, the four azaanalogues 6–9 are 
obtained (Figure 5.2). 
 
Figure 5.2 Projected azatropane analogues 6-9. 
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Although the synthesis of tropane analogues that contain alternative substitution patterns has 
been extensively investigated, there is little precedent of syntheses of azatropane analogues. 
In the Speckamp group versatile methodology was developed for the preparation of 1-
azatropane analogues via intermediate N-acylhydrazonium ions.3 Thus, hydrazine-derived 
N,O-acetals 10 (Scheme 5.1) were reacted under Lewis acidic conditions to form N-
acylhydrazonium ion 11, which then immediately led to the 1-azatropane via cyclization by 
attack of the olefin.3a,3b This methodology was successfully applied to the synthesis of 
analogues containing different substitution patterns.3c,3d 
 
Scheme 5.1 Synthesis of 1-azatropanes by Speckamp and co-workers. 
A route to 2-azatropanes was published by Moreno-Vargas and Vogel who used a radical-
induced ring-expansion to generate the desired 2,8-diazabicyclo[3.2.1]oct-2-ene (19) skeleton 
(Scheme 5.2).4 Their key-step commenced with the formation of an aminyl radical (16) upon 
reaction of tributyltin hydride with the azide moiety. The aminyl radical then rearranged to 
form intermediate 18 which upon concomitant radical desulfonylation gave rise to the desired 
product. 
 
Scheme 5.2 Key-step in the synthesis of 2-azatropanes by Vogel and Moreno-Vargas. 
Cignarella et al. reported the synthesis of 3-azatropane scaffold 21 via an intramolecular 
condensation of amide 20 and subsequent reduction of the intermediate imide (Scheme 5.3).5 
Barlocco and co-workers relied on this methodology for the synthesis of several 3-azatropane 
analogues, which were evaluated in a biological assay as epibatidine (22) analogues.6 
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Scheme 5.3 Preparation of 3-azatropane 21 by Cignarella et al. 
Recently, the group of Singh published related methodology in which the desired product was 
formed via intramolecular amide formation upon nitro reduction and double bond 
hydrogenation of 23 under the action of ammonium formate and Pd/C (Scheme 5.4).7 
 
Scheme 5.4 Synthesis of 3-azatropane 24 by Singh et al. 
Surprisingly, only scant precedent for the synthesis of 6-azatropane analogues can be found. 
Husson and co-workers have published the most notable synthetic efforts to 6-azatropane 
analogues albeit that the authors did not impart these scaffolds as such.8 They reported the 
synthesis of several 6,8-diazabicyclo[3.2.1]oct-6-enes (25) and their application as 
intermediates for enantiopure 2-(1-aminoalkyl)piperidines (26) and azepines (27) (Scheme 
5.5). 
 
Scheme 5.5 6,8-Diazabicyclo[3.2.1]oct-6-ene 25 as precursor for piperidines 26 and azepines 27. 
In continuation of Chapter 4, we planned to synthesize azatropanes using an analogous 
strategy, which would give rise to 6-azatropane analogues with two orthogonally protected 
nitrogen atoms. Furthermore, the persistent enone functionality offers an additional handle 
that could be used to introduce other functionalities using different types of chemistries. 
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Scheme 5.6 General example of a [5+2] cycloaddition of oxidopyridinium ion 28. 
We also became interested in the products that are accessible via inter- or intramolecular 
[5+2] cycloadditions of betaines (or oxidopyridinium ions) and olefins. These reactions have 
amongst others been applied to synthesize tropane analogues (Scheme 5.6)9a-f and other 
natural products.9g-j The oxidopyridinium ion (e.g. 28) is commonly generated by N-alkylation 
of a 3-hydroxypyridine species although Peese and Gin reported an interesting procedure that 
builds on the aza-Achmatowicz reaction for the generation of the requisite ion 32 (Scheme 
5.7).9h The authors subsequently used the oxidopyridinium ion in an intramolecular [5+2] 
cycloaddition for an asymmetric synthesis of the core of the hetisine alkaloids. 
 
Scheme 5.7 Synthesis of the hetisine core by Peese and Gin via an intramolecular [5+2] cycloaddition of 32. 
The group of Mascareñas and Castedo used an allyl ether as the olefinic reaction partner in 
the intramolecular [5+2] cycloaddition (Scheme 5.8).9e Methylation of pyridinone 34 
furnished the corresponding pyridinium zwitterion, which upon treatment with 2,2,6,6-
tetramethylpiperidine (35) at 100 °C in a sealed tube in acetonitrile gave the intermediate 
oxidopyridinium species 36. Instantaneous [5+2] cycloaddition then afforded the targeted 
tricyclic tropane analogue 37. Inspired by this work, we recognized that similar 
oxidopyridinium ions might be accessible using the methodology described in Chapter 3. An 
intramolecular [5+2] cycloaddition would then lead to azatricyclotropane analogues, of which 
the combination of two endocyclic nitrogens and the increased level of three-dimensionality 
render them highly interesting as pharmaceutically relevant building blocks. 
 
Scheme 5.8 Intramolecular [5+2] cycloaddition as reported by the group of Mascareñas and Castedo. 
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5.2 Studies towards intramolecular [5+2] cycloadditions 
In order to investigate [5+2] cycloadditions that would lead to tricyclic tropane analogue 38 
(Scheme 5.9), we first had to synthesize oxidopyridinium ion precursor 39. Since structurally 
related oxidopyrylium ions are typically generated from acetylated O,O-acetals10, we 
reasoned that hemiaminal 39 may require O-acetylation prior to inducing the essential 
oxidopyridinium ion formation. Thus, retrosynthetic analysis of 38 shows that precursor 40 
can be prepared by an aza-Achmatowicz rearrangement of furanyl diamine 41. Orthogonal 
protection and mono-alkylation of the diamine would be achieved starting from azide 42, 
which might be prepared via Mitsunobu reaction with diphenylphosphoryl azide (DPPA) of 
amino alcohol 43. The preparation of amino alcohol 43 starting from furfural (44) has been 
described in Section 4.3. 
 
Scheme 5.9 Retrosynthetic analysis of oxidopyridinium ion precursor 40 and its [5+2] cycloaddition product 38. 
Thus, by starting from 43, the requisite azide moiety was introduced in a Mitsunobu reaction 
using DPPA furnishing 42 in 92% yield (Scheme 5.10). Subsequent N-alkylation afforded 
allyl carbamate 46, which was then reduced in good yield to the corresponding amine in a 
Staudinger reaction with trimethylphosphine. The resulting primary amine (47) was then 
protected with a 4-nitrobenzenesulfonyl group (nosyl, Ns) and the stage was thereby set for 
the aza-Achmatowicz reaction. In order to avoid double bond oxidation, N-bromosuccinimide 
(NBS) was used as the oxidant instead of m-CPBA, resulting in the formation of piperidinone 
39 as a single diastereoisomer. Although the stereochemistry could not be unambiguously 
established, it was tentatively assigned based on literature precedent of similar aza-
Achmatowicz products.11 In order to conclude the synthesis, it was attempted to acetylate the 
hydroxyl using Ac2O and albeit that the desired oxidopyridinium ion precursor 40 was 
obtained, the 23% yield of the reaction did not meet our expectations. It was observed that, 
next to the desired product, pyridine side product 52 (Scheme 5.11) was formed during the 
reaction in an isolated yield of 27%. 
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Scheme 5.10 Synthesis of oxidopyridinium ion precursor 40. 
It is most likely that the formation of pyridine 52 proceeds via the anticipated 
oxidopyridinium intermediate 49. However, subsequent nucleophilic aromatic attack of the 
liberated acetate anion at the electron-deficient nosyl group resulted in the deprotected 
oxidopyridine 51. Subsequent acetylation with acetic anhydride resulted in the formation of 
pyridine derivative 52. 
 
Scheme 5.11 Plausible mechanism for the formation of pyridine 52. 
Despite the fact that the anticipated precursor 40 was successfully synthesized, the formation 
of pyridine 52 in the final acetylation step indicated the unstable character of the putative 
oxidopyridinium ion intermediate. In addition, the yield of the acetylated product was low 
and this procedure would hence not be viable for the preparation of larger quantities of the 
scaffold. It was therefore attempted to prevent side product formation by applying a one-pot 
procedure for the [5+2] cycloaddition in which the acetylation was conducted at 0 °C to 
circumvent formation of the oxidopyridinium ion intermediate. Thus upon acetylation of 39 
with Ac2O at 0 °C in CH2Cl2, DBU was added and the reaction mixture was slowly allowed to 
warm to room temperature (Scheme 5.12). Unfortunately, this afforded pyridine 52 as the 
major product in 53% yield and formation of the desired cyclization product (38) was not 
observed. 
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Scheme 5.12 One-pot acetylation and intramolecular [5+2] cycloaddition of 39. 
Since it is plausible that the intermediate oxidopyridinium ion has been formed during the 
reaction, we are convinced that the electron-deficient nosyl group renders intermediate 49 
prone to desulfonylation by an external nucleophile. It is therefore hypothesized that this side 
reaction may be avoided by using a less electron-withdrawing protective group (e.g. tosyl). 
5.3 Synthesis of a 6-azatropane analogue 
We also intended to synthesize the azatropane analogue 53, which can be retrosynthetically 
traced back to N,O-acetal 54 via cyclization of the carbamate nitrogen on the corresponding 
N-acyliminium ion intermediate (Scheme 5.13). Compound 54 should be accessible via an 
aza-Achmatowicz reaction of furanyl diamine 55, which would be prepared via Staudinger 
reduction and subsequent protection of azide 42. Azide 42 was readily available from furfural 
as it is also an intermediate in the synthesis of oxidopyridinium ion precursor 44 (see Scheme 
5.10). 
 
Scheme 5.13 Retrosynthetic analysis of azatropane scaffold 53. 
Since the preparation of azide 42 has already been described in Section 5.2 (Scheme 5.10), 
the synthesis of the anticipated 6-azatropanes began by reducing the azide functionality in a 
Staudinger reduction using triphenylphosphine resulting in primary amine 56 (Scheme 5.14). 
At this point, a suitable protective group for the primary amine was required, which was 
compatible with the conditions in later stages of the targeted scaffolds (e.g. oxidative and 
Lewis acidic conditions). In addition, because the protective group should enable facile 
orthogonal deprotection, a nosyl group was selected. Hence, amine 56 was reacted with NsCl 
in pyridine to afford the diprotected diamine 57 in a somewhat moderate 50% yield. 
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Scheme 5.14 Synthesis of 6-azatropane analogue 59. 
Attempts to improve the yield of the protection by changing the base to Et3N or by 
conducting the reaction under Schotten–Baumann conditions using a 0.3 M NaOH/CH2Cl2 
mixture did not gave the intended result. We hypothesized that the unsatisfactory yield was 
caused by the formation of Meisenheimer complex 60 during the reaction, causing a side 
reaction that leads to primary amine 61 (Scheme 5.15). Although we were not able to isolate 
61, the presence of the [M+H]+ signal (ESI, 381 m/z) in the low-resolution mass spectrum of 
the crude reaction mixture indicated its formation. 
 
Scheme 5.15 Putative side reaction during Ns-protection of diamine 57. 
Next, diamine 57 was converted into the required piperidinone via the aza-Achmatowicz 
reaction. Treatment with m-CPBA under the conditions that were described in Chapters 3 and 
4, led to the desired product in low, irreproducible yields. When NBS was applied as the 
oxidant at −10 °C, however, the requisite piperidinone 58 was isolated in 79% yield as a 
single diastereoisomer. Assignment of the relative stereochemistry was again based on 
literature precedent of related compounds.11 Subsequent cyclization of the Cbz-protected 
amine on the Sn(OTf)2-generated N-sulfonyliminium ion furnished the targeted 6-azatropane 
analogue 59 in 82% yield. 
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5.4 Orthogonal deprotection and functionalization of the 6-
azatropane analogue 
With the intended 6-azatropane analogue 59 in hand, we wished to investigate its scope as a 
pharmaceutically relevant building block. However, 59 still contains the enone moiety that 
renders the compound toxic in biological systems due to its electrophilic character. Thus, 59 
was reduced by conjugate addition with a copper hydride species and the resulting silyl enol 
ether was subsequently desilylated to furnish ketone 62 in 58% yield (Scheme 5.16).12  
 
Scheme 5.16 Conjugate reduction of 59 and subsequent reaction of 62 with HBr/AcOH. 
The orthogonal deprotection of the Cbz group was initially investigated, and since the nosyl 
group would not survive hydrogenolysis conditions, alternative conditions were mandatory. It 
is well known that a solution of HBr in acetic acid can smoothly liberate N-Cbz protected 
amines, but when these conditions were applied to 62, a complex mixture of side products 
was formed (Scheme 5.16). It is expected that the nosyl group is not resistant to bromide ions 
resulting in desulfonylation and consequent hydrolysis of the unprotected aminal. 
Because orthogonal deprotection of the Cbz group appeared difficult in the presence of the 
nosylated amine, it was decided to first desulfonylate the bridging nitrogen using thiophenol 
and a base. It was observed that the choice of the base or thiol had a detrimental effect on the 
outcome of the reaction i.e. no product was formed when LiOH or mercaptoacetic acid was 
used. Gratifyingly, the reaction of 62 with thiophenol and potassium carbonate delivered 
mono-protected bicyclic aminal 63 in 57% yield (Scheme 5.17). N-Functionalization of 63 
would demonstrate the applicability of 62 as a scaffold for the preparation of 6-azatropane 
analogues. Therefore, methylation of 63 via an Eschweiler–Clarke reaction was expeditiously 
investigated and although not isolated, the existence of an additional signal in the 1H NMR 
spectrum at 2.39 ppm integrating for ca. three protons gave strong evidence that 64 was 
formed. 
 
Scheme 5.17 Desulfonylation and subsequent methylation of 62. 
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5.5 Conclusions 
In summary, an oxidopyridinium ion precursor was prepared starting from an amino alcohol 
that was prepared in Chapter 4 via the aza-Achmatowicz reaction. Attempts to form the 
oxidopyridinium ion and the anticipated cyclization product did not succeed since an 
undesired aromatic side product was formed by desulfonylation of the intermediate. 
Furthermore, a 6-azatropane analogue was synthesized via the aza-Achmatowicz reaction and 
its orthogonal deprotection was investigated. Removal of the Cbz group in the presence of a 
nosylated amine appeared to be troublesome, but it was shown that the bridging amine could 
be successfully desulfonylated in the presence of the Cbz group. 
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5.7  Experimental section 
For general remarks see Section 3.8. 
Benzyl [2-azido-2-(2-furanyl)ethyl]carbamate (42) 
To a solution of amino alcohol 43 (8.36 g, 32.0 mmol) in toluene (160 mL) at 0 °C 
was added diphenyl phosphoryl azide (8.28 mL, 38.4 mmol) and DBU (5.79 mL, 
38.4 mmol). The reaction mixture was stirred for 30 minutes at 0 °C under an 
argon atmosphere and was then stirred for another 16 h at room temperature. The 
reaction was quenched by addition of water (300 mL) and the product was extracted with EtOAc (3 × 
300 mL). The combined organic layers were washed with aqueous 1 M HCl (500 mL) and brine (500 
mL). Subsequent drying over Na2SO4 and removal of the solvents under reduced pressure afforded the 
crude product, which was purified by flash chromatography (silica gel, EtOAc/heptane, 10%→20% 
EtOAc) to furnish azide 42 (8.45 g, 29.5 mmol, 92%) as a yellowish oil that solidified upon freezing. 
Rf 0.53 (EtOAc/heptane, 1:1). Mp 30–32 °C. IR (ATR) ν 3329, 2103, 1702, 1524, 1253, 742 cm−1. 1H 
NMR (500 MHz, CDCl3) δ 7.43 (s, 1H), 7.40–7.30 (m, 5H), 6.40–6.33 (m, 2H), 5.23–5.07 (m, 3H), 
4.70 (dd, J = 5.8, 7.6 Hz, 1H), 3.68 (dt, J = 6.2, 13.9 Hz, 1H), 3.51 (ddd, J = 5.8, 7.9, 13.9 Hz, 1H). 13C 
NMR (125 MHz, CDCl3) δ 156.3, 149.8, 143.4, 136.3, 128.6, 128.3, 128.2, 110.5, 109.1, 67.1, 58.3, 
43.2. HRMS (EI+) calcd for C14H14N2O3 [M−N2]+ 258.1004, found 258.1004. 
Benzyl allyl[2-azido-2-(2-furanyl)ethyl]carbamate (46) 
Azide 42 (453 mg, 1.58 mmol) and allyl bromide (164 µL, 1.90 mmol) were 
dissolved in an anhydrous 1:1 mixture of THF/DMF (8 mL) and the solution was 
cooled to 0 °C. Sodium hydride (76 mg, 1.9 mmol) was slowly added and the 
resulting white suspension was stirred at room temperature until TLC indicated full 
conversion of the starting material. The reaction was quenched by careful addition of water (8 mL) and 
the product was extracted with EtOAc (3 × 8 mL). The combined organic layers were dried over 
Na2SO4 and concentrated in vacuo to afford the crude product as a yellow oil. Purification by flash 
chromatography (silica gel, EtOAc/heptane, 15% EtOAc) furnished allylated amine 46 (432 mg, 1.32 
mmol, 84%) as a colorless oil. Rf 0.61 (EtOAc/heptane, 1:1). IR (ATR) ν 2102, 1697, 1464, 1413, 
N3 H
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1234, 737, 697 cm−1. 1H NMR (500 MHz, CDCl3, mixture of rotamers A and B) δ 7.46–7.27 (m, 
6HA+B), 6.40–6.23 (m, 2HA+B), 5.81–5.66 (m, 1HA+B), 5.24–5.05 (m, 4HA+B), 4.91 (dd, J = 6.3, 7.8 Hz, 
1HA), 4.69 (t, J = 6.8 Hz, 1HB), 3.99–3.76 (m, 2HA+B), 3.70–3.52 (m, 2HA+B). 13C NMR (125 MHz, 
CDCl3, mixture of rotamers A and B) δ 156.3 (A), 155.8 (B), 150.0 (A), 149.8 (B), 143.2 (A+B), 136.6 
(A), 136.5 (B), 133.4 (A), 133.2 (B), 128.7 (A+B), 128.6 (A+B), 128.2 (B), 128.1 (A), 128.0 (B), 127.8 
(A), 117.5 (B), 116.9 (A), 110.6 (A), 109.2 (B), 67.6 (B), 67.5 (A), 57.9 (B), 57.3 (A), 51.0 (A), 50.9 
(B), 49.7 (A), 48.7 (B). HRMS (ESI+) calcd for C17H19N2O3 [M−N2+H]+ 299.1396, found 299.1399. 
Benzyl allyl[2-amino-2-(2-furanyl)ethyl]carbamate (47) 
To a solution of azide 46 (359 mg, 1.10 mmol) in a 1:5 mixture of H2O/THF (5.5 
mL) was added trimethylphosphine (1.65 mL, 1.65 mmol, 1 M in THF) at 0 °C. 
The reaction mixture was stirred for 5 minutes at 0 °C and was then allowed to 
warm to room temperature. After 1 h, the reaction mixture was diluted with H2O 
(5.5 mL) and the product was extracted with EtOAc (3 × 10 mL). The combined organic layers were 
washed with 1 M NaHCO3 (50 mL) and brine (50 mL) and subsequently dried over Na2SO4. 
Concentration under reduced pressure gave the crude product, which was purified by flash 
chromatography (silica gel, EtOAc/heptane/MeOH, 4:4:1) affording amine 47 (283 mg, 0.942 mmol, 
86%) as an yellow oil. Rf 0.35 (EtOAc/heptane/MeOH, 4:4:1). IR (ATR) ν 1693, 1465, 1414, 1238, 
919, 734, 698 cm−1. 1H NMR (500 MHz, CDCl3, mixture of rotamers) δ 7.44–7.27 (m, 6H), 6.30 (br s, 
1H), 6.23–6.05 (m, 1H), 5.82–5.62 (m, 1H), 5.21–5.00 (m, 4H), 4.39–4.13 (m, 1H), 4.02–3.81 (m, 1H), 
3.62 (ddt, J = 1.3, 5.9, 16.0 Hz, 1H), 3.56–3.41 (m, 2H), 1.65 (br s, 2H). 13C NMR (125 MHz, CDCl3, 
mixture of rotamers A and B) δ 156.8 (B), 156.4 (A), 156.3 (B), 156.2 (A), 141.7 (A+B), 136.8 (A+B), 
133.6 (A+B), 128.6 (A+B), 128.1 (A+B), 127.9 (A+B), 117.3 (B), 116.8 (A), 110.4 (A+B), 105.9 (B), 
105.8 (A), 67.4 (A+B), 52.8 (A), 52.1 (B), 50.7 (B), 50.5 (A), 49.1 (B), 48.8 (A). HRMS (ESI+) calcd 
for C17H20N2O3Na [M+Na]+ 323.1372, found 323.1374. 
Benzyl allyl{2-(2-furanyl)-2-[(4-nitrophenyl)sulfonamido]ethyl}carbamate (41) 
A flask containing a solution of amine 47 (216 mg, 0.719 mmol) in anhydrous 
pyridine (4.8 mL) was brought to 0 °C using an ice bath. 4-Nitrobenzenesulfonyl 
chloride (199 mg, 0.899 mmol) was added and the mixture was stirred for 15 
minutes at 0 °C under an argon atmosphere. Then cooling bath was then removed 
and the reaction mixture was stirred at room temperature until TLC indicated full conversion of the 
starting material after 1.5 h. The mixture was diluted with water (5 mL) and the product was extracted 
with CH2Cl2 (3 × 5 mL). The combined organic layers were dried over Na2SO4 and concentrated in 
vacuo to afford the crude product. Purification by flash chromatography (silica gel, EtOAc/heptane, 
1:2) furnished diprotected diamine 41 (244 mg, 0.503 mmol, 70%) as an oil. Rf 0.46 (EtOAc/heptane, 
1:1). IR (ATR) ν 3205, 1678, 1528, 1347, 1243, 1164, 735, 612 cm−1. 1H NMR (500 MHz, CDCl3, 
mixture of rotamers A and B) δ 8.18–8.03 (m, 2HA+B), 7.89–7.78 (m, 2HA), 7.72–7.63 (m, 2HB), 7.46–
7.29 (m, 5HA+B), 7.13–7.04 (m, 1HA+B), 6.63 (d, J = 6.5 Hz, 1HA), 6.17–6.04 (m, 1HA+B+1HA), 5.89 (br 
s, 1HB), 5.72–5.60 (m, 1HB), 5.66 (ddt, J = 5.7, 10.4, 11.2 Hz, 1HA+B), 5.22–5.04 (m, 4HA+B), 4.82–4.66 
(m, 1HA+B), 3.94–3.74 (m, 2HB), 3.89 (dd, J = 9.9, 14.6 Hz, 1HA), 3.78 (dd, J = 5.2, 16.2 Hz, 1HA), 3.68 
(dd, J = 5.9, 16.2 Hz, 1HA), 3.47 (dd, J = 4.8, 15.6 Hz, 1HB), 3.41 (dd, J = 6.6, 14.1 Hz, 1HB), 3.29 (dd, 
J = 4.2, 14.6 Hz, 1HA). 13C NMR (125 MHz, CDCl3) δ 158.0, 150.7, 149.7, 146.7, 142.5, 136.1, 132.7, 
128.7, 128.4, 128.2, 127.9, 123.9, 117.7, 110.5, 108.4, 68.0, 51.6, 50.4, 50.0. HRMS (ESI+) calcd for 
C23H23N3O7SNa [M+Na]+ 508.1154, found 508.1151. 
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Benzyl allyl({6-hydroxy-1-[(4-nitrophenyl)sulfonyl]-3-oxo-1,2,3,6-tetrahydropyridin-2-
yl}methyl)carbamate (39) 
Diamine 41 (200 mg, 0.412 mmol) and NaHCO3 (69 mg, 0.82 mmol) were 
added to a 10:1 acetone/water mixture (1.03 mL) and the resulting solution was 
cooled to −10 °C. A solution of N-bromosuccinimide (88 mg, 0.49 mmol) in 
acetone/water (10:1, 1.03 mL) was added and the reaction mixture was stirred 
for 3 h at −10 °C. The mixture was then diluted with a half saturated aqueous NaCl solution (5 mL) and 
the product was extracted with EtOAc (3 × 5 mL). The combined organic layers were dried over 
Na2SO4 and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (silica gel, EtOAc/heptane, 1:2) affording piperidinone 39 (90 mg, 0.18 mmol, 44%) 
as a yellow oil. Rf 0.26 (EtOAc/heptane, 1:1). IR (ATR) ν 3369, 1683, 1531, 1349, 1167, 907, 727, 603 
cm−1. 1H NMR (500 MHz, CDCl3, mixture of rotamers) δ 8.40–8.18 (m, 2H), 8.03–7.64 (m, 2H), 7.49–
7.28 (m, 5H), 7.00–6.60 (m, 1H), 6.06–5.63 (m, 3H), 5.27–5.03 (m, 4H), 4.69–4.37 (m, 1H), 4.24–3.91 
(m, 2H), 3.79–3.26 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 191.6, 157.9, 150.4, 145.5, 136.0, 132.3, 
128.7, 128.4, 128.2, 127.9, 126.4, 124.9, 124.8, 118.1, 73.7, 68.3, 59.2, 50.0, 49.6. HRMS (ESI+) calcd 
for C23H23N3O8SNa [M+Na]+ 524.1104, found 524.1104. 
6-({Allyl[(benzyloxy)carbonyl]amino}methyl)-1-[(4-nitrophenyl)sulfonyl]-5-oxo-1,2,5,6-
tetrahydropyridin-2-yl acetate (40) 
 To a solution of piperidinone 39 (61 mg, 0.12 mmol) in dry CH2Cl2 (750 µL) at 
0 °C was added Ac2O (23 µL, 0.24 mmol), dry Et3N (34 µL, 0.24 mmol) and 
DMAP (3.0 mg, 25 µmol). After stirring for 1 h at 0 °C under an argon 
atmosphere, the reaction mixture was diluted with Et2O (5 mL) and 
subsequently washed with 1 M HCl (5 mL) and 1 M NaOH (5 mL). The organic layer was dried over 
Na2SO4 and concentrated in vacuo to afford the crude product. Purification by flash chromatography 
(silica gel, EtOAc/heptane, 1:2) afforded acetylated piperidinone 40 (15 mg, 28 µmol, 23%) as a 
yellow oil. Rf 0.42 (EtOAc/heptane, 1:1). IR (ATR) ν 1753, 1704, 1533, 1417, 1369, 1207, 1171, 739 
cm−1. 1H NMR (500 MHz, CDCl3, mixture of rotamers A and B) δ 8.38–8.30 (m, 2HA), 8.29–8.21 (m, 
2HB), 8.05–7.95 (m, 2HA), 7.82–7.73 (m, 2HB), 7.41–7.29 (m, 5HA+B), 6.95 (d, J = 4.6 Hz, 1HA), 6.88 
(d, J = 4.4 Hz, 1HB), 6.82 (dd, J = 4.7, 10.3 Hz, 1HA), 6.66 (dd, J = 4.7, 10.2 Hz, 1HB), 6.14 (d, J = 
10.3 Hz, 1HA), 5.87–5.73 (m, 1HA+B+1HB), 5.25–5.15 (m, 2HA+B), 5.13–5.06 (m, 2HA+B), 4.64 (dd, J = 
6.2, 9.1 Hz, 1HA), 4.59 (dd, J = 6.8, 8.8 Hz, 1HB), 4.03 (dd, J = 9.3, 14.0 Hz, 1HA+B), 4.04–3.85 (m, 
2HA+B), 3.43 (dd, J = 6.1, 14.0 Hz, 1HA+B), 2.10 (s, 3HA), 2.08 (s, 3HB). 13C NMR (125 MHz, CDCl3, 
mixture of rotamers A and B) δ 190.9 (A), 190.7 (B), 169.2 (A), 169.0 (B), 156.3 (A), 155.3 (B), 150.7 
(A+B), 144.8 (A), 144.6 (B), 139.3 (B), 139.2 (A), 136.4 (A), 136.2 (B), 133.4 (A+B), 128.7 (A+B), 
128.6 (A+B), 128.4 (A+B), 128.2 (A+B), 127.9 (A+B), 124.9 (A+B), 118.0 (B), 117.6 (A), 73.4 (B), 
73.3 (A), 67.8 (B), 67.7 (A), 59.0 (B), 58.6 (A), 50.4 (B), 50.3 (A), 21.0 (A+B). HRMS (ESI+) calcd 
for C25H25N3O9SNa [M+Na]+ 566.1209, found 566.1197. 
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2-({Allyl[(benzyloxy)carbonyl]amino}methyl)pyridin-3-yl acetate (52) 
Compound 52 (11 mg, 32 µmol, 27%) was obtained as a side product in the synthesis 
of 40. Pyridine 52 was also obtained as the major product of the intended [5+2] 
cycloaddition upon treating a solution of 39 (30 mg, 60 µmol) CH2Cl2 (0.6 mL) with 
DMAP (0.4 mg, 3 µmol), anhydrous pyridine (6.3 µL, 78 µmol) and Ac2O (6.8 µL, 
72 µmol) at 0 °C. After stirring the reaction mixture for 1 h at 0 °C under an argon 
atmosphere, DBU (20 µL, 0.13 mmol) was added and the cooling bath was removed. After stirring for 
another 2 h at room temperature, the mixture was diluted with EtOAc (1 mL) and subsequently washed 
with saturated aqueous NH4Cl and brine. The organic layer was dried over Na2SO4, concentrated in 
vacuo and the resulting crude product was purified by flash chromatography (silica gel, 
EtOAc/heptane, 1:2) to furnish 52 (11 mg, 32 µmol, 53%) as a colorless oil. Rf 0.34 (EtOAc/heptane, 
1:1). IR (ATR) ν 1768, 1697, 1414, 1232, 1196, 1158, 909, 751, 697 cm−1. 1H NMR (500 MHz, CDCl3, 
mixture of rotamers A and B) δ 8.47–8.38 (m, 1HA+B), 7.49–7.17 (m, 7HA+B), 5.88–5.63 (m, 1HA+B), 
5.22–4.99 (m, 4HA+B), 4.66 (s, 2HA), 4.56 (s, 2HB), 4.02 (br s, 2HB), 3.90 (d, J = 4.3 Hz, 2HA), 2.26 (s, 
3HA), 2.20 (s, 3HB). 13C NMR (125 MHz, CDCl3, mixture of rotamers A and B) δ 169.2 (A), 168.8 (B), 
156.3 (A+B), 149.9 (A), 149.5 (B), 146.8 (B), 146.6 (A), 137.0 (A+B), 133.5 (B), 133.3 (A), 130.7 
(A), 130.1 (B), 128.5 (A+B), 128.0 (A+B), 127.8 (A+B), 123.6 (A), 123.1 (B), 117.4 (B), 116.9 (A), 
67.4 (A+B), 50.2 (B), 48.9 (A), 47.7 (A), 46.7 (B), 21.0 (A+B). HRMS (ESI+) calcd for C19H20N2O4Na 
[M+Na]+ 363.1321, found 363.1332. 
Benzyl [2-amino-2-(2-furanyl)ethyl]carbamate (56) 
Azide 42 (86 mg, 0.30 mmol) was dissolved in a 1:5 H2O/THF mixture (1.5 mL) 
and triphenylphosphine (118 mg, 0.450 mmol) was added at room temperature. The 
reaction mixture was stirred at the same temperature until TLC indicated full 
conversion of the starting material after 3 h. The mixture was diluted with H2O (1.5 
mL) and the product was extracted with EtOAc (3 × 2 mL). The combined organic layers were washed 
with aqueous 1 M HCl (3 × 5 mL) and the combined aqueous layers were neutralized with saturated 
aqueous Na2CO3 until a pH of ± 9. The product was then extracted with EtOAc (3 × 10 mL) and the 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated in vacuo 
affording amine 56 (75 mg, 0.29 mmol, 97%) as a yellow oil. The product contained only trace 
amounts of triphenylphosphine oxide, which if necessary, could be removed by flash chromatography 
(silica gel, EtOAc/heptane, 9:1). Rf 0.29 (EtOAc/heptane, 9:1). IR (ATR) ν 3307, 1700, 1505, 1248, 
1144, 1009, 733, 696 cm−1. 1H NMR (300 MHz, CDCl3) δ 7.39–7.28 (m, 6H), 6.31 (dd, J = 3.2, 1.9 Hz, 
1H), 6.18 (d, J = 3.2 Hz, 1H), 5.20 (br s, 1H), 5.11 (s, 2H), 4.12–4.02 (m, 1H), 3.66–3.52 (m, 1H), 
3.43–3.31 (m, 1H), 2.22 (br s, 3H). 13C NMR (125 MHz, CDCl3) δ 156.8, 156.2, 150.5, 150.4, 141.9, 
136.5, 129.9, 128.5, 128.1, 125.6, 120.2, 120.1, 110.2, 110.0, 105.4, 66.8, 49.6, 45.9, 30.3, 18.4, 17.8. 
HRMS (ESI+) calcd for C14H17N2O3 [M+H]+ 261.1239, found 261.1244. 
Benzyl {2-(2-furanyl)-2-[(4-nitrophenyl)sulfonamide]ethyl}carbamate (57) 
4-Nitrobenzenesulfonyl chloride (1.44 g, 6.50 mmol) was added to a solution of 
amine 56 (1.35 g, 5.19 mmol) in anhydrous pyridine (35 mL) at 0 °C. After stirring 
5 min at 0 °C, the cooling bath was removed and the mixture was stirred for 4 h at 
room temperature under an argon atmosphere. The reaction mixture was then 
diluted with H2O (35 mL) and the product was extracted with CH2Cl2 (3 × 35 mL). The combined 
organic layers were dried over Na2SO4 and the solvent was removed under reduced pressure affording 
the crude product. Purification by flash chromatography (silica gel, EtOAc/heptane, 20%→50% 
EtOAc) furnished diprotected diamine 57 (1.16 g, 2.60 mmol, 50%) as a yellow solid. Rf 0.36 
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(EtOAc/heptane, 1:1). Mp 133–135 °C. IR (ATR) ν 1699, 1527, 1348, 1260, 1164, 1090, 1013, 736, 
614 cm−1. 1H NMR (500 MHz, CDCl3) δ 8.20–8.09 (m, 2H), 7.92–7.75 (m, 2H), 7.41–7.28 (m, 5H), 
7.09 (d, J = 0.9 Hz, 1H), 6.29 (d, J = 7.2 Hz, 1H), 6.14–6.09 (m, 1H), 6.05 (d, J = 2.9 Hz, 1H), 5.28 (t, 
J = 6.0 Hz, 1H), 5.09 (s, 2H), 4.70–4.57 (m, 1H), 3.61–3.44 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 
157.5, 150.4, 149.8, 146.4, 142.6, 136.1, 128.7, 128.5, 128.3, 128.2, 124.1, 110.5, 108.4, 67.4, 52.6, 
44.3. HRMS (ESI+) calcd for C20H19N3O7SNa [M+Na]+ 468.0841, found 468.0833. 
Benzyl ({6-hydroxy-1-[(4-nitrophenyl)sulfonyl]-3-oxo-1,2,3,6-tetrahydropyridin-2-
yl}methyl)carbamate (58) 
A flask was charged with a mixture of diprotected diamine 57 (1.00 g, 2.24 
mmol) and NaHCO3 (377 mg, 4.49 mmol) in 1:10 H2O/acetone (5.6 mL) and 
was brought to −10 °C. A solution of NBS (480 mg, 2.70 mmol) in 1:10 
H2O/acetone (5.6 mL) was added and the reaction mixture was stirred for 4 h at 
−10 °C. Then, half saturated aqueous NaCl solution (20 mL) was added and the product was extracted 
with EtOAc (3 × 20 mL). The combined organic layers were dried over Na2SO4 and the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography (silica gel, 
EtOAc/heptane, 1:2 to 1:1) to afford piperidinone 58 (820 mg, 1.78 mmol, 79%) as an off-white foam. 
Rf 0.19 (EtOAc/heptane, 1:1). Mp 53–55 °C. IR (ATR) ν 3370, 1689, 1528, 1349, 1247, 1167, 1004, 
854, 738, 603 cm−1. 1H NMR (500 MHz, CD3OD) δ 8.40–8.25 (m, 2H), 8.14–7.98 (m, 2H), 7.45–7.22 
(m, 5H), 6.98 (dd, J = 4.6, 10.3 Hz, 1H), 6.11 (d, J = 4.6 Hz, 1H), 5.90 (d, J = 10.3 Hz, 1H), 5.14–5.03 
(m, 2H), 4.52 (t, J = 7.2 Hz, 1H), 3.60 (dd, J = 7.1, 13.9 Hz, 1H), 3.47 (dd, J = 7.4, 13.9 Hz, 1H). 13C 
NMR (125 MHz, CD3OD) δ 193.8, 158.7, 151.8, 146.8, 146.7, 138.1, 129.7, 129.4, 129.0, 128.8, 
127.0, 125.7, 74.5, 67.6, 61.6, 45.2. HRMS (ESI+) calcd for C20H19N3O8SNa [M+Na]+ 484.0791, found 
484.0780. 
Benzyl 8-(4-nitrophenylsulfonyl)-2-oxo-6,8-diazabicyclo[3.2.1]oct-3-ene-6-carboxylate (59) 
Tin(II)triflate (48 mg, 0.12 mmol) was added to a solution of piperidinone 58 (530 mg, 
1.15 mmol) in MeCN (11.5 mL) at 0 °C. The reaction mixture was slowly allowed to 
warm to room temperature and stirred for 4 h under an argon atmosphere. The reaction 
mixture was diluted with EtOAc (20 mL) and the reaction was quenched by addition of 
saturated aqueous NaHCO3 (10 mL). The layers were separated and the product was 
extracted with EtOAc (2 × 20 mL). The combined organic layers were washed with brine, dried over 
Na2SO4 and concentrated in vacuo to afford the crude product. Purification by flash chromatography 
(silica gel, EtOAc/heptane, 20%→40% EtOAc) furnished bicyclic aminal 59 (419 mg, 0.945 mmol, 
82%) as a white powder. Rf 0.45 (EtOAc/heptane, 1:1). Mp 56–59 °C. IR (ATR) ν 1699, 1531, 1411, 
1350, 1313, 1171, 1088, 739, 640 cm−1. 1H NMR (500 MHz, CDCl3, mixture of rotamers A and B) δ 
8.34–8.25 (m, 2HA), 8.16–8.08 (m, 2HB), 8.08–8.00 (m, 2HA), 7.92–7.84 (m, 2HB), 7.52–7.29 (m, 
4HA+B), 7.24–7.16 (m, 1HA+B), 6.26–6.03 (m, 2HA+B), 5.25–4.96 (m, 2HA+B), 4.78 (d, J = 6.2 Hz, 1HA), 
4.73 (d, J = 6.0 Hz, 1HB), 3.31–3.22 (m, 1HA+B), 3.08 (s, 1HA), 3.06 (s, 1HB). 13C NMR (125 MHz, 
CDCl3, mixture of rotamers A and B) δ 191.4 (A), 191.2 (B), 153.1 (A), 152.1 (B), 150.9 (A+B), 147.7 
(A), 147.0 (B), 143.3 (A), 143.0 (B), 135.7 (B), 135.2 (A), 129.3 (A+B), 129.0 (A+B), 128.8 (A+B), 
128.2 (A+B), 128.0 (A), 127.9 (B), 124.74 (B), 124.66 (A), 68.3 (B), 68.1 (A), 67.6 (A), 67.5 (B), 65.9 
(A), 65.0 (B), 43.50 (B), 43.45 (A). HRMS (CI+) calcd for C20H18N3O7S [M+H]+ 444.0865, found 
444.0881. 
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Benzyl 8-(4-nitrophenylsulfonyl)-2-oxo-6,8-diazabicyclo[3.2.1]octane-6-carboxylate (62) 
A flame-dried Schlenk tube was loaded with copper(II)acetate monohydrate (1.4 mg, 
7.0 µmol), dry toluene (2 mL), triisopropyl phosphite (3.65 µL, 14.0 µmol) and 
diethoxy(methyl)silane (226 µL, 1.35 mmol). The mixture was stirred for 3 h at room 
temperature under an argon atmosphere until the color had changed from blue through 
light green to light brown. A suspension of bicyclic aminal 59 (300 mg, 0.677 mmol) in 
dry toluene (4 mL) was added to the catalyst solution and the resulting mixture was stirred for 3 h at 
room temperature under an argon atmosphere. The reaction was quenched by addition of 1 M TBAF in 
THF (1.0 mL, 1.0 mmol) and the mixture was stirred for 5 minutes at room temperature. Glacial acetic 
acid (195 µL, 3.41 mmol) was then added and the mixture was stirred for 15 minutes after which the 
mixture was concentrated in vacuo. The crude product was directly purified by flash chromatography 
(silica gel, EtOAc/heptane, 1:3 to 1:1) furnishing aminal 62 (174 mg, 0.391 mmol, 58%) as a yellow 
solid. Rf 0.21 (EtOAc/heptane, 1:1). Mp 163–166 °C. IR (ATR) ν 1721, 1524, 1406, 1347, 1172, 1088, 
740, 686, 649, 552 cm−1. 1H NMR (500 MHz, CDCl3, mixture of rotamers A and B) δ 8.30–8.24 (m, 
2HA), 8.08–8.00 (m, 4HA+B), 8.88–8.81 (m, 2HB), 7.51–7.30 (m, 4HA+B), 7.23–7.17 (m, 1HA+B), 6.04–
5.96 (m, 1HA), 5.94–5.86 (m, 1HB), 5.28–4.96 (m, 2HA+B), 4.54 (d, J = 6.0 Hz, 1HA), 4.50 (d, J = 6.2 
Hz, 1HB), 3.22 (dd, J = 4.9, 11.3 Hz, 1HA+B), 2.94 (dd, J = 6.3, 11.2 Hz, 1HA), 2.90 (dd, J = 6.4, 11.4 
Hz, 1HB) 2.62–2.52 (m, 1HB), 2.45 (dt, J = 8.8, 17.7 Hz, 1HA), 2.30–2.17 (m, 2HA+B). 13C NMR (125 
MHz, CDCl3, mixture of rotamers A and B) δ 199.9 (A), 199.2 (B), 153.1 (A), 152.5 (B), 150.9 (A+B), 
143.8 (A), 143.5 (B), 135.9 (B), 135.4 (A), 129.13 (A+B), 129.08 (B), 129.0 (A), 128.9 (B), 128.8 (A), 
128.7 (B), 128.3 (A), 124.8 (B), 124.7 (A), 70.9 (A), 70.6 (B), 68.2 (B), 67.9 (A), 65.5 (A), 64.7 (B), 
47.1 (B), 47.0 (A), 32.3 (A), 32.2 (B), 30.8 (B), 30.0 (A). HRMS (CI+) calcd for C20H20N3O7S [M+H]+ 
446.1022, found 446.1041. 
Benzyl 2-oxo-6,8-diazabicyclo[3.2.1]octane-6-carboxylate (63) 
To a suspension of 62 (21 mg, 47 µmol) in MeCN (500 µL) at room temperature was 
added K2CO3 (20 mg, 0.14 mmol) and thiophenol (5.9 µL, 56 µmol). The resulting 
mixture was stirred for 20 h at room temperature until the starting material was fully 
consumed as indicated by TLC. The reaction mixture was concentrated under reduced 
pressure and the residue was brought in water (1 mL). The product was extracted with CH2Cl2 (3 × 1 
mL) and the combined organic layers were dried over Na2SO4 and concentrated in vacuo to afford the 
crude product. Purification by flash chromatography (silica gel, EtOAc/heptane/MeOH, 4:4:1) 
furnished desulfonylated 63 (7.0 mg, 27 µmol, 57%) as a colorless oil. IR (ATR) ν 3297, 2957, 1700, 
1420, 1359, 1106, 698 cm−1. 1H NMR (500 MHz, CD3OD, mixture of rotamers A and B) δ 7.43–7.26 
(m, 5HA+B), 5.21–5.08 (m, 2HA+B+1HB), 4.91 (br s, 1HA), 3.80 (d, J = 5.6 Hz, 1HB), 3.54–3.34 (m, 
2HA+B+1HA), 2.27–1.97 (m, 2HB), 1.96–1.41 (m, 2HA+B+2HA). 13C NMR (125 MHz, CD3OD, mixture 
of rotamers A and B) δ 210.3 (A+B), 155.3 (A+B), 138.1 (A+B), 129.6 (A+B), 129.2 (A), 129.1 (B), 
129.0 (A), 128.8 (B), 96.7 (A+B), 71.2 (A), 70.8 (B), 68.1 (A), 68.0 (B), 65.8 (B), 61.6 (A), 30.8 (B), 
29.5 (A+B), 28.7 (A+B), 28.4 (A). LRMS (ESI+) calcd for C14H17N2O3 [M+H]+ 261.1, found 261.1. 
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6.1 Introduction 
Sedacryptine (1, Figure 6.1), an alkaloid produced by the Sedum acre, was first isolated by 
Hootelé and co-workers in 1980.1 Its relative configuration was solved by single crystal X-ray 
diffraction of its HCl salt and the absolute configuration was determined in 1983 by the same 
group via esterification of the secondary free hydroxyl with a chiral auxiliary.2 The sedum 
alkaloids, of which products 2–5 are representative examples, share the same 1,3-
aminoalcohol skeletal feature with identical absolute configuration. This important fragment, 
encountered in a variety of natural products, is also increasingly incorporated in drugs or 
drug-like molecules, especially protease inhibitors for the treatment of HIV. More 
specifically, potential anti-Alzheimer activity was claimed for the class of piperidine 
containing alkaloids3 and in addition, the structurally related alkaloid lobeline (6) (isolated 
from Lobelia inflata) has a stimulating effect on nicotinic acetylcholine receptor sites and has 
been applied as a smoking cessation aid.4 Furthermore, the large number of reported 
syntheses of Sedum alkaloids demonstrates the relevance as test ground for new synthetic 
methodologies.5 
 
Figure 6.1 Natural products bearing an identical 1,3-aminoalcohol skeletal feature. 
Several syntheses of sedacryptine have been reported since its discovery. The first total 
synthesis of sedacryptine was established in 1983 by Natsume and co-workers.6 Key-step in 
their synthesis is the photooxygenation of dihydropyridine 6 and subsequent opening of the 
intermediate endoperoxide using SnCl4 and silyl enol ether 7 (Scheme 6.1).7 The resulting 
tetrahydropyridine 8 was then converted into (±)-sedacryptine via standard functional group 
interconversions. 
 
Scheme 6.1 Total synthesis of (±)-sedacryptine as reported by Natsume and co-workers. 
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Kobayashi et al. published a more concise synthesis involving the introduction of C-2 and C-
4 substituents via an N-acyliminium ion intermediate.8 The first N-acyliminium ion was 
formed by Me3SiOTf-mediated ring opening of cyclic N,O-acetal 9 (Scheme 6.2). Addition of 
2-(trimethylsilyloxy)propene (10) furnished 11, which upon oxidation with SO3·Py and 
DMSO furnished the second N,O-acetal. Again, formation of the iminium ion intermediate 
using Me3SiOTf and immediate nucleophilic addition of silyl enol ether 7 gave 3-
hydroxypiperidine 12. Racemic sedacryptine was obtained in four additional synthetic 
transformations.	  
 
Scheme 6.2 Total synthesis of (±)-sedacryptine by Kobayashi et al. 
In 1996, the first synthesis of enantiomerically pure (−)-sedacryptine was reported by 
Akiyama and Hirama.9 A ten-step synthesis was required to furnish intermediate 13, which 
under basic conditions underwent dual Michael addition of the primary amide resulting in 
bicyclic carbamates 14 and 15 as a mixture of diastereoisomers (Scheme 6.3). Both 
diastereoisomers were converted into (−)-sedacryptine in five further steps and the desired 
handedness of 13 was obtained by using enantiomerically pure starting materials that were 
available from commercial sources. 
 
Scheme 6.3 Keystep of the total synthesis of (−)-1 by Akiyama and co-workers. 
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Hootelé and Plehiers applied a more stepwise approach to (+)-sedacryptine by introducing the 
C-1 and C-2 substituents using two consecutive anionic oxidations (Scheme 6.4).10 Their 
synthesis started with 2-hydroxy-2-phenylethylpiperidine 17, of which the preparation was 
described in an earlier report by the same group.11 Anionic oxidation of a methanolic solution 
of 17 by applying a constant potential of 8 V in an electrolysis cell afforded N,O-acetal 18 in 
95% yield starting from 16. Protonolysis of the double bond resulted in 19, which is amenable 
to hydroboration for the introduction of the requisite C-1 hydroxyl. Thus, hydroboration and 
acetylation of both alcohols afforded 20 in 75% yield. A second anionic oxidation then 
furnished N-acyliminium ion precursor 21, which smoothly led to (+)-sedacryptine in four 
additional transformations. 
 
Scheme 6.4 Aniodic oxidation strategy to (+)-1 by Plehiers and Hootelé. 
More recently, Wee and Fan reported the synthesis of (−)-1 starting from non-racemic 
building block 22 (Scheme 6.5),12 which was readily obtained from L-(+)-glutamic acid.13 
Thiolactam formation with Lawesson’s reagent and subsequent thio-Wittig reaction with an 
alkyl bromide and triphenylphosphine gave enone 24, which was converted in (−)-1 in ten 
more steps. 
 
Scheme 6.5 Total synthesis of (−)-1 by Wee and Fan. 
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6.2 Retrosynthetic analysis 
A retrosynthetic analysis of (−)-1 is shown in Scheme 6.6. We envisioned that the 2-hydroxy-
2-phenylethyl substituent of (−)-1 could be introduced either from 53 by ozonolysis and 
subsequent stereoselective Grignard addition or via diastereoselective reduction of benzylic 
ketone 59. Either 53 or 59 can be traced back to β-amino ketone 26 via N-acyliminium ion 
precursor 28 using the reaction sequence described in Chapter 3. Thus, 28 could be prepared 
by aza-Achmatowicz reaction of β-amino ketone 26, which would be accessible from 
commercially available achiral starting materials using the proline-catalyzed asymmetric 
Mannich reaction. 
 
Scheme 6.6 Retrosynthetic analysis of (−)-1. 
6.3 Synthesis of 4-epi-sedacryptine 
The synthesis commenced with the conversion of α-amidosulfone 25 into the corresponding 
imine via the same procedure as described in Section 3.3 (Scheme 6.7). The resulting imine 
was subsequently reacted with acetone in a proline-catalyzed asymmetric Mannich reaction 
affording 26 in 71% yield and excellent ee (99%). It was necessary to conduct this reaction 
rather diluted at a concentration of 0.02 M. When the reaction was performed at 0.2 M, we 
observed that the desired product 26 underwent a second Mannich reaction leading to the 
corresponding bisadduct. Subsequent protection of β-amino ketone 26 as a dioxolane then 
afforded 27 in 81% yield. 
 
Scheme 6.7 Synthesis of 27 and initial attempt for the aza-Achmatowicz reaction. 
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With dioxolane 27 in hand, the stage was set for the aza-Achmatowicz reaction. 
Unfortunately, reaction with m-CPBA in CH2Cl2 resulted in significant side product 
formation. This was caused by oxidation of the desired hemiaminal 28 into the corresponding 
6-oxo-1H-pyridine derivative 29, which was obtained in yields varying between 25 and 50%. 
We reasoned that 29 was formed via a m-chlorobenzoic acid-facilitated (30) dehydration of 
28, followed by a Baeyer–Villiger type oxidation of the intermediate iminium ion 32 (Scheme 
6.8). Even adding a slight excess of m-CPBA (1.1 equiv) resulted in large amounts of 29, 
indicating that oxidation of the iminium ion proceeds faster than the desired aza-
Achmatowicz reaction. Switching to non-acidic oxidants might suppress iminium ion 
formation and hence oxidation of the product. We therefore investigated the aza-
Achmatowicz reaction of 27 under alternative conditions. 
 
Scheme 6.8 Plausible mechanism for the formation of 29. 
We initially investigated oxidants that are commonly used for (aza-)Achmatowicz reactions. 
When substrate 27 was reacted with N-bromosuccinimide or Br2 in MeOH,14,15 the starting 
material was readily converted, however, a complex mixture of products was formed. In 
contrast, the VO(acac)2 catalyzed oxidation of 27 with tert-butyl hydroperoxide did not result 
in any conversion of the starting material.16  
 
Scheme 6.9 Possible reactions pathways for the 1O2-mediated aza-Achmatowicz reaction of 27. 
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As a viable alternative, singlet oxygen (1O2) was considered as a useful oxidant for the aza-
Achmatowicz reaction of 27. Several reports have described the application of 1O2 as an 
oxidant for Achmatowicz reactions in total syntheses of natural products.17 As the substrates 
therein have multiple functional groups that could potentially interfere with the oxidant, these 
examples designate the selectivity of 1O2 for furans. However, all examples hitherto 
described, report on oxy-Achmatowicz reactions with 1O2 and to the best of our knowledge, 
there are no prior reports of 1O2-mediated aza-Achmatowicz reactions. Although the side 
reaction that was described by Gollnick and Vassilikogiannakis (Scheme 6.9, pathway a) is 
also likely to take place with 2-(α-aminoalkyl)furans,18 we reasoned that the N-carbamoyl 
protective group might reduce the electron density at the nitrogen to a level that this undesired 
side reaction is in fact eliminated and that the reaction preferred path c (Scheme 6.9). 
 
Scheme 6.10 Singlet oxygen mediated aza-Achmatowicz reaction. 
To investigate the 1O2-mediated aza-Achmatowicz reaction, we applied the conditions as 
described by Vassilikogiannakis et al. using Methylene Blue or Rose Bengal in methanol at 5 
°C to substrate 27 (Scheme 6.10).18b Despite the fact that we observed full conversion of the 
starting material with both sensitizers; NMR analysis of the crude reaction mixture showed 
clear formation of a major side product, while we were unable to detect the desired product. 
We hypothesize that the substrate had reacted with 1O2 based on the observation that the 
typical furan signals had disappeared in the NMR spectrum of the crude product. 
Furthermore, we observed that an equivalent of MeOH was incorporated based on the 
presence of an additional –OMe signal at 3.95 ppm. Although the analytical data were not 
conclusive, we reasoned that intermediate peroxide 41a or b might have been formed. 
However, when the crude product was treated with either Me2S or PPh3, we hardly observed 
any reaction apart from decomposition after an extended period of time. We then attempted to 
force the reaction to follow pathway b (Scheme 6.9) by leaving out a nucleophilic solvent and 
conducting the reaction in CH2Cl2 at 0 °C. When the starting material was consumed, the 
presumed endoperoxide intermediate 36 was in situ reduced with Me2S.17 The desired product 
was nonetheless never observed, but instead we noticed the formation of multiple side 
products. 
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Dioxiranes are a class of oxidants that are commonly applied in the epoxidation of olefins 
(Scheme 6.11).19 Due to their instability, these reagents are typically freshly prepared or 
generated in situ by the action of Oxone® (peroxymonosulfate or caroate anion) on the 
corresponding ketone. As demonstrated by the work of Adger and co-workers in 1991, 
dimethyldioxirane (43, DMDO) could also be used as oxidant for the conversion of various 
substituted furfuryl alcohols into the corresponding Achmatowicz products.20 We rationalized 
that dioxiranes could also be advantageous for the specific substrate (27) in the aza-
Achmatowicz reaction, since the non-acidic remainder would preclude formation of iminium 
ion 32 and the subsequent formation of side product 29 (Scheme 6.8). Indeed, reacting 
substrate 27 with DMDO furnished the desired piperidinone 28 in 82% yield (Scheme 6.11). 
However, since the preparation of large quantities of DMDO is rather laborious, we 
experienced difficulties preparing satisfactory amounts of 28. The low yields hampering the 
preparation of the required quantities of DMDO are caused by a combination of ketone-
catalyzed Oxone® decomposition, which occurs via a dioxirane intermediate,21 and its self-
decomposition under the formation of (singlet) oxygen.22 Therefore, we investigated the in 
situ formation of dioxiranes derived from ketones 44a–d by stirring a solution of substrate 27, 
Oxone® (5 equiv), the corresponding ketone (7.5 equiv) and base, which appeared to be 
crucial to initiate dioxirane formation. The reactions with ketones 44a and 44b did not show 
any conversion of the starting material at all, indicating that the required dioxiranes were not 
formed under these conditions. Only partial conversion was observed with the dioxirane 
derived from ketone 44c, while the reaction with 1,1,1-trifluoroacetone (44d) showed full 
consumption of the starting material.23 Unfortunately, both reactions resulted in the formation 
of multiple side products and the desired product was not detected. Also by applying the 
conditions for the Shi epoxidation, in which the reaction is catalyzed by fructose-derived 
ketone 45,24 we were not able to obtain the desired product but again, we observed the 
formation of multiple side products. Although unverified, we hypothesize that the reaction of 
substrate 27 with the singlet oxygen that is liberated upon ketone-catalyzed Oxone® 
decomposition is faster than the desired reaction with dioxirane. This is underlined by the fact 
that gas was released during the reaction in the cases were the starting material was fully 
converted. 
 
Scheme 6.11 Reaction of 27 with DMDO. 
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Instead of using a non-acidic oxidant, we reasoned that overoxidation could also be prevented 
by removal of the acidic remainder during the reaction. However, performing the aza-
Achmatowicz reaction in de presence of an inorganic base (K2CO3 or Cs2CO3) resulted in low 
conversion of the starting material. Adjusting the initial procedure, on the other hand, by 
introducing a biphasic system to remove the acidic remainder solved the problem. Thus, 
conducting the aza-Achmatowicz reaction with m-CPBA in a CH2Cl2/phosphate buffer of pH 
7.4 furnished 28 in 60% yield as a 1:1.9 mixture of diastereoisomers (Scheme 6.12). 
 
Scheme 6.12 Synthesis of 46. 
At this point, introduction of the C-4 substituent via N-acyliminium ion addition was 
envisaged. By applying the conditions described in Section 3.5 to prepare 2,6-disubstituted 
piperidinones, ketone 46 was smoothly obtained as a single diastereoisomer in 88% yield. 
Since 2D NOESY analysis did not give conclusive information of the stereochemistry at this 
stage, we chose to continue the synthesis by reduction of both ketones and the double bond. 
Two approaches towards diol 48 were investigated varying the order of steps for reducing the 
ketones and the double bond. First, we investigated the approach commencing with 
hydrogenating 46 over Pd/C with Ph2S to furnish piperidinone 47 (Table 6.1). We found the 
presence of Ph2S crucial to prevent hydrogenation of the benzylic ketone resulting in the 
corresponding alcohol as the major product.25 Next, we investigated the stereoselective 
reduction of diketone 47 with various reducing agents (Table 6.1). Although some selectivity 
was observed, we obtained mixtures of diastereoisomers in each reaction, forcing us to 
investigate an alternative approach. 
Table 6.1 Reductions of diketone 47. 
 
Entry Reducing agent Temperature (°C) ratioa 48a/b 
1 NaBH4 20 0.5:1 
2 NaBH4 −15 0.6:1 
3 NaBH4, CeCl3·7H2O −78 0.9:1 
4 NaBH4, Et3B 20 0.8:1 
5 LiEt3BH 0 0.8:1 
a Determined by HPLC of the crude reaction mixture. The structural assignment of 
the HPLC peaks is based on comparison with the chromatogram of the 
hydrogenated product of 49a (vide infra). 
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Thus, we initially reduced 46 with BH3·Me2S in the presence of (R)-(+)-2-methyl-CBS-
oxazaborolidine resulting in a separable mixture of diastereoisomers 49a and b (Scheme 
6.13). It is important to mention that the selectivity of the reaction was inverted when 46 was 
reduced with NaBH4 (65% yield of 49b). Subsequent hydrogenation of the desired 
diastereoisomer (49a) over PtO2 furnished diol 48a. The stereochemistry of 48a was 
confirmed by 2D NOESY analysis of cyclic carbamate 50 (Figure 6.2), which was obtained 
upon treatment of 48a with KOt-Bu.12 The 1H NMR signals were assigned to the 
corresponding protons in 50 using COSY and HSCQ analysis. The NOE interactions of the 
protons at C-1 and C-12 with the same proton at C-5 indicate that both substituents at C-1 and 
C-12 are positioned at the same side of the molecular plane. The interaction between the C-4 
and C-9 protons and the absence of an NOE signal of the C-2 and C-4 protons indicate a 2,4-
trans relationship. With the stereochemistry of 48a established, it became clear that this 
strategy would not result in the total synthesis of (−)-sedacryptine (1). We nevertheless 
continued our efforts on the synthesis of 4-epi-sedacryptine (51) by reduction of the 
carbamate with LiAlH4 and subsequent acetal hydrolysis in hot aqueous HCl (Scheme 6.13). 
This provided 4-epi-sedacryptine (51) in 9% overall yield. 
 
Scheme 6.13 Synthesis of 4-epi-sedacryptine (51). 
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Figure 6.2 NOESY analysis of 50. 
6.4 Total synthesis of (−)-sedacryptine 
In order to synthesize sedacryptine with the naturally occurring chirality, we decided to 
continue with the cis-substituted piperidinone 53, readily obtained as a single diastereoisomer 
in 46% yield by addition of allyltrimethylsilane to the N-acyliminium ion derived from 28 
(Scheme 6.14). 2D NOESY analysis of 53 unambiguously showed interaction between the C-
9 and C-11 methylene protons indicating that both substituents are positioned axially. With 
the desired cis-diastereoisomer in hand, subsequent conjugate reduction with a copperhydride 
species followed by fluoride-mediated desilylation afforded 54 in 84% yield over two steps.26 
After reduction of ketone 54 with NaBH4 and CeCl3·7H2O, ozonolysis of olefin 55 resulted in 
an inseparable mixture of the aldehyde and triphenylphosphine oxide. For the next step, 
Grignard addition with PhMgBr to the contaminated aldehydes failed and we therefore 
silylated the free hydroxyl with TBDMSCl allowing us to obtain aldehyde 56 in pure form 
after column chromatography. 
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Scheme 6.14 Synthesis of aldehyde 56. 
Construction of the 2-hydroxy-2-phenylethyl substituent was then finished by Grignard 
addition of PhMgBr to aldehyde 56 resulting in the benzylic alcohol as a separable mixture of 
diastereoisomers 57a and b (Scheme 6.15). Either diastereoisomer was subjected to the action 
of LiAlH4 in refluxing toluene resulting in removal of the TBDMS-group and carbamate 
reduction. Finally, ketone deprotection and isomerization of the resulting hemiacetals in hot 
aqueous HCl furnished (−)-1 or 12-epi-sedacryptine 58 in 41 and 56% yield, respectively. 
Synthetic (−)-1 showed a specific rotation of [α]!!" = −14.0 (c 0.14, CHCl3) which is in 
accordance with the reported value in literature of [α]!!! = −14 (c 1.5, CHCl3).2  
 
Scheme 6.15 Synthesis of (−)-sedacryptine and 58. 
6.5 Conclusions 
We have successfully applied the methodology described in Chapter 3, involving the 
organocatalyzed Mannich/aza-Achmatowicz/N-acyliminium ion chemistry sequence, to a 
total synthesis of the natural product (−)-sedacryptine and two of its epimers. When the 
conditions for the aza-Achmatowicz reaction were applied as described in Chapter 3, 
significant amounts of the overoxidized aromatic product were observed. Formation of this 
undesired side product was successfully suppressed by conducting the reaction in a biphasic 
system in the presence of buffer. The selectivity of the subsequent N-acyliminium ion-
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mediated addition reactions showed a dependency on the nature of the nucleophile similar to 
that described in Chapter 3 giving, in addition to the natural isomer, access to the C-4 epimer 
of sedacryptine. 
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6.7 Experimental section 
For general remarks see Section 3.8. 
tert-Butyl (1S)-[1-(furan-2-yl)-3-oxobutyl]carbamate (26) 
A three-neck flash was charged with K2CO3 (49.2 g, 0.36 mol) and Na2SO4 (68.5 g, 
0.48 mol). The solids were flame-dried and allowed to cool back to room 
temperature while the flash was kept under a vacuum. Then, amidosulfone 25 (20.4 
g, 60.5 mmol) and dry THF (600 mL) were added and the mixture was refluxed for 
16 h under an argon atmosphere. The resulting suspension was filtered over Celite® and the filtrate was 
concentrated in vacuo affording the imine as a yellow oil in quantitative yield (11.8 g, 60.4 mmol). Part 
of this imine (10.0 g, 51.2 mmol) was dissolved in acetone (2.5 L) and L-proline (1.47 g, 12.8 mmol) 
was added. The reaction mixture was allowed to stir for 16 h at room temperature under an argon 
atmosphere. After this period, the reaction was cautiously quenched by addition of half-saturated 
aqueous NH4Cl solution (500 mL) and the product was extracted with EtOAc (3 × 500 mL). The 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated in vacuo 
affording the crude product which was purified by flash chromatography (silica gel, EtOAc/heptane, 
0:1 to 1:4) furnishing 26 (9.20 g, 36.3 mmol, 71%) as a white powder. Rf 0.41 (EtOAc/heptane, 1:1). 
Mp 63–67 °C. [α]!!" = −40.2 (c 1.0, CH2Cl2). IR (ATR) ν 3339, 2980, 1701, 1502, 1368, 1247, 1165, 
1048, 1005, 737 cm−1. 1H NMR (400 MHz, CDCl3) δ 7.31 (dd, J = 0.9, 1.8 Hz, 1H), 6.29 (dd, J = 1.8, 
3.3 Hz, 1H), 6.17 (dt, J = 0.8, 3.3 Hz, 1H), 5.36 (br s, 1H), 5.21–5.04 (m, 1H), 3.13–2.99 (m, 1H), 2.92 
(dd, J = 6.2, 16.6 Hz, 1H), 2.15 (s, 3H), 1.44 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 206.5, 155.1, 
154.0, 141.8, 110.5, 106.1, 80.0, 46.7, 45.5, 30.4, 28.4. HRMS (ESI+) calcd for C13H19NO4Na [M+Na]+ 
276.1212, found 276.1216. HPLC: ee: 99%, Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 mL/min, n-
heptane/2-propanol 80/20, retention times: 26: 6.2 min, ent-26: 5.6 min. 
tert-Butyl (1S)-[1-(furan-2-yl)-2-(2-methyl-1,3-dioxolan-2-yl)ethyl]carbamate (27) 
A flask was charged with ketone 26 (6.89 g, 27.2 mmol), ethylene glycol (36 mL, 
0.65 mol), triethylorthoformate (27 mL, 0.16 mol) and TsOH (162 mg, 0.852 
mmol). The mixture was stirred for 3 days at 40 °C under an argon atmosphere. The 
reaction was quenched by addition of saturated aqueous NaHCO3 (125 mL) and the 
product was extracted with Et2O (3 × 250 mL). The combined organic layers were washed with brine 
(500 mL), dried over Na2SO4 and concentrated in vacuo to afford the crude dioxolane as an orange oil. 
Purification by flash chromatography (silica gel, EtOAc/heptane, 1:4) furnished 27 (6.50 g, 21.9 mmol, 
81%) as a pale yellow oil. Rf 0.39 (EtOAc/heptane, 1:1). Mp 35–38 °C. [α]!!" = −56.2 (c 1.5, CH2Cl2). 
IR (ATR) ν 3355, 2980, 1706, 1505, 1367, 1249, 1164, 1044, 1008, 734 cm−1. 1H NMR (500 MHz, 
CDCl3) δ 7.32 (dd, J = 0.9, 1.8 Hz, 1H), 6.28 (dd, J = 1.8, 3.2 Hz, 1H), 6.15 (d, J = 3.2 Hz,  1H), 5.21 
(br s, 1H), 4.95 (br s, 1H), 3.98–3.86 (m, 4H), 2.20 (dd, J = 5.3, 14.6 Hz, 1H), 2.14 (dd, J = 8.3, 14.6 
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Hz, 1H), 1.42 (s, 9H), 1.27 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 155.6, 155.3, 141.5, 110.3, 109.0, 
105.4, 79.5, 64.9, 64.5, 45.7, 42.2, 28.5, 24.3. HRMS (ESI+) calcd for C15H24NO5 [M+H]+ 298.1655, 
found 298.1662. 
tert-Butyl (2S,6RS)-6-hydroxy-2-[(2-methyl-1,3-dioxolan-2-yl)methyl]-3-oxo-1,2,3,6-tetrahydro-
pyridine-1-carboxylate (28) 
m-CPBA (1.5 g, >77 wt %) was dissolved in CH2Cl2 (88 mL) and the resulting 
solution was washed with 0.1 M phosphate buffer pH 7.4 (3 × 88 mL) and brine 
and the organic layer was dried over Na2SO4. The concentration of the resulting 
m-CPBA solution in CH2Cl2 was 0.075 M as determined by weighing the residue 
of a 1.00 mL aliquot that was carefully concentrated under a stream of argon. The purity was >95% as 
determined by 1H NMR analysis of the residue. To a mixture of the 0.075 M m-CPBA in CH2Cl2 
solution (56 mL) and 0.1 M phosphate buffer pH 7.4 (56 mL) was added furanyl amine 27 (1.04 g, 3.50 
mmol). The resulting biphasic mixture was stirred at room temperature and after 3 h, an additional 
amount of m-CPBA in CH2Cl2 (11.3 mL, 0.075 M, 0.85 mmol) was added. After stirring for another 4 
h at room temperature, the layers were separated and the aqueous layer was extracted with CH2Cl2 (1 × 
75 mL). The combined organic layers were subsequently washed with 20% aqueous KI solution (200 
mL), 10% aqueous NaHSO3 solution (200 mL), water (200 mL), 1 M aqueous NaHCO3 (200 mL), 
water (200 mL) and brine (200 mL). The organic layer was dried over Na2SO4 and the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography (silica gel, 
EtOAc/heptane, 1:4 to 1:2) affording 28 (659 mg, 2.10 mmol, 60%) as an inseparable 1:1.9 mixture of 
anomeric diastereoisomers. Rf 0.23 (EtOAc/heptane, 1:1). IR (ATR) ν 3435, 2980, 1679, 1367, 1254, 
1162, 1030, 731 cm−1. 1H NMR (500 MHz, CDCl3, mixture of diastereoisomers) δ 6.93–6.83 (m, 1H), 
6.10 (d, J = 10.3 Hz, 1H), 5.99 (br s, 0.65Hmajor), 5.92 (br s, 0.35Hminor), 4.82 (br s, 0.35Hminor), 4.71–
4.58 (m, 0.65Hmajor), 4.11–3.99 (m, 1H), 3.97–3.80 (m, 4H), 2.51–2.38 (m, 0.35Hminor), 2.37–2.23 (m, 
1H), 2.21–2.10 (m, 0.65Hmajor), 1.51 (s, 9H), 1.43 (s, 3H). 13C NMR (125 MHz, CDCl3, mixture of 
diastereoisomers) δ 195.5 (minor), 195.3 (major), 154.8 (major), 153.5 (minor), 144.3, 126.8 (major), 
126.5 (minor), 109.5 (minor), 108.9 (major), 82.1 (major), 81.8 (minor), 72.7 (minor), 72.2 (major), 
64.5, 64.4 (major), 64.1 (minor), 57.2 (major), 56.2 (minor), 43.0 (major), 41.9 (minor), 28.4, 24.7 
(minor), 24.4 (major). HRMS (ESI+) calcd for C15H23NO6Na [M+Na]+ 336.1423, found 336.1430. 
tert-Butyl 5-hydroxy-6-[(2-methyl-1,3-dioxolan-2-yl)methyl]-2-oxo-1,2-dihydropyridine-1-
carboxylate (29) 
Rf 0.17 (EtOAc/heptane, 1:1). 1H NMR (500 MHz, CDCl3) δ 7.20 (d, J = 9.8 Hz, 
1H), 6.42 (d, J = 9.8 Hz, 1H), 4.02–3.89 (m, 5H), 3.04 (s, 2H), 1.61 (s, 9H), 1.41 
(s, 3H). 13C NMR (125 MHz, CDCl3) δ 160.0, 150.6, 138.0, 136.6, 124.4, 120.6, 
111.3, 86.9, 65.3, 38.1, 27.5, 24.5. 
tert-Butyl (2S,6S)-2-[(2-methyl-1,3-dioxolan-2-yl)methyl]-3-oxo-6-(2-oxo-2-phenylethyl)-1,2,3,6-
tetrahydropyridine-1-carboxylate (46) 
 Hemiaminal 28 (627 mg, 2.00 mmol) was dissolved in CH2Cl2 (20 mL) and 
the solution was cooled to −78 ºC. Trimethyl[(1-phenylvinyl)oxy]silane 
(2.05 mL, 10.0 mmol) and Sn(OTf)2 (83 mg, 0.20 mmol) were subsequently 
added and the mixture was stirred at −78 ºC under an argon atmosphere for 3 
h. The reaction mixture was then diluted with EtOAc (40 mL) and saturated aqueous NaHCO3 (40 mL) 
was added. The layers were separated and the aqueous layer was extracted with EtOAc (3 × 40 mL). 
The combined organic layers were washed with brine, dried over Na2SO4 and concentrated in vacuo to 
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afford the crude product, which was purified by flash chromatography (silica gel, EtOAc/heptane, 1:9 
to 1:4) affording 46 (730 mg, 1.76 mmol, 88%) as a white solid. Rf 0.41 (EtOAc/heptane, 1:1). Mp 90–
92 ºC. [α]!!" = +187.2 (c 1.0, CH2Cl2). IR (ATR) ν 2983, 1693, 1680, 1367, 1294, 1164, 1130, 1055, 
1011, 755, 691 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.95–7.90 (m, 2H), 7.57 (t, J = 7.4 Hz, 1H), 7.46 
(t, J = 7.7 Hz, 2H), 6.94 (dd, J = 3.8, 10.5 Hz, 1H), 6.08 (dd, J = 1.7, 10.5 Hz, 1H), 5.07–4.99 (m, 1H), 
4.55 (dd, J = 4.4, 8.5 Hz, 1H), 4.04 (d, J = 16.8 Hz, 1H), 3.96–3.79 (m, 4H), 3.10 (dd, J = 9.1, 17.4 Hz, 
1H), 2.34 (dd, J = 8.8, 14.3 Hz, 1H), 2.19 (dd, J = 4.3, 14.3 Hz, 1H), 1.46 (s, 9H), 1.35 (s, 3H). 13C 
NMR (125 MHz, CDCl3) δ 197.4, 195.4, 154.9, 146.8, 136.7, 133.6, 128.8, 128.2, 125.7, 108.4, 81.5, 
64.8, 64.3, 58.8, 50.0, 44.8, 41.3, 28.4, 24.2. HRMS (ESI+) calcd for C23H29NO6Na [M+Na]+ 438.1893, 
found 438.1896. 
tert-Butyl (2S,6R)-2-[(2-methyl-1,3-dioxolan-2-yl)methyl]-3-oxo-6-(2-oxo-2-phenylethyl)-
piperidine-1-carboxylate (47) 
To a solution of unsaturated diketone 46 (270 mg, 0.650 mmol) in MeOH 
(6.5 mL) were added diphenylsulfide (1.1 µL, 6.6 µmol) and Pd/C (27 mg, 
10 wt %). Hydrogen was bubbled through the solution for one minute and the 
reaction was then stirred for 90 minutes under a positive pressure (1 atm) of 
hydrogen. Filtration of the reaction mixture over Celite® and concentration under reduced pressure 
afforded the crude product, which was purified by flash chromatography (silica gel, EtOAc/heptane, 
1:3 to 1:2) to furnish diketone 47 (195 mg, 0.467 mmol, 72%) as a colorless oil. Rf 0.45 
(EtOAc/heptane, 1:1). [α]!!" = −13.3 (c 0.6, CH2Cl2). IR (ATR) ν 3435, 2978, 1678, 1380, 1159, 1091, 
1064, 749 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 7.7 Hz, 2H), 7.57 (t, J = 7.3 Hz, 1H), 7.47 
(t, J = 7.8 Hz, 2H), 4.67–4.60 (m, 1H), 4.41 (dd, J = 4.0, 9.9 Hz, 1H), 3.95 (t, J = 6.5 Hz, 2H), 3.88–
3.76 (m, 2H), 3.50–3.35 (m, 1H), 2.89 (dd, J = 10.5, 15.0 Hz, 1H), 2.65 (ddd, J = 1.7, 7.6, 18.4 Hz, 
1H), 2.54–2.31 (m, 4H), 2.22 (dd, J = 10.3, 14.3 Hz, 1H), 2.10–2.01 (m, 1H), 1.45 (s, 9H), 1.35 (s, 
3H). 13C NMR (125 MHz, CDCl3) δ 208.2, 198.1, 154.2, 136.7, 133.5, 128.9, 128.4, 108.2, 81.0, 65.1, 
64.3, 59.9, 48.5, 42.3, 41.3, 32.5, 28.5, 24.2, 22.9. HRMS (ESI+) calcd for C23H31NO6Na [M+Na]+ 
440.2049, found 440.2046. 
tert-Butyl (2S,3S,6S)-3-hydroxy-6-[(2S)-2-hydroxy-2-phenylethyl]-2-[(2-methyl-1,3-dioxolan-2-
yl)methyl]-1,2,3,6-tetrahydropyridine-1-carboxylate (49a) and tert-Butyl (2S,3S,6S)-3-hydroxy-6-
[(2R)-2-hydroxy-2-phenylethyl]-2-[(2-methyl-1,3-dioxolan-2-yl)methyl]-1,2,3,6-
tetrahydropyridine-1-carboxylate (49b) 
A solution of (R)-(+)-2-methyl-CBS-
oxazaborolidine (1.05 mL, 1.05 mmol, 1 M in 
toluene) and BH3·Me2S (525 µL, 1.05 mmol, 2 M in 
THF) in anhydrous THF (7.5 mL) was stirred for 30 
min at 0 °C. A solution of diketone 46 (208 mg, 
0.501 mmol) in anhydrous THF (2.5 mL) was then slowly added and the resulting mixture was stirred 
for 45 min at 0 °C. The reaction was quenched by addition of saturated aqueous NH4Cl (1.5 mL) and 
the mixture was allowed to warm to room temperature. Brine (7.5 mL) was added and the product was 
extracted with EtOAc (3 × 12.5 mL). The combined organic layers were washed with brine, dried over 
Na2SO4 and concentrated in vacuo. The crude product was purified by flash chromatography (silica gel, 
EtOAc/heptane, 1:9 to 1:2) affording both diastereoisomers 49a (138 mg, 0.329 mmol, 66%) and 49b 
(50 mg, 0.12 mmol, 24%). 
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49a was obtained as a colorless oil. Rf 0.27 (EtOAc/heptane, 1:1). [α]!!" = +121.7 (c 2.9, CH2Cl2). IR 
(ATR) ν 3420, 2979, 2932, 2887, 1666, 1367, 1162, 1054, 731, 701 cm–1. 1H NMR (500 MHz, CDCl3) 
δ 7.40–7.36 (m, 2H), 7.36–7.31 (m, 2H), 7.27–7.22 (m, 1H), 5.89 (dd, J = 3.5, 9.8 Hz, 1H), 5.70 (dd, J 
= 4.3, 9.8 Hz, 1H), 4.82 (d, J = 9.7 Hz, 1H), 4.64 (br s, 1H), 4.11 (br s, 1H), 4.03–3.89 (m, 4H), 3.77 
(br s, 1H), 3.50 (br s, 1H), 2.46 (dd, J = 7.8, 15.0 Hz, 1H), 2.36–2.15 (m, 1H), 1.97 (ddd, J = 2.8, 10.0, 
14.2 Hz, 1H), 1.82 (ddd, J = 4.2, 8.3, 10.0 Hz, 1H), 1.71 (br s, 1H), 1.50, (s, 9H), 1.42 (s, 3H). 13C 
NMR (500 MHz, CDCl3) δ 157.8, 144.0, 131.1, 130.0, 128.5, 127.3, 125.7, 109.4, 81.9, 70.7, 67.7, 
64.6, 64.5, 53.6, 52.3, 42.4, 38.4, 28.5, 24.1. HRMS (ESI+) calcd for C23H33NO6Na [M+Na]+ 442.2206, 
found 442.2208. 
49b was obtained as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.39–7.30 (m, 4H), 7.26–7.21 (m, 
1H), 5.91–5.85 (m, 2H), 4.80 (dt, J = 3.3, 9.4 Hz, 1H), 4.47–4.38 (m, 1H), 4.20 (br s, 1H), 4.02–3.94 
(m, 4H), 3.43 (br s, 1H), 2.31 (dd, J = 8.4, 15.0 Hz, 1H), 2.26 (ddd, J = 5.4, 9.3, 14.1 Hz, 1H), 2.01 (br 
s, 1H), 1.84 (ddd, J = 3.5, 6.6, 14.1 Hz, 1H), 1.48 (s, 9H), 1.44 (s, 3H). 13C NMR (500 MHz, CDCl3) δ 
156.8, 144.9, 130.6, 129.6, 128.6, 127.5, 125.7, 109.4, 81.2, 72.7, 67.8, 64.6, 64.5, 52.6, 39.0, 28.5, 
23.9. HRMS (ESI+) calcd for C23H33NO6Na [M+Na]+ 442.2206, found 442.2208. 
tert-Butyl (2S,3S,6R)-3-hydroxy-6-[(2S)-2-hydroxy-2-phenylethyl]-2-[(2-methyl-1,3-dioxolan-2-
yl)methyl]piperidine-1-carboxylate (48a) 
To a solution of olefin 49a (93 mg, 0.22 mmol) in EtOAc (4.5 mL) was 
added PtO2 (10 mg, 0.044 mmol). Hydrogen gas was bubbled through the 
solution for one minute and the mixture was then allowed to stir at room 
temperature under an atmosphere of hydrogen (1 atm). After 30 minutes, the 
mixture was filtered over a pad of Celite® and the filtrate was concentrated in vacuo. Purification of the 
crude product by flash chromatography (silica gel, EtOAc/heptane, 1:2 to 1:1) afforded 48a (84 mg, 
0.20 mmol, 91%) as a colorless oil. Rf 0.22 (EtOAc/heptane, 1:1). [α]!!" = +14.4 (c 1.2, CH2Cl2). IR 
(ATR) ν 3443, 2981, 2935, 1668, 1251, 1070, 1045, 906, 726 cm−1. 1H NMR (500 MHz, CDCl3) δ 
7.40–7.35 (m, 2H), 7.34–7.29 (m, 2H), 7.25–7.19 (m, 1H), 4.70 (d, J = 10.4 Hz, 1H), 4.17–4.07 (m, 
1H), 4.05–3.92 (m, 5H), 3.91–3.83 (m, 1H), 3.47 (d, J = 6.6 Hz, 1H), 2.27–2.13 (m, 3H), 2.05–1.95 (m, 
1H), 1.82–1.68 (m, 2H), 1.50 (s, 9H), 1.48–1.43 (m, 2H), 1.42 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
157.3, 144.6, 128.4, 127.1, 125.6, 109.6, 81.0, 70.4, 68.7, 64.6, 64.5, 53.5, 50.2, 44.6, 37.2, 28.6, 28.0, 
26.4, 24.1. HRMS (ESI+) calcd for C23H35NO6Na [M+Na]+ 444.2362, found 444.2356. 
(3S,5R,8S,9S)-7-Hydroxy-8-[(2-methyl-1,3-dioxolan-2-yl)methyl]-3-phenyl-2-oxa-8a-aza-
4,4a,5,6,7,8-hexahydro-3H-naphthalen-1-one (50) 
A solution of diol 48a (45 mg, 0.11 mmol) in dry THF (10 mL) was cooled to 0 
°C and KOt-Bu (30 mg, 0.27 mmol) was added. The cooling bath was removed 
and the mixture was allowed to stir for 3.5 h at room temperature under an 
argon atmosphere. The reaction was quenched by addition of saturated aqueous 
NH4Cl (5 mL) and the product was extracted with CH2Cl2 (3 × 10 mL). The combined organic layers 
were washed with brine, dried over Na2SO4 and concentrated in vacuo. Purification of the crude 
product by flash chromatography (silica gel, EtOAc/heptane, 4:1) afforded 50 (28 mg, 0.081 mmol, 
74%) as a colorless oil. Rf 0.25 (EtOAc/heptane, 5:1). [α]!!" = +3.1 (c 1.2, CH2Cl2). IR (ATR) ν 3392, 
2939, 1667, 1436, 1272, 1228, 1073, 1049, 729 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.40–7.28 (m, 
5H), 5.28 (d, J = 9.0 Hz, 1H), 4.84 (q, J = 5.4 Hz, 1H), 4.08–3.95 (m, 4H), 3.85–3.78 (m, 1H), 3.46 (br 
s, 1H), 3.38–3.29 (m, 1H), 2.32–2.23 (m, 1H), 2.18 (dd, J = 5.8, 14.7 Hz, 1H), 2.00 (d, J = 14.1 Hz, 
1H), 1.94–1.87 (m, 1H), 1.75 (ddd, J = 1.2, 5.3, 14.8 Hz, 1H), 1.72–1.52 (m, 3H), 1.41 (s, 3H). 13C 
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NMR (125 MHz, CDCl3) δ 153.1, 139.1, 128.7, 128.3, 125.6, 109.5, 74.4, 67.9, 64.8, 64.7, 52.2, 46.7, 
35.4, 34.8, 31.2, 27.6, 24.1. HRMS (ESI+) calcd for C19H25NO5Na [M+Na]+ 370.1630, found 370.1627. 
4-epi-Sedacryptine (51) 
Diol 48a (34 mg, 0.081 mmol) was dissolved in dry THF (1.6 mL) and 
LiAlH4 (31 mg, 0.81 mmol) was added at room temperature. The reaction 
mixture was warmed to 65 °C and allowed to stir for 3 h at this temperature 
under an argon atmosphere. The reaction was quenched by careful addition of 
water until hydrogen formation ceased. Na2SO4 was added and the mixture was filtered over Celite®. 
The filtrate was concentrated in vacuo and the crude dioxolane was dissolved in aqueous 0.1 M HCl 
solution (2 mL). The mixture was refluxed for 1 h and after it was allowed to cool to room temperature, 
it was washed with CH2Cl2 (3 × 2 mL). The aqueous layer was neutralized with NH4OH (25%) until 
pH 8–9 and the product was extracted with CH2Cl2 (3 × 3 mL). The combined organic layers were 
dried over Na2SO4 and concentrated in vacuo to afford the crude product. This was purified by flash 
chromatography (silica gel, 90% CH2Cl2, 5% MeOH, 5% 7 N NH3/MeOH) affording 51 (12 mg, 0.041 
mmol, 51%) as a pale yellow oil. Rf 0.26 (90% CH2Cl2, 5% MeOH, 5% 7 N NH3/MeOH). [α]!!" = −6.4 
(c 0.5, CH2Cl2). IR (ATR) ν 3381, 2938, 2867, 1451, 1369, 1061, 1014, 920, 701 cm−1. 1H NMR (500 
MHz, CDCl3) δ 7.40–7.29 (m, 5H), 4.65 (t, J = 7.1 Hz, 1H), 4.06–4.03 (m, 1H), 2.90 (t, J = 3.6 Hz, 
1H), 2.70–2.65 (m, 1H), 2.24–2.22 (m, 1H), 2.21 (s, 3H), 2.04–1.98 (m, 1H), 1.97–1.84 (m, 4H), 1.78 
(dd, J = 4.0, 13.2 Hz, 1H), 1.70–1.63 (m, 1H), 1.45 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 144.0, 
128.9, 128.3, 126.2, 104.7, 77.1, 73.7, 59.5, 56.1, 42.4, 39.8, 30.5, 25.6, 23.8, 21.7. HRMS (ESI+) calcd 
for C17H25NO3Na [M+Na]+ 314.1732, found 314.1734. 
tert-Butyl (2S,6R)-2-[(2-methyl-1,3-dioxolan-2-yl)methyl]-3-oxo-6-(prop-2-en-1-yl)-1,2,3,6-
tetrahydropyridine-1-carboxylate (53) 
Hemiaminal 28 (826 mg, 2.64 mmol) was dissolved in dry CH2Cl2 (26.6 mL) 
and the solution was brought to −50 °C. Trimethylallylsilane (2.09 mL, 13.2 
mmol) and Sn(OTf)2 (110 mg, 0.264 mmol) were added and the mixture was 
stirred for 4.5 h while the temperature was kept at −50 ºC. After quenching the 
reaction with saturated NaHCO3 solution (25 mL), the mixture was allowed to warm to room 
temperature. The product was extracted with CH2Cl2 (3 × 35 mL) and the combined organic layers 
were dried over Na2SO4 and concentrated in vacuo. The crude product was purified by flash 
chromatography (silica gel, EtOAc/heptane, 1:7 to 1:5) affording olefin 53 (410 mg, 1.22 mmol, 46%) 
as a colorless oil. Rf 0.48 (EtOAc/heptane, 1:1). [α]!!" = −13.2 (c 1.3, CH2Cl2). IR (ATR) ν 2979, 1691, 
1409, 1368, 1345, 1254, 1171 cm−1. 1H NMR (500 MHz, CD3OD, 323 K) δ 7.06 (dd, J = 3.9, 10.5 Hz, 
1H), 6.04 (dd, J = 2.2, 10.5 Hz, 1H), 5.96 (dddd, J = 6.5, 7.8, 10.2, 16.9 Hz, 1H), 5.20 (ddd, J = 1.6, 
3.0, 16.9 Hz, 1H), 5.16 (br d, J = 10.2 Hz, 1H), 4.92 (br s, 1H), 4.69 (br s, 1H), 3.98–3.84 (m, 4H), 
2.72–2.63 (m, 1H), 2.51–2.41 (m, 1H), 2.00–1.95 (m, 2H), 1.50 (s, 9H), 1.38 (s, 3H). 13C NMR (75 
MHz, CD3OD) δ 197.1, 155.7, 150.1, 135.7, 125.5, 118.6, 109.8, 82.3, 65.5, 58.3, 56.6, 54.8, 53.8, 
44.6, 44.0, 40.9, 28.6, 24.3. HRMS (ESI+) calcd for C18H27NO5Na [M+Na]+ 360.1787, found 360.1785. 
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tert-Butyl (2S,6S)-2-[(2-methyl-1,3-dioxolan-2-yl)methyl]-3-oxo-6-(prop-2-en-1-yl)piperidine-1-
carboxylate (54) 
To a solution of Cu(OAc)2·H2O (1.4 mg, 7.0 µmol) in dry toluene (1.76 mL) 
were added triisopropyl phosphite (3.65 µL, 14.0 µmol) and diethoxymethyl 
silane (175 µL, 1.05 mmol). The mixture was stirred for 4 h at room 
temperature until the color changed from blue through light green to light 
brown. A solution of enone 53 (207 mg, 0.613 mmol) in dry toluene (1.76 mL) was added to the 
catalyst solution and the resulting mixture was stirred for 90 minutes at room temperature. The reaction 
was quenched by addition of glacial acetic acid (176 µL, 3.07 mmol) followed by addition of 1 M 
TBAF in THF (920 µL, 0.920 mmol). After stirring for 15 minutes, the mixture was concentrated in 
vacuo and the crude was purified by flash chromatography (silica gel, EtOAc/heptane, 1:6 to 1:3) 
yielding saturated ketone 54 (175 mg, 0.516 mmol, 84%) as a colorless oil. Rf 0.49 (EtOAc/heptane, 
1:1). [α]!!" = +116.7 (c 0.6, CH2Cl2). IR (ATR) ν 2976, 1727, 1687, 1393, 1365, 1162, 1049 cm−1. 1H 
NMR (500 MHz, CD3OD, 323 K) δ 5.86 (dddd, J = 6.5, 7.8, 10.2, 16.9 Hz, 1H), 5.14 (dddd, J = 1.3, 
1.7, 2.0, 17.1 Hz, 1H), 5.07 (dddd, J = 0.8, 1.3, 2.0, 10.2 Hz, 1H), 4.82 (br s, 1H), 4.09–4.00 (m, 1H), 
3.97–3.87 (m, 4H), 2.74 (dddt, J = 1.5, 4.4, 6.4, 13.5 Hz, 1H), 2.45 (dt, J = 4.1, 16.4 Hz, 1H), 2.37–
2.28 (m, 2H), 2.23 (ddt, J = 4.7, 7.0, 14.4 Hz, 1H), 2.06–2.03 (m, 2H), 1.78–1.67 (m, 1H), 1.48 (s, 9H), 
1.36 (s, 3H). 13C NMR (125 MHz, CD3OD, 323 K) δ 211.7, 156.9, 136.4, 117.6, 109.9, 81.8, 65.5, 
59.8, 54.0, 43.9, 42.5, 36.8, 28.7, 28.6, 26.1, 24.3. HRMS (ESI+) calcd for C18H30NO5 [M+H]+ 
340.2124, found 340.2128. 
tert-Butyl (2S,3S,6S)-3-hydroxy-2-[(2-methyl-1,3-dioxolan-2-yl)methyl]-6-(prop-2-en-1-
yl)piperidine-1-carboxylate (55) 
To a stirred solution of ketone 54 (145 mg, 0.42 mmol) in MeOH (4.3 mL) at 0 
°C was added CeCl3·7H2O (239 mg, 0.64 mmol). After 5 minutes, NaBH4 (24 
mg, 0.64 mmol) was added and the reaction mixture was stirred for 1 h at 0 °C. 
The mixture was concentrated in vacuo and purification of the crude by flash 
chromatography (silica gel, EtOAc/heptane, 1:3 to 1:2) yielded alcohol 55 (100 mg, 0.29 mmol, 69%) 
as a colorless oil. Rf 0.31 (EtOAc/heptane, 1:1). [α]!!" = −7.5 (c 1.05, CH2Cl2). IR (ATR) ν 3441, 2977, 
2876, 1686, 1365, 1168, 1043 cm−1. 1H NMR (500 MHz, CDCl3) δ 5.74 (ddt, J = 7.2, 10.1, 14.1 Hz, 
1H), 5.10–4.99 (m, 2H), 4.57 (br s, 1H), 4.36–4.09 (m, 2H), 4.09–3.93 (m, 4H), 3.75–3.63 (m, 1H), 
2.32 (dd, J = 9.0, 14.7 Hz, 1H), 2.33–2.14 (m, 2H), 1.86 (d, J = 14.7 Hz, 1H), 1.73–1.55 (m, 4H), 1.46 
(s, 9H), 1.44 (br s, 3H). 13C NMR (125 MHz, CDCl3) δ 154.9, 136.3, 135.4, 117.1, 109.6, 80.0, 77.7, 
69.1, 64.8, 64.6, 50.3, 41.0, 39.1, 28.6, 24.0, 23.9. HRMS (ESI+) calcd for C18H31NO5Na [M+Na]+ 
364.2100, found 364.2099. n.b. the 13C NMR signal at 50.3 ppm was peak-picked from the HSQC 
spectrum. 
tert-Butyl (2S,3S,6S)-3-[(tert-butyldimethylsilyl)oxy]-2-[(2-methyl-1,3-dioxolan-2-yl)methyl]-6-(2-
oxoethyl)piperidine-1-carboxylate (56) 
 Through a solution of olefin 55 (64 mg, 0.19 mmol) in anhydrous CH2Cl2 
(18.7 mL) at −78 °C was bubbled ozone for 15 min until the mixture turned 
pale blue. Residual ozone was removed by bubbling nitrogen through the 
mixture. Then, triphenylphosphine (75 mg, 0.29 mmol) was added and the 
mixture was stirred for 2 h at −78 °C. The reaction mixture was concentrated 
in vacuo and dry-loaded on silica gel. Purification by flash chromatography (silica gel, EtOAc/heptane, 
1:2 to 1:1) afforded the corresponding aldehyde (63 mg, 68%) as an inseparable mixture with 
triphenylphosphine oxide (70 wt % aldehyde). 1H NMR (400 MHz, CDCl3) δ 9.73 (t, J = 2.5 Hz, 1H), 
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4.89–4.65 (m, 1H), 4.63–4.46 (m, 1H), 4.39–4.15 (m, 1H), 4.04–3.97 (m, 4H), 3.77–3.66 (m, 1H), 2.67 
(ddd, J = 2.8, 6.9, 15.4 Hz, 1H), 2.58 (ddd, J = 2.1, 7.9, 15.4 Hz, 1H), 2.31 (dd, J = 8.9, 14.6 Hz, 1H), 
1.85 (dd, J = 2.4, 14.6 Hz, 1H), 1.86–1.54 (m, 4H), 1.45 (s, 9H), 1.43–1.41 (m, 3H). 
Imidazole (19 mg, 0.28 mmol) and TBDMSCl (21 mg, 0.14 mmol) were added to a solution of the 
aldehyde (38 mg, 0.077 mmol, 70 wt %) in dry DMF (1 mL) at room temperature. After stirring for 24 
hours, the mixture was diluted with EtOAc (1.5 mL) and washed with water (3 × 1 mL). To improve 
layer separation, 0.5 mL brine was added during the first washing stage. The organic layer was then 
dried over Na2SO4 and concentrated in vacuo. The crude product was purified by flash chromatography 
(silica gel, EtOAc/heptane, 1:3) to give TBDMS-ether 56 (23 mg, 0.050 mmol, 44% from 55) as a 
colorless oil. Rf 0.35 (EtOAc/heptane, 1:2). [α]!!" = +26.4 (c 0.9, CH2Cl2). IR (ATR) ν 2955, 2859, 
1725, 1689, 1369, 1113, 1078, 836 cm−1. 1H NMR (500 MHz, CDCl3) δ 9.77–9.73 (m, 1H), 5.06–4.24 
(m, 2H), 3.97–3.81 (m, 4H), 3.69–3.58 (m, 1H), 2.90 (br d, J = 16.6 Hz, 1H), 2.62 (ddd, J = 2.1, 9.1, 
16.6 Hz, 1H), 2.29–2.13 (m ,1H), 1.86–1.75 (m, 1H), 1.71 (dd, J = 13.3, 14.7 Hz, 1H), 1.60–1.50 (m, 
3H), 1.45 (s, 9H), 1.37 (s, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
201.6, 155.2, 110.2, 80.0, 70.3, 64.6, 63.9, 49.4, 43.9, 35.3, 28.5, 28.1, 25.9, 24.7, 23.4, 18.2, 1.16, 
−4.6, −4.7. HRMS (ESI+) calcd for C23H44NO6Si [M+H]+ 458.2938, found 458.2937. 
tert-Butyl (2S,3S,6S)-3-[(tert-butyldimethylsilyl)oxy]-2-[(2-methyl-1,3-dioxolan-2-yl)methyl]-6-
[(2R)-2-hydroxy-2-phenylethyl]piperidine-1-carboxylate (57a) and tert-Butyl (2S,3S,6S)-3-[(tert-
butyldimethylsilyl)oxy]-2-[(2-methyl-1,3-dioxolan-2-yl)methyl]-6-[(2S)-2-hydroxy-2-
phenylethyl]piperidine-1-carboxylate (57b) 
 To a mixture of phenylmagnesium bromide (52 µL, 
0.16 mmol, 3 M in THF) in dry THF (200 µL) at 
−78 °C was dropwise added a solution of aldehyde 
56 (18 mg, 0.039 mmol) in dry THF (300 µL). 
After stirring the resulting mixture for 4 h at −78 
°C, the reaction was quenched by addition of 
saturated NH4Cl (1 mL). The product was extracted with EtOAc (3 × 1.5 mL) and the combined 
organic layers were washed with brine, dried over Na2SO4 and concentrated in vacuo. The crude was 
purified by flash chromatography (silica gel, EtOAc/heptane, 1:5) affording both diastereoisomers 57a 
(5.9 mg, 11 µmol, 28%) and 57b (7.0 mg, 13 µmol, 33%). 
57a was obtained as a colorless oil. Rf 0.46 (EtOAc/heptane, 1:3). [α]!!" = −38.0 (c 0.3, CH2Cl2). IR 
(ATR) ν 3417, 2931, 2858, 1657, 1412, 1364, 1251, 1110, 1079, 837, 775, 701 cm−1. 1H NMR  (500 
MHz, CDCl3) δ 7.42–7.27 (m, 5H), 5.34 (s, 1H), 4.98 (d, J = 10.0 Hz, 1H), 4.56–4.43 (m, 2H), 3.98–
3.88 (m, 4H), 3.69–3.60 (m, 1H), 2.37 (d, J = 14.5 Hz, 1H), 2.30–2.22 (m, 1H), 1.94–1.81 (m, 2H), 
1.58–1.52 (m, 4H), 1.49 (s, 9H), 1.38 (s, 3H), 0.90 (s, 9H), 0.090 (s, 3H), 0.085 (s, 3H). 13C NMR (125 
MHz, CDCl3) δ 157.6, 145.0, 128.3, 126.7, 125.3, 110.3, 80.9, 70.7, 68.6, 64.4, 63.7, 52.8, 46.8, 46.0, 
36.0, 28.9, 28.5, 26.0, 25.3, 22.4, 18.3, −4.7. HRMS (ESI+) calcd for C29H50NO6Si [M+H]+ 536.3407, 
found 536.3400. 
57b was obtained as a colorless oil. Rf 0.26 (EtOAc/heptane, 1:3). [α]!!" = −23.3 (c 0.4, CH2Cl2). IR 
(ATR) ν 3429, 2930, 2858, 1688, 1368, 1255, 1113, 1078, 836, 775, 701 cm−1. 1H NMR (500 MHz, 
CD3OD, 323 K) δ 7.75–7.57 (m, 1H), 7.41–7.18 (m, 4H), 4.60–4.37 (m, 2H), 4.36–4.24 (m, 1H), 3.96–
3.75 (m, 4H), 3.68–3.55 (m, 1H), 2.24–2.11 (m, 2H), 2.03 (ddd, J = 5.2, 9.9, 13.5 Hz, 1H), 1.86 (dd, J 
= 10.8, 14.8 Hz, 1H), 1.82–1.75 (m, 1H), 1.68–1.52 (m, 4H), 1.48–1.44 (m, 9H), 1.36 (s, 3H), 0.92–
0.90 (m, 9H), 0.11–0.08 (m, 6H). 13C NMR (125 MHz, CD3OD, 323 K) δ 146.5, 132.3, 129.4, 128.4, 
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127.2, 111.3, 81.2, 73.7, 72.0, 65.6, 65.0, 49.7, 35.9, 30.4, 28.8, 27.7, 26.3, 25.9, 24.3, 19.0, −4.6, −4.7. 
HRMS (ESI+) calcd for C29H50NO6Si [M+H]+ 536.3407, found 536.3398. 
12-epi-Sedacryptine (58) 
A solution of carbamate 57a (6.3 mg, 12 µmol) in dry THF (500 µL) was 
treated with LiAlH4 (9.0 mg, 0.24 mmol) and the resulting suspension was 
stirred for 24 h at 65 °C under an argon atmosphere. The mixture was then 
cooled to 0 °C and the reaction was quenched by subsequent addition of H2O 
(10 µL), 15% aqueous NaOH (10 µL) and H2O (30 µL). The mixture was stirred for 1 h at room 
temperature and was then filtered over Celite®. The filtrate was concentrated in vacuo affording the 
crude desilylated dioxolane. This was brought in 0.1 M aqueous HCl (750 µL) and the resulting 
mixture was stirred for 1 h at 95 °C. After allowing the mixture to cool to room temperature, it was 
neutralized with aqueous NH4OH (25%) until pH 9–10. The product was extracted with CH2Cl2 (5 × 1 
mL) and the combined organic layers were dried over Na2SO4. Concentration in vacuo afforded the 
crude product, which was purified by flash chromatography (silica gel, 90% CH2Cl2, 5% MeOH, 5% 7 
N NH3/MeOH) affording 58 (2.0 mg, 6.7 µmol, 56%) as a pale yellow oil. Rf 0.17 (EtOAc/MeOH, 
9:1). [α]!!" = +46.5 (c 0.2, CHCl3). IR (ATR) ν 3398, 2933, 2855, 1454, 1023, 761, 702 cm−1. 1H NMR 
(500 MHz, CDCl3) δ 7.40–7.27 (m, 5H), 4.91 (dd, J = 5.5, 7.5 Hz, 1H), 4.04 (apparent d, J = 3.1 Hz, 
1H), 2.61 (t, J = 3.6 Hz, 1H), 2.33 (s, 3H), 2.24 (dd, J = 9.9, 12.3 Hz, 2H), 2.11–1.93 (m, 4H), 1.91 (dd, 
J = 3.9, 13.1 Hz, 1H), 1.66–1.51 (m, 3H), 1.49 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 145.0, 128.8, 
127.9, 126.0, 105.2, 77.7, 72.5, 65.5, 60.7, 53.6, 44.6, 42.7, 40.3, 26.7, 26.0, 25.7. HRMS (ESI+) calcd 
for C17H26NO3 [M+H]+ 292.1913, found 292.1911. 
(−)-Sedacryptine (1) 
 To a solution of carbamate 57b (8.3 mg, 15 µmol) in dry THF (500 µL) was 
added LiAlH4 (9.4 mg, 0.25 mmol) at room temperature. The mixture was 
stirred for 4 h at 65 °C under an argon atmosphere. Another amount of 
LiAlH4 (6.6 mg, 0.17 mmol) was added and the reaction was stirred for 20 h 
at 65 °C. The mixture was then cooled to 0 °C and the reaction was quenched by subsequent addition 
of H2O (16 µL), 15% aqueous NaOH (16 µL) and H2O (48 µL). After stirring the resulting suspension 
for 20 minutes at room temperature, it was filtered over Celite® and the filtrate was concentrated in 
vacuo. The crude dioxolane was brought in 0.1 M aqueous HCl (750 µL) and stirred for 1 h at 95 °C. 
Upon cooling the mixture to room temperature, it was neutralized with aqueous NH4OH (25%) until 
pH 9–10. The product was extracted with CH2Cl2 (5 × 1 mL) and the combined organic layers were 
dried over Na2SO4 and concentrated in vacuo. The crude was purified by flash chromatography (silica 
gel, 90% CH2Cl2, 5% MeOH, 5% 7 N NH3/MeOH) affording (−)-sedacryptine (1.8 mg, 6.2 µmol, 
41%) as a yellow solid. Rf 0.18 (EtOAc/MeOH, 9:1). [α]!!" = −14.0 (c 0.14, CHCl3). IR (ATR) ν 3408, 
2925, 2854, 1670, 1455, 1085, 1007, 761, 701 cm−1. 1H NMR (500 MHz, CDCl3) δ 7.40–7.30 (m, 5H), 
4.86 (dd, J = 3.0, 10.2 Hz, 1H), 4.09 (dd, J = 3.1, 6.1 Hz, 1H), 2.70 (t, J = 3.6 Hz, 1H), 2.36–2.30 (m, 
1H), 2.29 (s, 3H), 2.28–2.17 (m, 2H), 2.10 (ddd, J = 2.9, 5.8, 14.5 Hz, 1H), 2.01 (dd, J = 6.4, 12.2 Hz, 
1H), 1.92 (dd, J = 3.9, 13.0 Hz, 1H), 1.89–1.82 (m, 2H), 1.66–1.53 (m, 3H), 1.49 (s, 3H). 13C NMR 
(125 MHz, CDCl3) δ 145.4, 128.8, 127.9, 125.7, 105.2, 77.7, 71.4, 65.7, 59.8, 44.5, 43.6, 39.9, 26.7, 
25.7, 25.0. HRMS (ESI+) calcd for C17H26NO3 [M+H]+ 292.1913, found 292.1903. 
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7.1 Perspective 
The research described in this thesis, executed as part of the CatchBio program,1 focuses on 
developing novel catalytic methodologies for the conversion of renewables from biomass into 
fuels, chemicals and pharmaceuticals. Regarding chemicals from biomass, two strategies can 
be followed as is shown in Figure 7.1.2 A drop-in strategy relies heavily on existing 
infrastructure by generating common intermediates from biomass that can be directly fed into 
the fossil feedstock stream. In order to make this strategy interesting, a competitive process is 
required for the generation of the particular intermediate. As an alternative, an emerging 
strategy is possible, which is totally detached from the current chemical process chain and the 
renewables from biomass are therefore converted into new chemical targets. Thus, instead of 
aiming at known chemical targets from the fossil feedstock product stream, this strategy 
anticipates on finding new targets by efficiently using the functionalities that are contained in 
the renewables from biomass. Although the emerging strategy brings significant challenges, it 
may also offer great opportunities by giving access to new and unrevealed products. This is 
clearly illustrated by the exemplary case of PEF (polyethylene furanoate). PEF is a plant-
based plastic derived from furandicarboxylic acid and can be directly utilized as a substituent 
for PET (polyethylene terephthalate). The Dutch company Avantium, which is world leading 
regarding PEF production and development, has recently closed a multimillion deal with 
several multinationals in order to make a leap towards commercial scale manufacturing of 
this novel plastic.3 PEF is therefore a typical example of a new innovative product that 
exploits the functionalities offered by the renewable resources from biomass. 
 
Figure 7.1 Two strategies for the conversion of renewables from biomass into target chemicals. 
As demonstrated by the previous example, the emerging strategy offers new opportunities for 
the chemical industry. However, this strategy is less conveniently applied to the 
pharmaceutical industry, primarily because Active Pharmaceutical Ingredients (API’s) are 
specifically designed to exhibit a desired activity and pharmacokinetic profile. Thus, the 
API’s are fixed and therefore the most obvious way to incorporate renewable resources from 
biomass is via the drop-in strategy. Albeit that this strategy is the most logical, it certainly has 
its limitations too. Registration and validation of API production processes are of utmost 
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importance to have the final products released to the market for human intake. By changing 
the starting material, the synthetic pathway of the API should often be revised, which is 
generally associated with costly registration and validation procedures to remain compliant. 
Notwithstanding these additional costs, changing to alternative starting materials often results 
in lower production costs and may therefore eventually turn out to be economically 
beneficial. The work that was described in Chapter 3 may contribute to the field by providing 
new synthetic methodologies for the preparation of enantiomerically pure piperidinone 
building bocks starting from renewables from biomass. The synthetic pathway to the targeted 
piperidinone building blocks might be competitive with the other more established routes to 
similar scaffolds.4 An application of these building blocks was provided in Chapter 6, where 
one of them has been successfully applied in a total synthesis of the natural product (−)-
sedacryptine, underlining that they can indeed give access to more complex enantiomerically 
pure products. 
As mentioned above, it is more straightforward to incorporate renewables from biomass via 
the drop-in strategy, however; the emerging strategy for generating novel pharmaceuticals 
might also be effective. Usually, the development of a drug commences by screening large 
compound libraries on their activity against the biological target of interest. By simply 
extending these libraries with compounds that are derived from biomass, the probability will 
increase that one of them will emerge as a potential lead compound and eventually may result 
in a commercial product. The furfural-derived scaffolds that were synthesized in Chapters 4 
and 5 are certainly relevant for this purpose. Because their bicyclic frameworks resemble the 
structural skeleton of biologically active tropane alkaloids, it is anticipated that these 
scaffolds might also exhibit some form of biological activity. 
The scaffolds that were synthesized in this thesis are all derived from furfural, and require 
multiple reaction steps involving reagents which are not derived from biomass. Therefore, 
new, preferably catalytic methodologies have to be developed in order to efficiently 
synthesize the targeted scaffolds without the need to rely on reagents derived from fossil 
feedstocks. For this reason, we initially investigated iron-based chiral Lewis acids for the 
activation of imines (see Chapter 1). However, to create asymmetric induction in reactions 
with imines by means of a chiral iron complex appeared more difficult than anticipated. 
These findings are in line with the rather limited number of reports on iron-based asymmetric 
imine activation that have been published since we abandoned this topic two years ago.5 
The work described in this thesis only aims at reactions using furfural as a starting material, 
but there are of course many other renewables from biomass that may give access to 
pharmaceutically relevant building blocks as well.6 The current major renewable resource 
from biomass is lignocellulose, which is composed of lignin, cellulose and hemicellulose and 
is obtained from forestry remains and agricultural waste. Lignin, a polymeric network of 
phenols, is considered the most potential resource for aromatics from biomass.7 However, 
conversion of lignin into small molecules that could be used as starting material for the 
chemical industry remains difficult. On the other hand, the cellulosic and hemicellulosic 
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components of lignocellulose can be readily converted into platform chemicals (i.e. succinic 
acid and lactic acid) via chemical transformation or fermentation.6c Since oxygen is highly 
abundant in these platform chemicals, introduction of nitrogen, for example via the 
organocatalyzed Mannich reaction, may turn these chemicals into pharmaceutically relevant 
building blocks. As an example, ethyl levulinate (1), which is directly derived from the plant-
based platform chemical levulinic acid, can be used for the asymmetric Mannich reaction 
with imine 2 (Scheme 7.1). An initial experiment showed that β-amino ketone 3 was 
successfully obtained in good yield and excellent ee. Subsequent cyclization under acidic 
conditions gave access to γ-lactam 4, which may be considered another potentially useful and 
synthetically versatile building block from biomass. 
 
Scheme 7.1 Organocatalyzed Mannich reaction of ethyl levulinate 1 and subsequent lactamization of 3. 
7.2 Outlook 
The identification of a number of basic platform chemicals derived from biomass has been an 
important step, since it has offered the chemical community handles to investigate the 
synthetic potential of these compounds.6 I am convinced that we should focus further efforts 
on investigating new lead compounds based on renewable sources instead of elaborating on 
the so-called drop-in strategy. As an integral part of this, identifying tailor-made catalysts for 
the conversion of renewables from biomass is required. Furthermore, newly synthesized 
pharmaceutically relevant building blocks from biomass should be made available to the 
pharmaceutical industry by adding them to (public) compound libraries (e.g. the European 
Lead Factory library). Finally, I expect that major breakthroughs such as PEF, will be 
obtained in the field of polymer and material science. For example, when lignin refinement 
becomes feasible, the compounds that can be isolated therefrom will enable the preparation of 
new classes of molecules that were before practically unavailable from fossil feedstocks. 
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Summary 
Fossil, oil-based feedstocks are mainly used for the production of energy, but also serve as the 
main source of starting materials for the fine chemical and pharmaceutical industry. Since 
these resources are at an increasing rate being depleted, it is a true societal challenge to 
globally change from an oil-based economy, to a sustainable renewable biomass-based 
economy. This holds for both the production of energy, and the production of commodity and 
fine chemicals. To address this challenge at a national level, a public-private consortium of 
academic and industrial partners was established, coined CatchBio (Catalysis for Sustainable 
Chemicals from Biomass), aiming at the development of new catalytic methodologies for the 
conversion of renewable sources from biomass into useful fuels, chemicals and pharma 
intermediates. The work described in this thesis has been conducted within this framework 
focusing on the development of new methodology for the preparation of pharmaceutically 
relevant building blocks from biomass. 
Based on the original project plan, we investigated novel catalytic approaches for the 
asymmetric functionalization of imines using iron-based chiral Lewis acids of which the 
results are briefly discussed in Chapter 1. It was our goal to induce enantioselectivity in 
(hetero-) Diels–Alder reactions by using combinations of iron salts and chiral ligands. 
Unfortunately, these attempts solely resulted in racemic mixtures of the anticipated products 
and the initial plans were therefore revised. 
From that moment, we focused on the preparation of enantiomerically pure building blocks 
from biomass by relying on organocatalytic strategies. More specifically, we identified 
furfural-derived imines as suitable electrophilic reaction partners in organocatalyzed Mannich 
reactions. The resulting 2-furanyl amines were deemed excellent substrates for the aza-
Achmatowicz reaction, in which the furan moiety is oxidatively rearranged into a highly 
functionalized piperidinone (Scheme 1). A comprehensive overview of aza-Achmatowicz 
reactions that have been reported in literature is provided in Chapter 2. 
 
Scheme 1 The Aza-Achmatowicz reaction. 
Chapter 3 describes the application of the proline-catalyzed Mannich reaction in the 
preparation of enantiomerically pure 2-furanyl amines. Screening of several nitrogen 
protective groups showed that the highest selectivities were obtained by using the N-Boc-
protected imine 4 as the Mannich acceptor (Scheme 2). By reacting various aldehydes 3 with 
imine 4, several β-amino aldehydes were successfully prepared in a highly stereoselective 
manner. Upon in situ reduction with NaBH4, the resulting Mannich products were isolated as 
primary alcohols 5. These enantiomerically pure 2-furanyl amines were subsequently treated 
with m-CPBA in the aza-Achmatowicz reaction to afford the ring-expanded products as 
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bicyclic hemiacetals 6. To explore the suitability of these species as potential building blocks, 
modification via nucleophilic addition to the in situ formed N-acyliminium ion 8 was further 
investigated. It was observed that the highest diastereoselectivities were obtained when these 
additions were conducted on the N-acyliminium ions derived from acetylated aza-
Achmatowicz products 7. Furthermore, the selectivity of the addition appeared highly 
dependent on the steric nature of the silane nucleophiles being used. 
 
Scheme 2 Preparation of building blocks 6 and modification of 7 via the corresponding N-acyliminium ion 8. 
The 6-aza-8-oxa[3.2.1]bicyclooctane moiety is a structural motif that is encountered in a 
number of natural products. Chapter 4 describes the preparation of N,O-acetals 14 containing 
this structural motif starting from furfural-derived amino alcohol 11 (Scheme 3). It was 
envisioned that these bicyclic N,O-acetals could be opened via either the N-acyliminium or 
the oxycarbenium ion resulting in azepanes 15 or pyranones 16, respectively. Bicyclic N,O-
acetals 14 were hence treated with allyltrimethylsilane in the presence of BF3·Et2O. It was 
observed that under these conditions, the N,O-acetal was selectively opened via the 
oxycarbenium ion to form the corresponding pyranones 16 in a highly diastereoselective 
manner (d.r. >1:20). When the intermediate oxycarbenium ion was reacted with other silane 
nucleophiles, the corresponding products were obtained in similarly high 
diastereoselectivities. 
 
Scheme 3 Synthesis and opening of bridged bicyclic N,O-acetals 13 and 14. 
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In extension of the work described in Chapter 4, Chapter 5 discusses the preparation of 
bicyclic bridged N,N-aminal 20 via a similar approach starting from amino alcohol 17 
(Scheme 4). The resulting scaffolds can be considered as 6-aza analogues of the tropane 
skeleton and might be of interest due to their potential biological activity. First, the 
orthogonally protected furanyl diamine 18 was prepared from amino alcohol 17, which 
smoothly underwent aza-Achmatowicz reaction upon treatment with NBS. Cyclization under 
Lewis acidic conditions of the in situ formed N-sulfonyliminium ion afforded the desired 
bicyclic scaffold. Initial experiments showed that the resulting bicyclic bridged N,N-aminal 
can be selectively desulfonylated rendering the liberated nitrogen susceptible for further 
functionalization (i.e. alkylation). 
 
Scheme 4 Synthesis of aza-tropane analogue 20. 
In Chapter 6, the methodology discussed in Chapter 3 has been successfully applied on a 
total synthesis of (−)-sedacryptine (23). Functionalization of aza-Achmatowicz product 21 
using allyltrimethylsilane afforded cis-disubstituted piperidinone 22, which could 
subsequently be converted into (−)-sedacryptine (23) and epimer 24. When aza-Achmatowicz 
product 21 was reacted with the silyl enol ether of acetophenone, trans-disubstituted 
piperidinone 25 was obtained which could ultimately be transformed into 4-epi-sedacryptine 
(26). 
Chapter 7 contains a personal reflection on the future use of biomass within the chemical 
industry. 
 
Scheme 5 Total synthesis of (−)-sedacryptine (23) and epimers 24 and 26. 
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Samenvatting 
Fossiele, op olie gebaseerde grondstoffen, worden hoofdzakelijk gebruikt voor het opwekken 
van energie, maar vormen daarnaast ook de benodigde uitgangsstoffen voor de fijnchemische 
en farmaceutische industrie. Aangezien deze fossiele bronnen in een steeds hoger tempo 
uitgeput raken, ligt er de uitdaging om wereldwijd van de huidige, op olie gebaseerde 
economie, over te stappen op een duurzame economie gebaseerd op biomassa. Dit geldt voor 
zowel het opwekken van energie, alsook voor de productie van chemicaliën. Om dit op 
nationaal niveau aan te pakken, is het publiek-private onderzoeksprogramma CatchBio 
(Catalysis for Sustainable Chemicals from Biomass) opgericht met als doel het ontwikkelen 
van nieuwe katalytische processen voor de omzetting van duurzame grondstoffen uit 
biomassa in energie, (bulk)chemicaliën en farmaceutische intermediairen. Het werk dat 
beschreven staat in dit proefschrift is uitgevoerd binnen dit onderzoeksprogramma en is 
gericht op het onderzoeken van nieuwe methoden voor de synthese van farmaceutisch 
relevante bouwstenen uitgaande van hernieuwbare grondstoffen uit biomassa. 
Op basis van het oorspronkelijke onderzoeksvoorstel is een nieuwe katalytische methode 
onderzocht voor het asymmetrisch functionaliseren van iminen gebruik makend van chirale 
ijzer gebaseerde Lewiszuren. In Hoofdstuk 1 staan de resultaten van dit werk beknopt 
beschreven, waarbij enantioselectieve (hetero-) Diels–Alder reacties werden uitgevoerd door 
gebruik te maken van verschillende combinaties van ijzercomplexen en chirale liganden. 
Ondanks dat verschillende katalysatoren en substraten zijn getest, zijn de producten in geen 
van de gevallen enantiozuiver, danwel enantioverrijkt verkregen. 
Vervolgens is besloten om de oorspronkelijke plannen te wijzigen en te kijken naar een 
organokatalytische benadering voor de bereiding van enantiomeerzuivere bouwstenen uit 
biomassa. Iminen afgeleid van furfural leken ons geschikte electrofiele reactiepartners voor 
organogekatalyseerde Mannich reacties. De 2-furanylaminen die hieruit voortkomen zijn 
ideale substraten voor de aza-Achmatowicz reactie, waarin de furanring oxidatief wordt 
omgezet in een gefunctionaliseerd piperidinon (Schema 1). In Hoofdstuk 2 wordt een 
compleet overzicht gegeven van aza-Achmatowicz reacties die beschreven zijn in de 
literatuur. 
 
Schema 1 De aza-Achmatowicz reactie. 
Hoofdstuk 3 beschrijft de toepassing van de proline gekatalyseerde Mannich reactie voor de 
bereiding van enantiomeerzuivere 2-furanylaminen. Een studie naar de invloed van de 
stikstofbeschermgroep in de Mannich reactie, wees uit dat de hoogste selectiviteit werd 
behaald door N-Boc beschermd imine 4 als substraat te gebruiken (Schema 2). Vervolgens 
zijn verschillende enantiomeerzuivere β-aminoaldehyden bereid door diverse aldehyden (3) 
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met imine 4 te laten reageren. De Mannich producten zijn geïsoleerd als de overeenkomstige 
primaire alcoholen na onmiddellijke reductie met NaBH4. Door de geïsoleerde 
enantiomeerzuivere 2-furanylaminen met m-CPBA te laten reageren konden de beoogde aza-
Achmatowicz producten worden verkregen als de bicyclische hemiacetalen 6. Om de 
toepasbaarheid van deze verbindingen als potentiële bouwstenen te beproeven, zijn deze 
vervolgens gemodificeerd via nucleofiele aanval op het in situ gevormde N-acyliminiumion 8. 
De hoogste diastereoselectiviteit werd behaald, wanneer deze reacties werden uitgevoerd op 
het N-acyliminiumion afgeleid van het geacetyleerde aza-Achmatowicz product 7. Daarnaast 
bleek de selectiviteit van de additie in hoge mate afhankelijk van de sterische aard van het 
gebruikte nucleofiel. 
 
Schema 2 De bereiding van bouwsteen 6 en de modificatie van 7 via N-acyliminium ion 8. 
Het 6-aza-8-oxa[3.2.1]bicyclooctaan fragment komt voor in een aantal natuurproducten. 
Hoofdstuk 4 gaat nader in op de synthese van N,O-acetalen 14 die dit fragment bevatten, 
waarbij werd uitgegaan van het van furfural afgeleide aminoalcohol 11 (Schema 3). Er werd 
aangenomen dat deze bicyclische N,O-acetalen konden worden geopend via het N-
acyliminiumion danwel het oxycarbeniumion, wat zou leiden tot respectievelijk het 
overeenkomstige azepaan 15 of pyranon 16. Behandeling van het bicyclisch N,O-acetaal 14 
met allyltrimethylsilaan en BF3·Et2O leidde vervolgens tot de selectieve opening van het N,O-
acetaal via het oxycarbeniumion onder vorming van pyranon 16. Het product werd met zeer 
hoge diastereoselectiviteit (d.r. > 1:20) gevormd. Gebruik van andere silaannucleofielen 
leverde de overeenkomstige producten op met een vergelijkbaar hoge diastereoselectiviteit. 
 
Schema 3 Synthese en opening van de gebrugde bicyclische N,O-acetalen 13 en 14. 
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Voortbordurend op het werk uit Hoofdstuk 4, is in Hoofdstuk 5 de synthese van bicyclisch 
N,N-aminaal 20 via een vergelijkbare benadering beschreven uitgaande van aminoalcohol 17. 
De zo ontstane bouwsteen kan beschouwd worden als een 6-aza-analogon van het 
tropaanskelet en daarom interessant vanwege zijn potentiële biologische activiteit. De 
synthese begint met de bereiding van het orthogonaal beschermde furanyldiamine 18 vanuit 
aminoalcohol 17, waarna reactie met N-broomsuccinimide het gewenste aza-Achmatowicz 
product oplevert. Ringsluiting door behandeling met een Lewiszuur vervolgens geeft via het 
in situ gevormde N-sulfonyliminiumion de beoogde bicyclische bouwsteen 20. Uit initiële 
experimenten blijkt dat bicyclisch N,N-aminaal 20 selectief gedesulfonyleerd kan worden, 
waarna het ontschermde stikstofatoom in potentie kan worden gebruikt voor het introduceren 
van functionele groepen (bijvoorbeeld via alkylering). 
 
Schema 4 Synthese van aza-tropaan-analogon 20. 
In Hoofdstuk 6 wordt de methode zoals beschreven in Hoofdstuk 3 succesvol toegepast in de 
totaal synthese van (−)-sedacryptine (23). Na functionaliseren van aza-Achmatowicz product 
21 met allyltrimethylsilaan, is het daaruit voortkomende cis-gesubstitueerde piperidinon 22 
omgezet in (−)-sedacryptine (23) alswel in epimeer 24. Wanneer men aza-Achmatowicz 
product 21 laat reageren met de silylenolether van acetofenon, wordt het trans-
gesubstitueerde piperidinon 25 gevormd, datvervolgens in een aantal stappen omgezet in 4-
epi-sedacryptine (26). 
Hoofdstuk 7, tenslotte, behelst een persoonlijke reflectie op het toekomstige gebruik van 
biomassa in de chemische industrie. 
 
Schema 5 Totaalsynthese van (−)-sedacryptine (23) en epimeren 24 en 26. 
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Dankwoord 
Na de master organische chemie was het voor mij helemaal duidelijk. Ik wilde gaan 
promoveren, maar dan wel in de synthetisch organische chemie. Toen de mogelijkheid zich 
voordeed om in de groep van Floris Rutjes op een synthetisch project aan de slag te gaan, 
twijfelde ik dan ook geen moment. Floris, ik ben je erg dankbaar dat je me de kans hebt 
gegeven een promotie in jouw groep te doen. Jouw manier van begeleiden waarbij je veel 
vrijheid en vertrouwen naar de promovendus uitstraalt heb ik altijd als erg plezierig ervaren. 
Ik denk mede hierdoor dat dit proefschrift als écht van mij aanvoelt. Floris van Delft, jou ben 
ik dankbaar voor de kritische noot en je ideeën tijdens de werkbesprekingen. Daarbij heb ik 
nog veel van je commentaar op het manuscript mee kunnen nemen wat heeft geresulteerd in 
een naar mijn idee zichtbaar verbeterde versie van dit proefschrift. 
Tevens wil ik prof. dr. Binne Zwanenburg, dr. Dennis Löwik en prof. dr. Henk Hiemstra 
bedanken voor het lezen van het manuscript en het zitting nemen in de manuscriptcommissie. 
Enkele keren per jaar werd de reis naar Nunspeet of het fraaie Lunteren gemaakt om acte de 
présence te geven bij de periodieke CatchBio meetings. Graag wil ik Pedro Hermkens, Gerjan 
Kemperman, Hans de Vries, Paul Alsters, Bernard Kaptein, Lavinia Panella en Michèlle 
Janssen bedanken. Jullie ideeën en feedback op mijn werk hebben beslist een postieve invloed 
gehad op de totstandkoming van dit proefschrift. 
Studenten tijdens een promotie zijn een soort gewassen. Eerst dien je te zaaien, dan goed te 
verzorgen om vervolgens te kunnen oogsten. Peter, nog voordat ik de spreekwoordelijke 
akker heb kunnen ploegen, kwam jij een maand nadat ik met mijn promotie was begonnen 
een stage lopen. Aangezien ik destijds nog erg zoekende was binnen de ijzer chemie, hebben 
we jou aan de aza-Achmatowicz reactie laten werken. Uiteindelijk heeft dit werk de basis 
gevormd voor Hoofdstuk 3 en daarmee in zekere zin ook voor de rest van het proefschrift. 
Het mag duidelijk zijn dat jij je stage niet op reguliere wijze bent doorlopen en ik vind het 
daarom des te knapper dat je het uiteindelijk toch allemaal netjes hebt kunnen afronden. 
Remco, ook jou wil ik bedanken voor je inzet. Ondanks dat de gehoopte successen uitbleven 
komt jouw werk toch nog even voorbij in dit proefschrift. Tot slot waren daar ineens Robert, 
Ruben en Gaston. Het kostte wat tijd, drie studenten die binnen een tijdsbestek van enkele 
weken begonnen met hun stage. Uiteindelijk is het het dubbel en dwars waard geweest en was 
de oogst goed. Veel van jullie werk is uiteindelijk dan ook opgenomen in dit proefschrift. 
Bedankt voor jullie inzet en de plezierige sfeer die jullie op het lab brachten. 
Jorgen en Henri, het zou er de schijn naar kunnen hebben dat ik in mijn keuze van mijn 
paranimfen enigszins gedirigeerd zou zijn. Het valt immers geheel binnen het 
verwachtingspatroon dat wij ons voor de derde keer als drietal in een rokkostuum gaan hijsen. 
Niets is echter minder waar! Mijn keuze is volstrekt autonoom en ik ben dan ook erg blij en 
trots dat jullie aan mijn zijde in de aula zullen verschijnen. 
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Hoewel een promotie een tamelijk solistische exercitie is, geven collega’s toch op significante 
wijze kleur hieraan. Ik wil daarom met name de volgende mensen bedanken voor hun 
bijdrage aan de goede sfeer in en om het lab: Roseri, Lieke, Bas Ritzen, Bas van den Broek, 
Jorge, Marloes, Ryan, Candice, Marjoke, Rinske, Angelique, Mariëlle, René Brinkhuis, 
Matthijs, Bram, Stefan, René Steendam, Thomas, Dani en ook Alejandra, Ivan, Peter, 
Sebastian en Catherina. Willem-Jan, bedankt voor je interesse in mijn werk en je ideeën over 
de potentiele ELF-waardige verbindingen die in Hoofdstuk 5 beschreven staan. 
Verder is het het vaste personeel onmisbaar voor het volbrengen van een promotieonderzoek. 
Voor de praktische zaken op het lab stonden Jan Dommerholt, René Aben en Theo Peters dan 
ook altijd klaar. Peter van Galen, Helene Amatdjais-Groenen, Ad Swolfs en Paul Schlebos 
zorgden ervoor dat het analytische machinepark ten alle tijden bleef functioneren en voor de 
overige zaken of gewoon een praatje stond de deur bij Jacky of Peter van Dijk altijd open. 
Martin Feiters, bedankt voor je hulp bij de interpretatie van de EPR spectra van de vermeende 
ijzercomplexen en natuurlijk voor je nuttige inbreng tijdens werkbesprekingen. Ook wil ik 
René de Gelder en Martin Lutz (Universiteit van Utrecht) bedanken voor hun hulp en 
expertise bij het bepalen van de kristalstructuren. 
En dan is er nog het thuisfront. Anton en Anjo en de rest van de familie, bedankt voor het 
warme nest dat jullie altijd hebben geboden. De deur staat altijd open en ondanks dat er nooit 
een punt van is gemaakt, hoop ik echt dat ik binnenkort die rode auto eens mee naar huis kan 
nemen. 
Pap en mam (en Paul natuurlijk), de laatste jaren is er veel veranderd maar desondanks bleef 
de interesse onverminderd voor waar datgene waar ik me in Nijmegen mee bezig hield. 
Bedankt daarvoor en ik ben erg trots op de manier hoe jullie het samen doen. 
Mijn laatste woorden van dank gaan uit naar Willeke. Ik heb me tijdens mijn promotie immer 
door je gesteund gevoeld. Zij het niet door een luisterend oor te bieden dan was het wel door 
me de ruimte te geven die ik verlangde. Dit zal misschien niet altijd even leuk zijn geweest, 
maar weet dat ik er iedere dag enorm van geniet om met jou door het leven te gaan. 
Ferdi 
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